<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2026-01-05 09:24:55 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>136</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>74</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="Severe pneumonia is associated with an increased risk of cognitive decline and dementia, particularly in the elderly. Changes in microglia, the most abundant immune cell population in the brain, are also associated with cognitive decline and dementia, including the emergence of a transcriptional cell state referred to as disease-associated microglia (DAM). We sought to test the hypothesis that non-neuroinvasive influenza A virus (IAV) pneumonia results in transcriptional responses in brain microglia that drive premature expansion of DAM. Using bulk and single-cell RNA-sequencing, metabolomics, and spatial transcriptomics, we profiled neuroimmune populations in young, middle-aged, and old male mice during IAV infection and recovery. We observed an increased abundance of DAM, interferon-responsive microglia (IRM), CD4+ T cells, and CD8+ T cells in white matter regions beginning in middle age and persisting in old animals, irrespective of IAV infection. DAM exhibited a metabolic shift toward aerobic glycolysis with disrupted TCA cycling, citrulline depletion, and an elevated itaconate/α-ketoglutarate ratio. Spatial transcriptomic profiling of the human middle frontal gyrus (MFG) in normal agers, SuperAgers, and patients with dementia revealed an analogous accumulation of DAM and CD8+ T cells in white matter. IAV pneumonia induced a transient immunosenescent-like response in microglia, marked by glucocorticoid-responsive gene expression and Ccnd3 upregulation. In response to IAV pneumonia, DAM expanded in middle-aged mice, whereas old mice were elevated at baseline and were largely unaffected by IAV infection. The age-related expansion of DAM was unaffected by pharmacological depletion and repopulation of microglia with a CSF1R antagonist or genetic gain or loss of function of the phagocytic receptor MERTK, suggesting the DAM phenotype is driven by the CNS microenvironment, rather than cell-intrinsic mechanisms. Our findings suggest that IAV pneumonia induces an acute immunosenescence response in microglia and accelerates the age-dependent expansion of DAM in white matter.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fda447848e1da3e24e80cd9f6f09a302a4923b4" target='_blank'>
              Influenza A infection accelerates disease-associated microglia formation during physiological aging
              </a>
            </td>
          <td>
            R. Grant, C. Runyan, Grace Minogue, J. Stoolman, Satoshi Watanabe, Fei Chen, Karolina J. Senkow, L. Cusick, M. Schleck, R. Nafikova, Ziyan Lu, E. Bunyan, H. Abdala-Valencia, Jacob I. Sznajder, Robert J. Vassar, Rudy J Castellani, Changiz Geula, T. Gefen, Navdeep S. Chandel, A. Misharin, G. S. Budinger
          </td>
          <td>2025-12-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="COVID-19 vaccines provide robust protection against severe disease, hospitalization, and death. Neutralizing antibodies are a strong correlate of protection and can prevent SARS-CoV-2 infection of the lungs. We used a conventional laboratory mouse model combined with high- or low-dose vaccination to understand the early immunological response following SARS-CoV-2 infection in the lungs of vaccinated mice. The lungs of high-dose vaccinated mice were completely protected against SARS-CoV-2 infection whereas low-dose vaccinated mice were partially protected. We observed a greater influx of total monocytes, macrophages, dendritic cells, neutrophils, and eosinophils in the lungs of low-dose vaccinated mice compared to naïve infected mice. The different proportions of innate immune cells in the lungs indicated that infection in low-dose vaccinated mice induces a unique inflammatory environment compared to naïve infected or uninfected mice. A prominent feature of infection of low-dose vaccinated mice was infiltration of eosinophils in the lungs, which we observed across different COVID-19 vaccines and SARS-CoV-2 variants. Single cell transcriptional profiling of lung parenchymal immune cells showed that viral RNA was predominantly associated with eosinophils. Eosinophils from low-dose vaccinated mice were transcriptionally distinct from naïve mice after challenge and showed an IFN-γ biased signature. Further, monocytes from low-dose vaccinated mice expressed eotaxin-2, suggesting a monocyte-eosinophil signaling axis. Antibody mediated depletion of eosinophils in low-dose vaccinated mice resulted in increased virus replication and dissemination in the lungs. These findings demonstrate the protective nature of eosinophils during SARS-CoV-2 infection in the context of vaccination and highlight quantitative and qualitative differences in the immune response in a model for vaccine breakthrough infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/206331da0365bbfba8d623c1563fc323742af9bb" target='_blank'>
              Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2
              </a>
            </td>
          <td>
            Kathryn M. Moore, Stephanie L. Foster, Meenakshi Kar, K. Floyd, Elizabeth J. Elrod, M. E. Williams, Jacob Vander Velden, M. Ellis, Ansa Malik, B. Wali, Stacey A. Lapp, Amanda Metz, S. Bosinger, Vineet D. Menachery, Robert A. Seder, R. Amara, Jacob E. Kohlmeier, Arash Grakoui, M. Suthar
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="Cytomegalovirus is the leading viral cause of congenital infection with neurological sequelae. Effective medical treatments are limited due to an inadequate understanding of the underlying pathogenesis. Here, we applied single-cell transcriptomics to analyze neonatal mouse brains with congenital cytomegalovirus infection (cCMV). We profiled cCMV in 22 cell types and identified neural progenitor cells (NPCs) and monocyte-derived macrophages (MDMs) as the most commonly infected cells. Infected NPCs exhibited dysregulated neurodevelopment-associated signaling pathways, correlating with viral transcript levels that indicate viral replication levels. Genes associated with phagocytosis and antigen presentation were downregulated exclusively in infected MDMs but remained largely unaffected in microglia and barrier-associated macrophages regardless of infection status. Analysis of intrinsic and induced interferon-stimulated gene expression revealed great heterogeneity across cell types but no direct correlation with cCMV susceptibility. Furthermore, our findings indicate that interferon type II is crucial for the control of cCMV and consequent cortical damage and calcification in the neonatal brain. This study advances our understanding of cCMV tropism and the molecular details of cCMV-induced neurodevelopmental impairment, cerebral immune response, and brain pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37e868bb50c4bf02ba4bc61b84aaec7d5968b07e" target='_blank'>
              Molecular features of congenital cytomegalovirus infection in neonatal mouse brain at single-cell resolution
              </a>
            </td>
          <td>
            Meng-Jie Mei, Yue-Peng Zhou, Yu-Ting Pan, Jin-yan Sun, Wen-Bo Zeng, Tong Wu, M. McVoy, William J. Britt, Wen Zhou, Bo Yang, Xuan Jiang, Simon Rayner, Han Cheng, Min-Hua Luo
          </td>
          <td>2025-11-17</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ebc988a2e535f97628e98387b125e8c2474e58f" target='_blank'>
              A CAR-T Cell-Based Strategy for Eliminating Pathogenic Microglia in ALS
              </a>
            </td>
          <td>
            M. Cicardi, Daniela Tejada-Martinez, S. Markandaiah, Karthik Krishnamurthy, Chiara Scopa, Brij Oza, Ivette Martorell Serra, Andrea Feci, Edoardo Manca, Adam E. Snook, A.R. Haeusler, P. Pasinelli, Davide Trotti
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Abstract After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a minority of patients experience persistent or emerging symptoms, termed ‘long coronavirus disease (COVID)’ or post-acute sequelae of COVID-19. The molecular causes of long COVID remain unclear, but disrupted immune functions, such as inflammation and immune deficit, have been posited as factors. In this retrospective cohort study, we measured markers of immune function in a group of patients with long COVID up to 40 months post infection. As proxies for immune function, we measured serum antibody levels, antibody neutralizing capability and production of IFN gamma (IFN-γ) and IL-2 against SARS-CoV-2 and other viral peptides. As expected, serum antibody levels increased over time with vaccinations and reinfections with later variants of SARS-CoV-2. Patients also showed corresponding increasing SARS-CoV-2-specific IL-2 responses and stable IFN-γ responses. We observed no significant differences in immune responses among patients with ongoing long COVID, those who had recovered from it or individuals who recovered from acute COVID-19. Overall, we found no indication of a reduction in these aspects of immune function after SARS-CoV-2 infection. This study provides a valuable foundation for further research aimed at understanding the causes of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd9f2a9af816e4527bff007fe6bd487c949ce190" target='_blank'>
              Robust antibody and T cell responses tracked longitudinally in patients with long COVID
              </a>
            </td>
          <td>
            M. Metaxaki, Ranjana Ram, Marianne Perera, Mark Wills, Ben Krishna, N. Sithole
          </td>
          <td>2025-12-01</td>
          <td>The Journal of General Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a leading cause of global morbidity and mortality. Although gamma-delta (γδ) T cells have increasingly been suggested to contribute to the TB immune response, quantitative and qualitative differences in this immune cell compartment between healthy and TB diseased individuals are not well-characterized. In this study, we used single-cell RNA sequencing to provide a high-resolution characterization of CD4-CD8- γδ T cells in peripheral blood across healthy Mtb-non-sensitized, healthy Mtb-sensitized, and TB disease pre-/post-treatment cohorts. We found upregulation of an activated and cytotoxic gene signature in γδ T cells of TB disease compared to both healthy cohorts. Strikingly, these differences persisted through one year following diagnosis of TB disease (corresponding to six months after completion of anti-TB therapy). We found that these transcriptomic differences were largely mediated by an NK-like cytotoxic Vδ1 and Vδ3 subset that was enriched in TB disease, with a unique Vδ3 TCR gene usage. Our findings suggest long-lasting changes in the CD4-CD8- γδ T cell compartment and highlight Vδ3 cells, a previously underappreciated γδ T cell subset, as potentially important in TB.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bfebb60d4d4f02fb39194b81fd4a071f887608f9" target='_blank'>
              Enrichment of a CD4−CD8− NK-like cytotoxic Vδ1/3 T cell subset in tuberculosis disease
              </a>
            </td>
          <td>
            Kendall Kearns, R. Tippalagama, Ashu Chawla, Jason A. Greenbaum, A. D. de Silva, Wathsala Gunasinghe, Judy Perera, Hansani Gunasekera, Darsha D Senevirathne, Thomas J. Scriba, Julie G. Burel, C. L. Lindestam Arlehamn, Bjoern Peters
          </td>
          <td>2025-11-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Chronically inflamed, reactive microglia represent a prominent feature of secondary progressive multiple sclerosis (SPMS). Especially their interplay with encephalitogenic T cells promotes neuroaxonal damage associated with disease progression. In our study, we aimed to explore the potential of siponimod, a sphingosine-1-phosphate modulator approved for the treatment of active SPMS, to inhibit disease-associated T cell-microglia interactions using a chronic murine experimental autoimmune encephalomyelitis (EAE) model of MS. We found that therapeutic siponimod treatment of chronic EAE improved clinical severity accompanied by reduced demyelination and neuroaxonal damage, diminished CNS T cell infiltration and altered proinflammatory microglia responses. This effect was partly attributed to a direct effect on microglia, as siponimod pretreatment inhibited interferon-γ-elicited responses of primary mouse microglia in vitro and limited their ability to induce T cell activation and proliferation in T cell-microglia co-cultures. Additionally, we observed reduced peripheral T cell numbers in our EAE model, with a pronounced shift to immunosenescent and regulatory T cell subsets, a pattern which we similarly detected in a cohort of SPMS patients following siponimod treatment. These findings indicate that siponimod dampens compartmentalized CNS inflammation by disrupting detrimental interactions between T cells and microglia through a dual central and peripheral mechanism of action.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/83f2db773998fbd7481c31e492b0b69aae1f4480" target='_blank'>
              Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis
              </a>
            </td>
          <td>
            Leila Husseini, Anastasia Geladaris, Marlene C. J. Steinleitner, Darius Häusler, Martin S. Weber
          </td>
          <td>2025-12-01</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/674509938f9c563edb49d12a46467f6b4538fa2f" target='_blank'>
              Single-Cell Dissection of Immunometabolic Rewiring in the Porcine Ileum during Salmonella Typhimurium Infection
              </a>
            </td>
          <td>
            José M. Suárez-Cárdenas, Tomàs Montserrat-Ayuso, Mónica Alfonso-Núñez, A. Esteve-Codina, Raúl Fernández-Rodríguez, Antonio Romero-Guillén, Tránsito García-García, Cristina Arce, Amparo Martínez Martínez, Juan J. Garrido, S. Zaldívar-López
          </td>
          <td>2025-12-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c559472c33293babdbbd5dda4f528462a56a71a7" target='_blank'>
              Meningeal γδ T cells facilitate bacterial entry into the brain in neonatal meningitis and trigger long-term behavioural sequelae
              </a>
            </td>
          <td>
            Inês Lorga, Joana Soares, Joana Bravo, Pedro Mesquita, Nuno Ribeiro, João Rodrigues, Ahmed Hassan, Morgana Mesquita, Bruno Cavadas, Hristo Georgiev, Ana Magalhães, T. Summavielle, Manuel Vilanova, J. Ribot, Elva Bonifácio Andrade
          </td>
          <td>2025-11-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab1f2f4806c4c9f5ee207406f2f653b5c11d67d7" target='_blank'>
              Persistent CD4+ T cell functional deficits during recovery from prolonged symptomatic SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Jadith Ziegler, Christina Lawrence, Sean Turner, Nathan P. Pezant, Nancy Redinger, Carla Guthridge, Kenneth Smith, Jingrong Chen, J. Guthridge, Judith A. James, Susannah Rankin, Linda F. Thompson, A. Farris, S. Kovats
          </td>
          <td>2025-12-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="Intracerebral hemorrhage (ICH) is a severe neurological disease with limited treatment options. Microglia, the primary immune cells of the brain, contribute significantly to secondary injury following ICH, exhibiting heterogeneity in response across different stages of ICH. However, the exact mechanisms regulating this process remain incompletely elucidated. In this study, we utilized single-nucleus RNA sequencing (snRNA-seq) in conjunction with the ICH model of mice to establish a comprehensive single-nucleus transcriptomic atlas for ICH and further elucidate its pathogenesis to identify potential therapeutic targets. We identified five principal brain clusters with cell-type specific gene expression patterns. Focused on microglia and inflammation-associated subgroup, we identified 8 distinct microglia subtypes and the key transcription factors (TFs) involved in the inflammatory response of microglia following ICH, including Stat2, Stat1, Irf7, Nfkb1, Etv6, Cebpb, Batf, and Bach1. Notably, Stat2 and Stat1 were identified as the most central TFs. In vitro experiments revealed that inhibiting Stat2 and Stat1 can attenuate the inflammatory response in microglia after ICH. Overall, our findings enhance the understanding of cell responses in ICH and highlight potential therapeutic targets, specifically suggesting that inhibiting STAT1 and STAT2 could mitigate microglial-mediated inflammation in ICH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3656b9b2cf60fce5d6a414f852d3b6e8b7436a9c" target='_blank'>
              snRNA-seq reveals key transcription factors in the inflammatory response of microglia after intracerebral hemorrhage
              </a>
            </td>
          <td>
            Zhuojin Wu, Danyang Chen, Shiling Chen, Ge Zhang, Xuan Wu, Kai Shu, Chao Pan, Zhouping Tang
          </td>
          <td>2025-11-20</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/60b51b9703dbfed647e79713910f273fb5017584" target='_blank'>
              STING–IFN–CH25H lipid axis links innate immune activation to tau pathology
              </a>
            </td>
          <td>
            Hao Chen, Li Fan, M. Wong, Y. Ambaw, Jingjie Zhu, Kendra Norman, Pearly Ye, Nessa R. Foxe, Daphne Zhu, Yuansong Wan, Mahalashmi Srinivasan, S. Mok, Laura Beth J McIntire, Tobias C. Walther, R. V. Farese, Li Gan, Wenjie Luo
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) remains a leading cause of chronic neurological impairment, yet the cellular mechanisms underlying long-term neurodegeneration in TBI remain incompletely understood. Astrocytes, the most abundant glial cell type, are central to maintaining neuroglial and neurovascular homeostasis. Following TBI, however, astrocytic activation contributes to sustained inflammation and neurotoxicity. In this study, we employed immunohistochemistry and RNA sequencing to longitudinally profile astrocyte morphology and transcriptional states at acute (2 days), subacute (2 weeks), and chronic (1 year) stages after controlled cortical impact in mice. We identified a temporally evolving astrocyte response—beginning with a pro-inflammatory profile acutely, transitioning through a profile suggestive of mixed inflammatory and neurodegenerative signatures subacutely, and culminating in a chronic state marked generally by expression of Alzheimer’s and Parkinson’s disease-associated genes. Notably, a subset of astrocyte-derived progenitor cells also was found up to one-year post-injury, expressing markers associated with neurogenesis. These findings reveal that astrocyte activation is not transient but persists chronically, undergoing a dynamic shift from inflammation to degeneration. The observed parallels between astrocyte states in chronic TBI and neurodegenerative disorders underscore their potential role in post-traumatic cognitive decline and highlight astrocyte-targeted interventions as a promising avenue for therapeutic development. Transcriptomic analysis of astrocytes in the acute, subacute, and chronic phases after traumatic brain injury reveal an evolving dynamic shift from neuroinflammation to neurodegeneration, and to a limited extent, regeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c70e1566bf8218bb883f7cd7c00852baff7513e" target='_blank'>
              Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration
              </a>
            </td>
          <td>
            Hadi Abou-El-Hassan, Taha Yahya, Benjamin E. Zusman, Omar Albastaki, Harm T. Imkamp, Jessica J. Ye, Francesca Percopo, Jonathan R Christenson, Maryam H. Al Mansi, Kuan-Jung Lu, Galina Gabriely, Bruna K. Tatematsu, K. Habashy, Juliana R Lopes, A. Maghzi, R. M. Rezende, F. Quintana, Howard L. Weiner, Saef Izzy
          </td>
          <td>2025-12-01</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Introduction Matrix metalloproteinases MMP-2 and MMP-9 modulate inflammatory processes at the blood–brain barrier (BBB), but their presence and function in the dura mater remain unclear. We therefore investigated their contribution to immune regulation at this site during neuroinflammation. Methods We analyzed dura mater from naïve and experimental autoimmune encephalomyelitis (EAE) mice using immunofluorescence, gelatin zymography, flow cytometry, and single-nucleus RNA sequencing (snRNA-seq). Comparisons were performed between wild-type (WT) and Mmp9-/- mice to define gelatinase expression, cellular sources, transcriptional alterations, and immune cell dynamics. Results Pro- and activated-MMP-2 and MMP-9 were detectable in naïve dura, with selective upregulation of MMP-9 during EAE. Mmp9-/- mice demonstrated delayed EAE onset but more severe disease at peak. SnRNA-seq revealed that Mmp9 deficiency altered endothelial transcriptional programs, especially in venous endothelial cells, and promoted expansion of granulocyte populations with mature neutrophil signatures. Flow cytometry and immunofluorescence confirmed increased Ly6C⁺Ly6G⁺ neutrophils in Mmp9-/- dura during EAE. Discussion Our findings indicate that MMP-9 regulates immune cell composition and activation within the dura during neuroinflammation. While Mmp9 deficiency delays disease onset, it enhances neutrophil accumulation and inflammatory responses at this CNS border, suggesting a previously unrecognized, potentially anti-inflammatory role for MMP-9 in the dura.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/db959f39888b4f8f3387804147ae4412570e0a00" target='_blank'>
              MMP-9 affects dural cell composition and granulocyte accumulation during neuroinflammation
              </a>
            </td>
          <td>
            Sheng-Hsiang Shen, Hanna Gerwien, Miriam Burmeister, Yi-Ling Tsang, I-Na Lu, Anna-Lena Börsch, Tushar Deshpande, Lydia Sorokin, Gerd Meyer zu Hörste
          </td>
          <td>2025-12-11</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections worldwide, particularly affecting infants, older adults, and immunocompromised individuals. Understanding the cellular immune response to RSV infection is essential for developing effective treatments for infection and its complications. In this study, we investigated the susceptibility of blood-derived primary monocytes and monocytic THP-1 cells to infection with a contemporary RSV A-ON1 strain and characterized the subsequent cytokine and chemokine secretion, as well as the expression of surface markers involved in antigen presentation. Our findings demonstrate that primary monocytes and related THP-1 cells are permissive to abortive infection by RSV, leading to increased expression of proinflammatory cytokines and chemokines, including IP-10, IL-6, and CCL2. Furthermore, primary monocytes expressed CD80, CD86, and HLA-DR upon direct infection or through potential paracrine stimulation. Collectively, these findings demonstrate the activation of monocytes by RSV infection, suggesting their contributory role in orchestrating early immune responses during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0a13235925d18993e167d01b4f6d405002e8701" target='_blank'>
              A contemporary strain of RSV activates primary human monocytes after abortive infection
              </a>
            </td>
          <td>
            Ayse Agac, M. Ludlow, Marie-Christin Knittler, C. K. Prajeeth, G. Saletti, A. Osterhaus, Robert Meineke, G. Rimmelzwaan
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>96</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/69df5fd6672a630864c6251428da30e869ad36a2" target='_blank'>
              Neuronal activity promotes repair by microglial reprogramming following demyelination
              </a>
            </td>
          <td>
            C. Perrot, R. Ronzano, Z. Li, M.S. Aigrot, V. Pantazou, P. Stheneur, FX Lejeune, B. Zalc, F. Quintana, B. Stankoff, C. Lubetzki, A. Desmazières
          </td>
          <td>2025-12-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="ABSTRACT Middle East respiratory syndrome coronavirus (MERS-CoV) causes a highly lethal respiratory infection for which no vaccines or antiviral therapeutics are currently available. Understanding the immune response is critical for designing effective therapeutics. Here, we comprehensively characterized the dynamics of B-cell responses in severely infected MERS-CoV patients and survivors with SARS-CoV-2 exposure history. Infected patients developed robust neutralizing antibody responses within 1 month of illness, with moderate-to-high cross-neutralization activity against SARS-CoV-2. The enhanced neutralization activity coincided with an increased abundance of specific mutated, class-switched IgG clones. Notably, one such clone was detected at moderate prevalence in both patients, and its expansion was accompanied by high neutralization activity against both viruses. Conversely, MERS-CoV survivors demonstrated higher neutralization activity against MERS-CoV after vaccination, despite minimal changes in antibody titers and limited alterations in B-cell repertoire properties. This suggests that the enhanced neutralization activity may be mediated by the reactivation and expansion of cross-reactive memory B cells targeting conserved epitopes, originally generated in response to the virus that triggered the primary immune response. These findings provide valuable insights into the B-cell repertoire landscape during natural MERS-CoV infection and highlight the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity. IMPORTANCE This study examines the immune responses of MERS-CoV patients and survivors who have had confirmed exposure to SARS-CoV-2. It offers a unique opportunity to characterize cross-reactive B-cell responses in individuals possessing hybrid immunity to both pathogenic coronaviruses. To our knowledge, no previous studies have examined longitudinal changes in the B-cell repertoire in MERS-CoV patients or survivors before and after SARS-CoV-2 vaccination. Our findings reveal enhanced neutralization activity against both MERS-CoV and SARS-CoV-2 following infection or vaccination, which appears to be associated with distinct patterns of B-cell repertoire dynamics. Notably, the data strongly suggest the presence of potent cross-neutralizing antibody responses, particularly in MERS-CoV patients, driven by dominant B-cell clones. These results underscore the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity. This study examines the immune responses of MERS-CoV patients and survivors who have had confirmed exposure to SARS-CoV-2. It offers a unique opportunity to characterize cross-reactive B-cell responses in individuals possessing hybrid immunity to both pathogenic coronaviruses. To our knowledge, no previous studies have examined longitudinal changes in the B-cell repertoire in MERS-CoV patients or survivors before and after SARS-CoV-2 vaccination. Our findings reveal enhanced neutralization activity against both MERS-CoV and SARS-CoV-2 following infection or vaccination, which appears to be associated with distinct patterns of B-cell repertoire dynamics. Notably, the data strongly suggest the presence of potent cross-neutralizing antibody responses, particularly in MERS-CoV patients, driven by dominant B-cell clones. These results underscore the potential for identifying broadly neutralizing antibodies in individuals with hybrid immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1207eb36a1ae9d0a38874b4fd9dcc3679243cee7" target='_blank'>
              Dynamics of B-cell response in MERS-CoV patients and survivors with hybrid immunity
              </a>
            </td>
          <td>
            H. Al-Khatib, Fatma H. Ali, H. Zedan, M. Smatti, Peter V. Coyle, Sara Taleb, A. A. Hssain, Asmaa A Al-Thani, H. Yassine
          </td>
          <td>2025-12-16</td>
          <td>mBio</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e3390d47a05cc167afea6dd6713ed3857300502" target='_blank'>
              PPARδ activation in microglia drives a transcriptional response that primes phagocytic function while countering inflammatory activation
              </a>
            </td>
          <td>
            Jacob S. Deyell, J. Hasselmann, Linda Stroud, Urmimala Raychaudhuri, Yunzi Guo, Byeonggu Cha, Christopher Karma, Deavin Tendean, Minh-Huy Vu Tran, Anastasia Gromova, Audrey S. Dickey, Mathew Blurton-Jones, Albert R. La Spada
          </td>
          <td>2025-12-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/32d744543512f7fd8cb097f605724c369cc5455a" target='_blank'>
              Single-Cell Multi-Omics Dissects Transcript Isoform and Immune Repertoire Dynamics in Human Immunosenescence
              </a>
            </td>
          <td>
            Yuhui Zheng, Ze-Hui Ren, Yafei Yang, Wenteng Liu, Fupeng Li, Yajun Zuo, Tao Zeng, Xue Wang, Xiumei Lin, Xinyue Zhu, Baibing Guan, Wenwen Zhou, Yunting Huang, Wangsheng Li, Yu Feng, Xiao Yang, Xin Liu, Xin Jin, Hanjie Li, Yuliang Dong, Xiangliang Yang, Xun Xu, Jianhua Yin, Chuanyu Liu
          </td>
          <td>2025-11-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/91babd22d3b6b86432a313b4b21fca0bc39e8c82" target='_blank'>
              Single cell RNA sequencing reveals limited effects of Lrrk2 genotype in a mouse model of acute CNS inflammation
              </a>
            </td>
          <td>
            Alice Kaganovich, Liam Horan-Portelance, Natalie Landeck, Dominic J. Acri, Jinhui Ding, R. Langston, Mark R. Cookson
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/687800177db6f90a1dee9be6bba3ed7087d04c6e" target='_blank'>
              Oncolytic Reovirus mediates innate-driven SARS-CoV-2 elimination in the absence of cell toxicity
              </a>
            </td>
          <td>
            Samantha Garcia-Cardenas, Gemma Swinscoe, Amy Moran, Liam Barningham, Graham P. Cook, A. Samson, Sam J. Wilson, Michael Malim, Russell Hughes, Stephen Griffin
          </td>
          <td>2025-12-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related sarbecoviruses encode a set of accessory proteins (3a, 3b, 6, 7a, 7b, 8, 9b, and 10) that control host responses to infection and promote virus growth. Of these accessory proteins, 7a is set apart by its intracellular localization near CoV budding sites and its incorporation into secreted virions. To investigate 7a functions during CoV infections under biosafety level 2 conditions, we constructed recombinant mouse hepatitis viruses (rMHVs) (rMHV strain A59) that express sarbecovirus 7a genes. Comparative infections revealed that 7a increased viral replication and viral output in immortalized murine cell cultures and in primary bone marrow-derived macrophages (BMDMs). This proviral effect was independent of a previously reported 7a-mediated interferon antagonizing activity. 7a is a type I transmembrane protein with a short cytoplasmic tail that operates in subcellular trafficking and signal transduction. To further elucidate tail functions, we generated a set of rA59 viruses expressing substitutions in the tail di-lysine motifs. Several substitutions reduced 7a proviral activities; notably, the K119A change in rA59-7a-KRATE eliminated 7a support of virus yield. The K119A change also reduced mouse-adapted SARS-CoV-2 virus yields in infected BALB/c mice. 7a expression was proinflammatory in BMDMs, as measured by cytokine arrays. Cytoplasmic tail substitutions tempered these proinflammatory responses, implying connections with proviral activities. SARS-CoV-2-infected macrophages have been implicated in inflammatory COVID-19, and these findings point to 7a cytoplasmic tails as potential contributors to cytokine-mediated disease. IMPORTANCE This study shows that SARS-CoV-2 accessory protein 7a promotes infection of a phylogenetically distinct embecovirus and, in doing so, elicits proinflammatory and potentially disease-relevant host responses. The proviral and proinflammatory activities were traced in part to a short 7a cytoplasmic tail. The findings localize and highlight a specific proviral component in a sarbecovirus accessory protein. This study shows that SARS-CoV-2 accessory protein 7a promotes infection of a phylogenetically distinct embecovirus and, in doing so, elicits proinflammatory and potentially disease-relevant host responses. The proviral and proinflammatory activities were traced in part to a short 7a cytoplasmic tail. The findings localize and highlight a specific proviral component in a sarbecovirus accessory protein.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5dfa631af078e38f4ca2e53db8a723825ceb2711" target='_blank'>
              A murine coronavirus infection platform identifies proviral and proinflammatory activities of SARS-CoV-2 accessory protein 7a
              </a>
            </td>
          <td>
            Grant M Hawkins, Enya Qing, Julisa Salgado, Pearl Chan, Edward M Campbell, Stanley Perlman, Thomas M. Gallagher
          </td>
          <td>2025-12-16</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Epstein-Barr virus (EBV) infects >95% of the adult population with diverse outcomes ranging from benign latency to cancers and autoimmune diseases. Immunological control of EBV infection is known to be an important determinant of EBV infection outcomes. However, species-specific viral tropism and limited infection models have impeded mechanistic insights into early host–immune control of EBV infection. Here, we use ex vivo infection of peripheral blood mononuclear cells (PBMCs), rather than routinely used B cell enriched culture systems, to study immune and viral dynamics during primary EBV infection. We combined bulk RNA sequencing, EBV transcript enrichment, and flow cytometry to characterize cellular responses across Days 1, 7–8, and 14 post-infection. Early infection triggered a monocyte-specific antiviral response marked by changes in the expression of genes associated with lipid metabolism (LIPA, lysosomal acid lipase) and chemotaxis (CCR1 and CCR2). Inhibitors of LIPA increased EBV titers during primary infection, indicating that LIPA is part of an early monocyte-driven antiviral response. At later timepoints post-infection, donor-dependent variability in lymphoblastoid cell line (LCL) outgrowth was associated with divergent immune states. Donors that failed to generate LCLs demonstrated increased frequencies of CD8+ T cells and reduced numbers of regulatory T cells (CD4⁺CD25⁺FOXP3⁺). EBV transcriptomics revealed that LCL-failed donors exhibited elevated early lytic gene expression but did not establish a type III latency program. Our findings suggest that individual variations in immune cell composition and gene expression may account for differences in the immune response to EBV. These findings define temporal immune and viral signatures that predict transformation outcome and highlight intact PBMCs as a tractable model to study EBV pathogenesis in a genetically diverse, human-specific context. AUTHOR SUMMARY Individual variation in response to Epstein-Barr virus (EBV) infection can lead to diverse pathogenic outcomes, ranging from cancers to autoimmune disease. To study this variation, we analyzed immune cell response and viral dynamics during the ex vivo primary EBV infection of peripheral blood mononuclear cells (PBMCs) from donors that either fail or succeed to generate lymphoblastoid cell lines (LCLs). Flow cytometry and RNA-seq revealed a rapid monocyte-specific antiviral response among all donors marked by genes associated with lipid metabolism (LIPA) and chemotaxis (CCR1 and CCR2). LIPA inhibition increased EBV titers during primary infection, demonstrating a functional antiviral role. At later timepoints, donor-specific differences in CD8+ T cells and Treg subsets, along with EBV gene expression, were correlated with successful LCL outgrowth. Treatment with the Treg-depleting antibody RG6292 suppressed viral transformation in donors that otherwise supported LCL outgrowth, confirming a functional role for Tregs in shaping early EBV infection outcomes. Viral transcript enrichment-seq revealed an upregulation of early lytic and failure to sustain latent gene expression correlating with failure to generate LCL. These findings highlight intact PBMCs as a tractable model to study EBV viral-host interaction in a genetically diverse, human-specific context, and that Tregs play a key determining role in viral transformation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c8803f87b9598f62e1119244e26857dfd233ed68" target='_blank'>
              EBV INFECTION OUTCOMES DETERMINED BY MONOCYTE AND TREG-DRIVEN IMMUNE DYNAMICS IN AN EX VIVO PBMC MODEL
              </a>
            </td>
          <td>
            Leena Yoon, Lauren N. MacMullen, Leonardo Josué Castro Muñoz, Alina Gu, Jamie Bregman, Mary S. Campion, Avi Srivastava, Rena R. Xian, Richard F Ambinder, A. Kossenkov, Samantha S. Soldan, Paul M. Lieberman
          </td>
          <td>2025-11-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/907f1f4b30075c4fd386fadca819b4f5e1e1f8f5" target='_blank'>
              Dysregulation of transcription networks regulating oligodendrogenesis in age-related decline in CNS remyelination
              </a>
            </td>
          <td>
            Penelope Dimas, Samuel Morabito, Khalil S. Rawji, Qing Wang, Fynn N Krause, Juan F. Cubillos, Nejma Belaadi, Peggy Assinck, Zechuan Shi, Zhenkun Cao, Holger Heyn, R. Kawaguchi, Daniel H. Geschwind, Vivek Swarup, Robin J. M. Franklin
          </td>
          <td>2025-11-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="West Nile virus (WNV) is a mosquito-borne virus that causes severe neurological disease in humans. Despite substantial advances, our knowledge of the mechanisms involved in damaging the human brain is still limited. To address this gap, we developed a physiologically relevant in vitro model using human neuronal/glial cells and aimed to determine WNV tropism, assess whether the virus induces innate immune and inflammatory responses, and elucidate the resulting pathophysiological consequences. We found that WNV productively infected glial cells, whereas neurons exhibited a remarkable and unexpected resistance to infection. Despite the induction of a robust innate immune response mediated by IFN signalling and a rapid control of WNV replication in glial cells, we observed substantial death of astrocytes, oligodendrocytes, and neurons. Analysis of cytokine and chemokine expression further revealed that infection triggered an inflammatory response, potentially contributing to bystander cell death. We also showed that IFN signaling did not contribute to the resistance of neurons and identified IFI6 as an effector of the antiviral response in human glial cells. Together, our results underscore the importance of human neural models for confirming previous findings obtained in less physiologically relevant models and for unravelling novel cellular and molecular mechanisms. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-27954-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/435c1519049ea8d464c2e723fc442d3c3c80d655" target='_blank'>
              Role of innate immune and inflammatory signaling in West Nile virus tropism and neuronal and glial cell death
              </a>
            </td>
          <td>
            Valentine Chaillot, François Piumi, Kamila Gorna, Noémie Berry, Jennifer Richardson, Alexandra Benchoua, Muriel Coulpier
          </td>
          <td>2025-12-19</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Zika virus (ZIKV) poses a significant threat to neural tissue, causing substantial damage to unborn children exposed to the virus in utero, with consequences that can manifest even after birth, despite being born with a normal head circumference. Regardless of the extensive research, the interactions between ZIKV and the nervous system cells remain insufficiently understood, particularly regarding how neuronal responses influence broader inflammatory and viral dynamics especially in postnatal stages of development. This study evaluated the susceptibility to ZIKV infection, viral replication, immune response, and survival of neurons, astrocytes and microglial cells during postnatal developmental stages, using both in vivo and in vitro mice models. In vivo, a non-lethal but extensive infection of neurons and microglia was shown. The infection caused a robust but controlled immune response with elevated levels of MCP-1, TNF-α, and IL-6, that prevented severe neuronal damage. In vitro, neurons exhibited high susceptibility to ZIKV, with elevated levels of pro-inflammatory cytokines and IFN-β, indicating a strong inflammatory response. In contrast, astrocytes and microglia displayed varied responses, contributing to a pro-inflammatory feedback loop. These findings offer critical insights into the cellular dynamics of ZIKV infection, enhancing our understanding of its effects during postnatal nervous system development. By clarifying the interactions between ZIKV and neuronal cell types, this study deepens the comprehension of the virus’s pathophysiology and its broader implications for neurodevelopmental outcomes, extending beyond the well-documented association with microcephaly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80aee6bf94647ce0fef40ccbfab9270cf8289aa9" target='_blank'>
              In vivo and in vitro susceptibility and inflammatory response of postnatal mouse cortical neurons and glial cells to zika virus infection
              </a>
            </td>
          <td>
            M. Calderón-Peláez, M. Velandia-Romero, Jaime E Castellanos
          </td>
          <td>2025-12-31</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by the sudden onset of obsessive-compulsive symptoms alongside a constellation of neuropsychiatric and somatic features. Disease progression typically includes flare and recovery states, with some patients exhibiting a persistent disease course (> 12 months of flare). We characterized circulating monocyte subsets during flare and recovery in pediatric patients with PANS, uncovering disease-state–dependent shifts in polarization and trafficking phenotypes. Inflammatory M1-like monocytes and monocyte-derived dendritic cells were elevated during flare, while anti-inflammatory M2-like monocytes were enriched in recovery. We also identified a circulating subset with a surface phenotype consistent with central nervous system (CNS) homing, which was reduced during flare and restored in recovery. These cells were detectable in the cerebrospinal fluid (CSF) of new-onset patients but not in persistent cases, suggesting differential compartmentalization during disease progression. Notably, monocyte phenotypes, including M2 polarization (monocytosis) and circulating CNS-homing profiles, exhibited striking sex-associated differences, particularly during recovery, with several subsets enriched in males but not females. Plasma from flare-phase patients modestly induced CNS-homing markers in monocytes from healthy donors, indicating the presence of circulating modulators. Together, these findings support a model in which distinct myeloid phenotypes—including sex-biased patterns—may contribute to both the pathogenesis and resolution of neuroinflammation in PANS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab805830c315ccc3f7c69d468623a69aa039f03c" target='_blank'>
              Sex-associated and disease state-dependent monocyte polarization and CNS-trafficking phenotypes in pediatric acute-onset neuropsychiatric syndrome (PANS)
              </a>
            </td>
          <td>
            Shamma S. Rahman, Noor Hussein, Silvia Giulia Galfrè, Fabian Gaertner, C. Macaubas, Avis L. Chan, Laurie Columbo, Jaynelle Gao, Samira Galehdari, Batuhan Bayram, Meiqian Ma, C. Manko, Kate Miles, B. Farhadian, M. Silverman, M. Thienemann, Noga Or-Geva, Keith Van Haren, Kari C Nadeau, Lu Tian, Jennifer Frankovich, Elizabeth D. Mellins
          </td>
          <td>2025-11-18</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/491d4d516b113109ac72078677aee9124493f965" target='_blank'>
              Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection.
              </a>
            </td>
          <td>
            Helen R. Wagstaffe, R. Thwaites, Jasmin K. Sidhu, Rik G. H. Lindeboom, Lorenz Kretschmer, Kaylee B. Worlock, L. Dratva, Ao Huang, S. Ascough, L. Papargyris, Richard McKendry, Ashley M. Collins, Jiayun Xu, Nana-Marie Lemm, Ben Killingley, M. Kalinova, Alex J. Mann, A. Catchpole, Leo Swadling, J. Tsang, MK Maini, M. Noursadeghi, Marko Z. Nikolić, Sarah A. Teichmann, P. Openshaw, Christopher Chiu
          </td>
          <td>2025-12-07</td>
          <td>Nature communications</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="ABSTRACT Porcine reproductive and respiratory syndrome virus (PRRSV), a major immunosuppressive pathogen, inflicts substantial economic losses on the global swine industry. Despite extensive research into PRRSV pathogenesis, the mechanisms by which PRRSV induces immune dysfunction in vivo remain incompletely understood. Here, we performed single-cell RNA sequencing on cells isolated from the lung of PRRSV-infected piglets, generating transcriptomic profiles for 46,922 single cells encompassing 15 major cell types. We observed a significant reduction in the number of macrophages in lung tissues, which was primarily attributed to the extensive apoptosis of macrophages induced by PRRSV infection. PRRSV infection triggered aberrant differentiation of macrophage, and the SPP1high macrophage subpopulation was identified as the primary target cells for PRRSV infection. Cell-cell communication analysis revealed that PRRSV infection enhanced ligand-receptor interactions between macrophages and other cell types, associated with inflammatory responses, activation of T cells and B cells, and cell adhesion. In addition, monocytes exhibited a tendency to differentiate into macrophages, potentially compensating for the depletion of macrophages caused by PRRSV infection. Moreover, PRRSV infection caused abnormal development of B cells and incomplete activation of cytotoxic T lymphocytes in the lungs. This study provides a comprehensive characterization of how PRRSV perturbs pulmonary immune cell populations, offering valuable insights into the mechanisms underlying PRRSV-induced lung injury. IMPORTANCE Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection. Porcine reproductive and respiratory syndrome virus (PRRSV) has consistently posed a significant and enduring threat to the swine industry. However, the virus-host interactions during in vivo infection in vivo remain poorly understood. In this study, we applied single-cell RNA sequencing to characterize the cellular heterogeneity of lung tissues from PRRSV-infected piglets. Through intracellular viral RNA tracking, we identified SPP1high macrophages as the primary reservoir of PRRSV. Furthermore, we analyzed the cell-cell communication between macrophages and other cell types and investigated the immune responses and heterogeneity of monocytes, T cells, and B cells upon PRRSV infection. Our findings provide a comprehensive single-cell landscape of the complex host-pathogen interplay during PRRSV infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a411b9a7f498fc257495d61e60998a9d94a15046" target='_blank'>
              Deciphering immune features and cellular heterogeneity in PRRSV infection via single-cell RNA sequencing
              </a>
            </td>
          <td>
            Jianda Li, Yue Liang, Yuyu Zhang, Yulin Xu, Fei Liu, Luogang Ding, Yu Wang, Zhihao Zhang, Zhi Chen, Wenbo Sun, Jiang Yu, Jiaqiang Wu
          </td>
          <td>2025-12-30</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="The integration of single-cell sequencing with spatial transcriptomics and multi-omics analyses has enabled a paradigm shift in biomedical research, thereby expanding its applicability and scientific impact. In the context of influenza virus studies, this technology has been instrumental in dissecting cellular heterogeneity, as demonstrated by its capacity to analyze differential transcriptomic profiles and reconstruct differentiation trajectories at the single-cell level following viral infection. These advances have provided mechanistic insights and a holistic understanding of influenza pathogenesis, surpassing the limitations of bulk-level analyses. This review provides a comprehensive dissection of cutting-edge applications of single-cell sequencing in elucidating influenza virus infection mechanisms, immune cell heterogeneity, and vaccine development. By highlighting the single-cell resolution of virus–host interactions and vaccine efficacy studies, this work offers novel perspectives for designing precision-targeted antiviral interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4f6de9c1519c1d75f459ef0760e41ce623109cf0" target='_blank'>
              New Insights into Influenza Virus-Host Interactions, ImmuneResponses, and Vaccine Development at Single-Cell Resolution
              </a>
            </td>
          <td>
            Xingting Li, Lingxi Gao
          </td>
          <td>2025-12-14</td>
          <td>Life Conflux</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="The COVID‐19 pandemic has disproportionately affected elderly individuals, who exhibit higher risks of severe disease and mortality. Although the precise molecular mechanisms underlying this disparity remain unclear, we employed an integrative multi‐omics approach to analyze lung tissues from young, adult, and aged mice infected with the SARS‐CoV‐2 Beta variant (B.1.351). Conserved molecular signatures across age groups included the activation of antiviral immune response pathways (such as antigen processing and presentation, and cytokine‐cytokine receptor interaction), and downregulation of metabolic regulatory pathways (such as cGMP‐PKG signaling). Concurrently, we observed activation of three proinflammatory kinases‐p38 delta mitogen‐activated protein kinase (p38D), mechanistic target of rapamycin (mTOR), cytoplasmic tyrosine kinase (CTK)–along with inhibition of the antiviral kinase mammalian Ste20‐like kinase 4 (MST4) across all age groups, suggesting conserved therapeutic targets. Our results also revealed age‐dependent characteristics, with aged mice showing severe weight loss (> 15% by day 4 postinfection) and hyperactivation of complement and coagulation cascades compared to their younger counterparts. The upregulation of complement system proteins, including complement component 3 (C3), complement component 4b (C4b), and neutrophil/M1 macrophage markers S100 calcium‐binding protein A8/A9 (S100A8/A9) in aged mice, coupled with a strong positive correlation (R² = 0.89) between C3 and S100A8, suggested S100A8‐mediated complement activation. These findings elucidate how aging exacerbates SARS‐CoV‐2 pathogenesis through dysregulated immune and inflammatory responses, providing potential targets for age‐tailored therapies to mitigate severe COVID‐19 outcomes in the elderly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0fe6305dd6a280dbd86cc633d792e9ee1a3012a" target='_blank'>
              Integrative Multi‐Omics Analysis Reveals Age‐Associated Molecular Mechanisms in SARS‐CoV‐2 Infection
              </a>
            </td>
          <td>
            Xiaoyue Tang, Yan Xiao, J. Zhong, Tao Ding, Qiaochu Wang, Chunmei Shi, Zhiyi Zhang, Yehong Yang, Yue Wu, Jiangfeng Liu, Lili Ren, Juntao Yang
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49a5db351ada41d17475ee46b247329414cc1f0f" target='_blank'>
              Dynamics of interactions between three major respiratory pathogens in reconstituted human epithelium
              </a>
            </td>
          <td>
            Aurélien Gibeaud, Charles Terra, Émilie Portier, Pascal Lukas, Audrey Le Gouellec, Jérémie Guedj, Frederik Graw, A. Pizzorno, O. Terrier
          </td>
          <td>2025-11-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="Abstract Objective Examine the role of T cells in shaping and sustaining humoral immunity to SARS‐CoV‐2 and identify immune factors associated with durable antibody responses. Methods Unvaccinated adults (n = 67) with SARS‐CoV‐2 infection (Wuhan) of any severity were followed longitudinally for up to 14 months. Anti‐Spike (S) binding and neutralising antibodies were measured. Bulk T cell IFNγ and IL‐2 responses were assessed by Fluorospot to multiple viral proteins. S‐specific T‐cell subsets and functions were analysed in detail by flow cytometry in a subset of participants (n = 14), combining activation‐induced markers (AIMs) and cytokines. Correlations between S‐specific T‐cell subsets, their polyfunctionality and antibody levels over time were defined. Results Over 14 months post infection, anti‐S IgG and neutralising antibodies declined significantly but remained detectable in > 85% of participants. Bulk T‐cell IFNγ and IL‐2 responses persisted without significant reduction. However, S‐specific CD4 T cells declined over time. A large proportion of these were peripheral helper T cells (Tph; CXCR5−PD‐1+), which were the main producers of IL‐21 and showed marked polyfunctionality during early convalescence, in contrast to circulating follicular helper T cells (cTfh). The early presence of polyfunctional, IL‐21‐producing Tph strongly correlated with S‐specific IgG and neutralising antibodies early post‐infection and predicted neutralising antibody maintenance a year later. Older age correlated with higher Tph and antibody levels. Conclusion Early S‐specific T‐cell responses—particularly polyfunctional, IL‐21‐producing Tph cells—play a key role in sustaining durable antibody levels post‐infection, offering insights for future vaccine strategies and understanding long‐term immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/63995037b8ae83290f6bb5ffec2deaef5580d4b2" target='_blank'>
              Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID‐19
              </a>
            </td>
          <td>
            Katie Tungatt, Gabriela Martins Costa Gomes, Nicole L. Fewings, Aija Stubis, C. Doyle, V. Merheb, A. Aggarwal, K. Byth, Harry Robertson, S. Dervish, Susan Maddocks, Janette Taylor, R. Bull, M. Martinello, F. Brilot, S. Turville, Anthony L. Cunningham, K. Sandgren
          </td>
          <td>2025-01-01</td>
          <td>Clinical & Translational Immunology</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23fe51bd03b4e6b215bef750c8f1bc98b4664ab0" target='_blank'>
              Mechanism of neuroinvasion and interferon response in human choroid plexus organoids during Japanese encephalitis virus infection
              </a>
            </td>
          <td>
            Y. Kumsang, Atsadang Boonmee, Chatpong Pethrak, Pisut Pongchaikul, U. Anurathapan, Chatchai Muanprasat, Phisit Khemawoot, Bunpote Siridechadilok, Natapong Jupatanakul, Nithi Asavapanumas, Nunya Chotiwan
          </td>
          <td>2025-12-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Background Ischemic stroke remains a leading cause of mortality and disability worldwide. Microglia, the resident immune cells of the central nervous system, perform critical roles in immune surveillance, debris clearance, and tissue repair. Analyzing the heterogeneity, activation trajectories, and metabolic states of microglia in ischemic stroke is essential for discovering therapeutic targets. Methods We performed single-cell RNA sequencing (scRNA-seq) on brains from ischemic and control rats and identified transcriptionally distinct microglial subpopulations. We conducted differential expression, pathway enrichment, pseudotime analysis, regulatory network inference, and cell-cell communication mapping to characterize functional states, key transcription factors, and intercellular crosstalk underlying microglial responses following cerebral ischemia-reperfusion injury. We used Real-Time Quantitative PCR (RT-qPCR), Western blot, and immunohistochemistry to measure relative RNA and protein expression levels. Results We identified seven microglial subclusters with distinct transcriptional signatures. Ischemia-associated clusters exhibited strong activation of inflammatory pathways, increased glycolysis and lipid metabolism, and suppressed TCA cycle and oxidative phosphorylation (OXPHOS), reflecting a shift toward proinflammatory, energy-demanding phenotypes. Pseudotime analysis revealed transitions from homeostatic to pathological states, highlighting potential therapeutic windows. Regulatory network analysis identified activating transcription factor 3 (ATF3) as a central regulator controlling the expression of cholesterol 25-hydroxylase (CH25H) and secreted phosphoprotein 1 (SPP1). Notably, ATF3 overexpression enhanced CH25H expression and selectively increased proinflammatory cytokine production, linking metabolic reprogramming to neuroinflammatory responses. Cell-cell communication analysis further revealed extensive remodeling of interactions with astrocytes, endothelial cells, and fibroblasts, potentially amplifying postischemic neuroinflammation. Conclusion Our study demonstrates that cerebral ischemia induces transcriptionally and functionally distinct microglial subpopulations, characterized by metabolic reprogramming and proinflammatory activation. ATF3 serves as a central regulator linking CH25H-mediated metabolic changes to cytokine-driven neuroinflammation, highlighting potential therapeutic targets for modulating microglial responses and mitigating ischemia-induced brain injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21c20effa3ad945d21b01c8ec4f5a72133113a12" target='_blank'>
              Single-Cell RNA Sequencing Reveals Microglial Heterogeneity and Functional States After Cerebral Ischemia-Reperfusion Injury
              </a>
            </td>
          <td>
            Yu-jing Tang, Qi Zhang, Yewei Qu, Lian Yi, Fangqin Li, Changda Qu, Shanshan Shi, Byron Fei Pan, Shirong Wen, Ruohan Sun, Yujun Pan
          </td>
          <td>2025-12-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Microglia are abundantly distributed throughout the central nervous system (CNS) to play critical roles in neural development and homeostasis, and act as immune sentinels to constantly monitor their surrounding neural environment. Given their high reactivity to brain insults, we hypothesised that the cerebral microenvironment altered by ischaemic stroke would significantly impact microglial morphology and function in a spatially dependent manner. To investigate this, we examined regional gene expression changes associated with microglial activation and neuroinflammation, microglial morphology using 3D image reconstruction and unbiased proteomics at 24 h after transient middle cerebral artery occlusion (tMCAO). We found the microenvironment within the ischaemic infarct core has a distinct proinflammatory profile versus that of the sham‐operated controls. Moreover, stroke induces region‐specific changes to microglia morphology with those closer to the infarct displaying a more ameboid shape and less complex dendritic processes. Additionally, we identified 108 differentially expressed proteins in microglia that were isolated from the ipsilateral ischaemic hemisphere compared to those isolated from the contralateral hemisphere. These differentially expressed proteins are predicted to influence signalling pathways that mediate TNFα superfamily cytokine production, chemokine activities and leukocyte chemotaxis and migration. These findings support microglia as critical regulators of the inflammatory signalling after stroke.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa2647b412a1efefc20b80a3dca4c72988457704" target='_blank'>
              Microglia Display Altered Spatial Morphology and Proteome After Stroke
              </a>
            </td>
          <td>
            B. Wanrooy, Jenny L. Wilson, Althea R. Suthya, Joshua H. Bourne, J. Steele, H. V. Kahrood, Ralf B. Schittenhelm, Giulia Ballerin, Cameron Skinner, Shu Wen Wen, Connie H Y Wong
          </td>
          <td>2025-11-10</td>
          <td>Proteomics</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="This study addressed the significant challenges in understanding the specific immune landscape and predicting patient outcomes of COVID-19, particularly in severe cases. To support clinical practice, we aimed to build a comprehensive single-cell atlas of the disease and develop a predictive model for severe patient outcomes. We collected single-cell RNA sequencing data from COVID-19 patients, influenza patients, and healthy controls. Our analysis encompassed alterations in cell abundance, transcriptomic profiles, and pathway activities across these groups. We then constructed a logistic regression model to predict the prognosis of severe COVID-19 patients, evaluating its performance using sensitivity, specificity, and area under the curve (AUC) metrics. Our integrated dataset comprised 434,703 cells from 233 samples across 8 datasets, categorized into major cell types including T/natural killer cells, B cells, myeloid cells, epithelial cells, and platelets. T/NK cells and myeloid cells constituted the largest proportions and exhibited the most significant changes in abundance among the different groups. We identified substantial alterations in inflammatory genes and metabolic pathways across various T cell and myeloid cell subtypes, with differential expression of these genes also correlating with COVID-19 severity and patient outcomes. The developed logistic regression model, incorporating the genes IL1R2, PI3, IGHG3, and CTTN, demonstrated a sensitivity of 80.0% and an AUC of 70.5% in the training set. These results were consistent in the test set, with a sensitivity of 81.1% and an AUC of 70.6%. By depicting a comprehensive single-cell atlas of COVID-19, this work unravels the complex cellular dynamics underlying the disease, thereby advancing our understanding of its mechanisms. The developed model shows promise for predicting outcomes in severe COVID-19 patients, which could facilitate clinical decision-making and ultimately benefit patient care.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/abe31cfbda1d59cafb726eee5c1f561f9696fd21" target='_blank'>
              Single-cell atlas of COVID-19 based on multiple sample integration
              </a>
            </td>
          <td>
            Pei Tang, Jinghan Wang, Hairui Li, Yong Qing, Zhixing Chen, Junliang Wu, Xiaolin Ran, Gang Zhong
          </td>
          <td>2025-12-26</td>
          <td>Medicine</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="There is a subgroup of people infected with the SARS-CoV-2 virus who manifest lingering sequelae (LongC), with neurological symptoms (nLongC). We recruited 86 COVID-19 volunteers, 35 of whom were fully recovered (Cov) and 51 who had neurological symptoms (nLongC) 4–53 months after infection and compared them to 51 healthy pre-pandemic controls (HC). Thirty-five percent of nLongC individuals carried the apolipoprotein E4 (APOE4) gene, compared to 11% of Cov. Four plasma proteins, interleukin 1 beta (IL-1β), interleukin 8 (IL-8), glial fibrillary acidic protein (GFAP), and hemopexin, continued to be elevated in both Cov and nLongC compared to HC. Soluble CD14 was elevated in nLongC but not Cov. As a group, IL-1β decreased over time in Cov but not nLongC. Two of the elevated proteins, IL-8 and GFAP, correlated with age, with both Cov and nLongC showing higher levels than HC. Using a combination of four plasma proteins, along with age, body mass index, and APOE4 presence, we were able to achieve an area under the curve (AUC) of 0.81. These results suggest that SARS-CoV-2 infection causes a low-grade inflammatory process that, even months or years after infection, does not return to pre-COVID-19 levels, which may contribute to neurologic sequelae and accelerated aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6dc097b9097119d707ae7261b40c50b96e52a07" target='_blank'>
              Chronic Inflammation and Altered Immune Responses in LongCOVID Associate with Neurological Manifestations and Accelerated Aging
              </a>
            </td>
          <td>
            Norina Tang, Judith M. Ford, Kaitlyn Dal Bon, Lynn Pulliam
          </td>
          <td>2025-11-26</td>
          <td>Cells</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Severe COVID‐19 is an immunological disorder characterized by excessive immune activation following infection with SARS‐CoV‐2, which typically occurs around the time of seroconversion. Anti‐spike IgG of critically ill COVID‐19 patients induces excessive inflammation by activation of Fc gamma receptors (FcγRs) on human alveolar macrophages, leading to tissue damage, pulmonary edema, and coagulopathy. While metabolic reprogramming of immune cells is critical for the induction of inflammatory responses, still little is known about the metabolic pathways that are involved in COVID‐19‐specific hyperinflammation. In this study, we identified that anti‐spike IgG immune complexes (ICs) induce rapid metabolic reprogramming of alveolar macrophages, which is essential for the induction of inflammation. Through functional inhibition, we identified that glycolysis, fatty acid synthesis, and pentose phosphate pathway (PPP) activation are critical for anti‐spike IgG‐induced hyperinflammation. Remarkably, while excessive proinflammatory cytokine production by macrophages is critically dependent on simultaneous stimulation with viral stimuli and anti‐spike IgG complexes, we show that the required metabolic reprogramming is specifically driven by anti‐spike IgG complexes. These findings provide new insights into the metabolic pathways driving hyperinflammation by macrophages in the context of severe COVID‐19. Targeting of these pathways may reveal new possibilities to counteract pathological inflammatory responses in severe COVID‐19 and related diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7d09f7fb7e4fd28a04356b3213eb05a7c8386673" target='_blank'>
              Hyperinflammation by Human Macrophages Induced by SARS‐CoV‐2 Anti‐Spike IgG Is Dependent on Glucose and Fatty Acid Metabolism
              </a>
            </td>
          <td>
            Chiara E. Geyer, Luís Almeida, Lynn Mes, F. Otto, W. Ashwin Mak, Graham A Heieis, Jennifer Veth, S. D. de Taeye, Tom G. Caniels, Tom P. L. Bijl, M. V. van Gils, M. D. de Winther, Jan Van den Bossche, Hung-Jen Chen, R. Houtkooper, Bart Everts, J. den Dunnen
          </td>
          <td>2025-12-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="ABSTRACT Mucosal immunity plays a crucial role in protection against respiratory viruses. However, the mechanisms underlying mucosal responses and their impact on COVID-19 outcomes are not well understood, as mucosal immunity is compartmentalized and not always reflected in the bloodstream. This study examined primary immune responses in 584 mucosal and blood specimens collected over a month from previously naïve adults and children with COVID-19. Various laboratory techniques were utilized to quantify and characterize viral RNA, antigens, antibodies, and cytokines in the samples, including PCR, sequencing, ELISA, and Luminex. Comprehensive system analysis uncovered distinctive characteristics associated with mild COVID-19 disease progression, including markedly early and elevated induction of mucosal IFN-α and IP-10, followed by increased levels of IL-1RA and IgG. Individuals experiencing mild COVID-19 demonstrated synchronized mucosal and systemic immune responses, with a gradual increase in antibody production that resulted in enhanced neutralization potency, potentially conferring greater protection against future infection. In contrast, individuals with moderate and severe COVID-19 exhibited diminished IFN-α and IP-10 responses and dysregulated mucosal and systemic immune responses marked by rapid and robust yet less effective humoral immunity, potentially driven by high antigen and cytokine levels in both compartments. Collectively, these findings underscore that early mucosal immune responses may play a pivotal role in attenuating COVID-19 disease severity. Additionally, they suggest that primary mucosal immune responses to novel viruses influence clinical outcomes, providing critical insights necessary for developing prognostic indicators, treatments, and mucosal vaccines that confer protection against SARS-CoV-2 and emerging respiratory pathogens. IMPORTANCE This research is crucial for understanding the intricate interplay between mucosal immunity and SARS-CoV-2 infection. By examining the distinct systemic and mucosal immune responses during COVID-19, this study addresses the critical gap in our knowledge of how the body defends itself at the primary site of infection: the respiratory mucosa. The findings shed light on the specific characteristics of the mucosal immune response, including the roles of different antibody isotypes, immune cells, and local factors in controlling viral entry and replication. Furthermore, because this study focuses on de novo immune responses, the results may have broad implications for understanding immune responses to future novel pathogens. Ultimately, this research will contribute to the development of more effective diagnostic tools, therapeutic strategies, and mucosal vaccines to prevent and control COVID-19. By focusing on the often-overlooked mucosal compartment, this work offers a new perspective on comprehending SARS-CoV-2 infection, its implications for public health, and preparedness for future pandemic threats. This research is crucial for understanding the intricate interplay between mucosal immunity and SARS-CoV-2 infection. By examining the distinct systemic and mucosal immune responses during COVID-19, this study addresses the critical gap in our knowledge of how the body defends itself at the primary site of infection: the respiratory mucosa. The findings shed light on the specific characteristics of the mucosal immune response, including the roles of different antibody isotypes, immune cells, and local factors in controlling viral entry and replication. Furthermore, because this study focuses on de novo immune responses, the results may have broad implications for understanding immune responses to future novel pathogens. Ultimately, this research will contribute to the development of more effective diagnostic tools, therapeutic strategies, and mucosal vaccines to prevent and control COVID-19. By focusing on the often-overlooked mucosal compartment, this work offers a new perspective on comprehending SARS-CoV-2 infection, its implications for public health, and preparedness for future pandemic threats.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2335005f4d41996d5dde9da49e85de154a439825" target='_blank'>
              Early mucosal IFN-α, IP-10, and IL-1RA and synchronized mucosal and systemic immune responses mediate COVID-19 disease progression
              </a>
            </td>
          <td>
            Mona Agrawal, Armando S Flores-Torres, John S Franks, Sarah Y. Lang, Thomas P. Fabrizio, Kristin E. McNair, Laura V. Boywid, Ashley J. Blair, Chloe Hundman, Nicholas D. Hysmith, Michael A Whitt, Rachael Keating, Paul G. Thomas, R. Webby, Amanda M. Green, Heather S Smallwood
          </td>
          <td>2025-11-28</td>
          <td>mBio</td>
          <td>0</td>
          <td>106</td>
        </tr>

        <tr id="The COVID-19 pandemic, which began in 2019 due to SARS-CoV-2, remains a global health crisis, especially as new variants emerge that could trigger widespread outbreaks again. While various aspects of SARS-CoV-2 infection warrant attention, the antiviral innate immune response is a crucial area of focus. Understanding how viruses evade host defenses is vital for developing effective vaccines and therapies. SARS-CoV-2 targets key components of the innate immune system for its survival, and this interference with the host immune system is central to the virus's ability to cause disease. However, the specific mechanisms by which the innate immune response counteracts SARS-CoV-2 infection have not been fully clarified. This review examines key elements of the antiviral innate immune response to SARS-CoV-2 infection, concentrating on viral evasion strategies and potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2283fdb7927a9966d77a4f3f180d82163d69d72b" target='_blank'>
              Host’s innate immune response to SARS-CoV-2 infection—Current understanding and trends
              </a>
            </td>
          <td>
            Nitin Saksena
          </td>
          <td>2025-11-08</td>
          <td>Journal of Cellular and Molecular Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="The mechanisms by which Enterovirus D68 (EV-D68) infection leads to acute flaccid myelitis (AFM), a severe neurological condition characterized by sudden muscle weakness and paralysis, remain poorly understood. To investigate the cellular tropism and infection dynamics of EV-D68, we profiled naive and EV-D68-infected human spinal cord organoids (hSCOs) derived from induced pluripotent stem cells (iPSCs) using single-cell RNA sequencing (scRNA-seq). Examining the cellular composition of healthy hSCOs, we found that hSCOs include diverse cell types, including neurons, astrocytes, oligodendrocyte progenitor cells (OPCs), and multipotent glial progenitor cells (mGPCs). Upon infection with 2 EV-D68 strains, US/IL/14-18952 (a B2 strain) and US/MA/18-23089 (a B3 strain), we observed distinct viral tropism and host transcriptional responses. Notably, US/IL/14-18952 showed a significant preference for neurons, while US/MA/18-23089 exhibited higher rates of infection in cycling astrocytes and OPCs. These findings provide novel insights into the host cell tropism of EV-D68 in the spinal cord, offering insight into the potential mechanisms underlying AFM pathogenesis. Understanding the dynamics of infection at single-cell resolution will inform future therapeutic strategies aimed at mitigating the neurological impact of enterovirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb54cf51aa995a2705a7d71cb812e43393ceb04a" target='_blank'>
              Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
              </a>
            </td>
          <td>
            Nathânia Dábilla, Sarah Maya, Colton McNinch, Taylor Eddens, Patrick T. Dolan, M. Freeman
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) characterized by multifocal inflammation and axonal degeneration, driven by innate and adaptive immune cells. The Janus Kinase (JAK)/Signal Transducers and Activators of Transcription (STAT)/Suppressors Of Cytokine Signaling (SOCS) pathway regulates immune cell activity, with SOCS proteins functioning as negative regulators. Using the Experimental Autoimmune Encephalomyelitis (EAE) model of MS, our prior work demonstrated that mice lacking Socs3 in myeloid cells (Socs3ΔLysM) developed severe, brain-targeted EAE (btEAE), with increased cerebellar infiltration of activated neutrophils. To define neutrophil-specific roles, we generated mice with Socs3 deletion restricted to neutrophils (Socs3ΔLy6G). Following MOG-induced EAE, these mice exhibited clinical features identical to Socs3ΔLysM mice, including severe cerebellar demyelination, increased cerebellar infiltration of activated neutrophils and CD4+ T-cells, and clinical symptoms of both btEAE and classical EAE (cEAE), the latter involving the spinal cord (SC). Cerebellar neutrophils from Socs3ΔLy6G mice exhibited a primed, inflammatory phenotype with elevated reactive oxygen species, neutrophil extracellular traps (NETs) and heightened production of pro-inflammatory cytokines/chemokines. Neutrophil depletion alleviated btEAE, confirming their pathogenic role. Single-cell RNA Sequencing (scRNA-Seq) of cerebellum (CB) and SC neutrophils revealed five clusters in naïve and EAE mice, with expansion of two clusters (Neu2 and Neu4) in Socs3ΔLy6G mice with EAE. Neu2, Neu3 and Neu4 clusters showed high expression of Saa3, Il1b and Cxcl2, with Neu4 enriched in cytokine signaling pathways and inflammatory responses. Strikingly, Saa3 mRNA and protein expression were markedly increased in the CB and SC of Socs3ΔLy6G mice with EAE compared to controls. Translationally, the human orthologue SAA1 was significantly elevated in plasma from MS patients relative to healthy controls. Collectively, these findings demonstrate that Socs3 deficiency unleashes pathogenic neutrophil activity in Socs3ΔLy6G mice with EAE. They further reveal neutrophil heterogeneity within the inflamed CNS, define inflammatory transcriptional states and identify Saa3/SAA1 as potential biomarkers and therapeutic targets to attenuate autoimmune neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fe5a2480e246a352587ff976b7ff5324d95b8c9e" target='_blank'>
              Single-Cell RNA Sequencing Uncovers Neutrophil Clusters Associated with Autoimmune Neuroinflammation
              </a>
            </td>
          <td>
            Yong Wang, William Turbitt, Lianna Zhou, Zhaoqi Yan, Sweta B Patel, Wei Yang, Zhang Li, Jessica A. Buckley, R. Welner, William R. Meador, Chander Raman, H. Qin, Etty N. Benveniste
          </td>
          <td>2025-11-19</td>
          <td>Research Square</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92b1464e350c468b0e960f74f8db814fa5f708d3" target='_blank'>
              Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey
              </a>
            </td>
          <td>
            Tomoyuki Suzuki, Yoshihiro Kita, Keisuke Yanagida, Kenji Maeda, T. Hashidate-Yoshida, Hiroki Nakanishi, Takayo Ohto-Nakanishi, J. Terada-Hirashima, Yoshie Tsujimoto, Masayuki Hojo, H. Mitsuya, Takao Shimizu, Hideo Shindou
          </td>
          <td>2025-12-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Hyperactivated immunity underpins severe outcomes of respiratory viral infections, yet specific immune perturbations are ill-defined. Our recent findings identified OLAH (oleoyl-ACP-hydrolase) as a driver of life-threatening viral diseases. In the same patient cohorts, we now identify the gene encoding IL-18Rα chain (IL18R1), as being highly expressed in life-threatening influenza, COVID-19, RSV and multisystem inflammatory syndrome in children (MIS-C) and demonstrate markedly elevated surface protein IL-18Rα expression on CD8 T cells in these infections. Using a mouse model of severe influenza, we further show that high IL-18Rα expression on effector T cells is associated with increased disease severity. We find that IL-18Rα expression on CD8 T cells is inversely associated with cytotoxicity-related genes, including granzyme A, granzyme B, perforin, Eomes, and KLRG-1. Our study demonstrates that IL-18Rα is associated with severe and fatal respiratory disease outcomes and proposes the use of IL-18Rα as a potential biomarker for severe respiratory viral disease. The authors previously pinpointed OLAH (oleoyl-ACP-hydrolase) as a driver of life-threatening viral diseases. Here, the authors identify increased IL-18Rα expression on CD8+ T cells, which acquire a reduced cytotoxic signature, correlates with severe respiratory viral infection of influenza A virus, RSV and COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6dcd9c2feb67dc8df25c889f6ca091e2fc94480c" target='_blank'>
              High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures
              </a>
            </td>
          <td>
            Aira F. Cabug, J. Crawford, Hayley A. McQuilten, Isabelle J. H. Foo, L. Allen, Deborah Gebregzabher, R. Mettelman, Tanya Novak, Janet Chou, L. Rowntree, Ruth R. Hagen, Abby J. Thomson, Genevieve E. Martin, Brad Gilbertson, Michael N. T. Souter, Fiona James, Emma Goodall, Simone Rizzetto, T. Flerlage, Xiaoxiao Jia, Lee-Ann Van de Velde, So Young Chang, Fabio Luciani, R. Thwaites, Jason A. Trubiano, Tom C. Kotsimbos, Allen C. Cheng, A. Randolph, P. Thomas, Jianqing Xu, Zhongfang Wang, Thi H. O. Nguyen, B. Chua, Lukasz Kedzierski, K. Kedzierska
          </td>
          <td>2025-11-24</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>72</td>
        </tr>

        <tr id="ABSTRACT Systemic lupus erythematosus (SLE), characterized by immune dysregulation, urgently requires improved diagnostic tools and mechanistic insights. The role of interferon regulatory factor-1 (IRF-1) remains unclear. We integrated single-cell transcriptomes (scRNA-seq; GSE254176), 6 bulk transcriptomic datasets (1079 SLE patients, 137 controls, GSE72326 and GSE61635 were merged as training datasets, including 256 SLE patients and 50 controls), and clinical samples (70 SLE patients and 58 controls). IRF-1 dynamics in T-cell subsets were analyzed via clustering and pseudotemporal trajectory. Diagnostic genes were identified by intersecting single-cell-derived IRF-1–associated markers with SLE differential genes, followed by feature selection. Six machine learning models were trained and validated in four independent cohorts. scRNA-seq revealed significant downregulation of IRF-1 in T-cell subsets (central memory CD8⁺, Th17) during active SLE, with compensatory overexpression in remission—validated clinically. Cross-analysis identified four IRF-1–correlated diagnostic genes: CCR7, CD274, KLRB1, and NRCAM, that are enriched in MAPK signaling and immune receptor activity. Generalized linear model (GLM) and partial least squares (PLS) models achieved superior diagnostic accuracy across validation cohorts. Immune analysis revealed decreased numbers of resting CD4⁺ memory T cells and Tregs (P < 0.01), alongside expanded proinflammatory cells (M1/M2 macrophages, neutrophils; P < 0.01). IRF-1 regulates T-cell differentiation and contributes to SLE immune imbalance. The IRF-1–associated gene–based machine learning model provides a robust, noninvasive diagnostic tool.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fee8fbcb2e712ec10437e9cabca33ae9f067a525" target='_blank'>
              The role of IRF-1 in mediating T-cell immune imbalance in systemic lupus erythematosus and the construction of a diagnostic model
              </a>
            </td>
          <td>
            Zichen Huang, Cheng Zhao, Fang Qin, Leting Zheng
          </td>
          <td>2025-11-19</td>
          <td>Autoimmunity</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Severe fever with thrombocytopenia syndrome virus (SFTSV) infection is associated with poor clinical outcomes and defective humoral immunity yet the immunometabolic mechanisms underlying B cell dysfunction remain incompletely defined. Through integrated single‐cell RNA sequencing and B cell receptor (BCR) repertoire profiling of peripheral B cells from SFTS patients, we dissected the molecular signatures between survivors and fatal cases. Functional validation and metabolic flux analysis were further performed. Seven transcriptionally distinct B cell subsets were identified. Fatal cases exhibited a marked expansion of CXCR3+Ki‐67+CXCR5‐ extrafollicular plasmablasts, coupled with depletion of naïve and memory B cells. These plasmablasts exhibited hyperactivation of interferon‐response genes (IFI27, ISG15), upregulation of inflammatory mediators (S100A8/A9), and contraction of BCR diversity, with skewed usage of λ‐light chains. Pseudotime trajectory analysis and metabolic scoring revealed progressive upregulation of oxidative phosphorylation, glycolysis and endoplasmic reticulum stress during terminal differentiation. In fatal cases, B cells exhibited suppressed antigen presentation capacity and impaired immunoglobulin gene expression, alongside heightened oxidative stress and elevated CD39 levels. Furthermore, analysis of SFTSV‐infected versus uninfected B cells revealed that infected plasmablasts displayed enhanced inflammatory and migratory features, including upregulated CXCR3 and CCR10 expression, suggesting direct viral modulation of B cell function and trafficking. Our study reveals that dysfunctional, metabolically reprogrammed plasmablasts underlie humoral immune failure in fatal SFTS. These findings provide mechanistic insight into B cell‐mediated immunopathogenesis and highlight potential targets for prognostic evaluation and immunomodulatory intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3800a9aa69e7fadce2b5246f5ad88f00ce2eb14b" target='_blank'>
              Dysregulated B Cell Responses in Severe Fever With Thrombocytopenia Syndrome Revealed by Single‐Cell RNA Sequencing
              </a>
            </td>
          <td>
            Hongyan Hou, Siyu Zou, Teding Chang, Yun Wang, Ting Wang, Wei Wei, Rujia Chen, Renren Ouyang, Hui Hu, Shiji Wu, Feng Wang
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/561fc69832beac4c1e41655e3f435bfb03fefa41" target='_blank'>
              Oncogene c-Myc Regulates Upper Respiratory Epithelial Repair for Host Immunity During Acute Influenza Infection
              </a>
            </td>
          <td>
            Alexander G. Foote, Le Xu, J. Verheyden, Belle Pan, Nikita Katoch, Xin Sun
          </td>
          <td>2025-12-23</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Type 1 and type 2 diabetes are associated with increased severity and mortality from respiratory virus infections. Vaccination in the general population significantly reduces the risk of severe respiratory viral infection and triggers a strong, polyfunctional, and lasting T cell response in healthy individuals. However, vaccine effectiveness in people with type 1 diabetes is unclear. Here, we studied the magnitude and functional characteristics of vaccine‐specific CD4+ and CD8+ T cell responses to vaccination in people with type 1 and type 2 diabetes and compared them to those of people living without diabetes, using the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine as a model. We found defects in both CD4+ and CD8+ T cell memory maintenance and the functionality of the vaccine‐specific T cells in people with diabetes compared with people without. In those individuals with type 1 and type 2 diabetes who harbored detectable vaccine‐specific T cells, they displayed an unfocused, tolerogenic phenotype characterized by increased expression of IL‐10 and IL‐13 compared with people without diabetes. These results have implications for vaccination strategies for people with diabetes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4031dbb61e7a04cf97ccca1bfecea6c7f4cd3624" target='_blank'>
              IL‐10‐ and IL‐13‐Biased T Cell Responses to SARS‐CoV‐2 Vaccination in Diabetes
              </a>
            </td>
          <td>
            Emma M. Jones, C. Sourij, M. Stradner, Peter Schlenke, Nazanin Sereban, O. Moser, Rachael A Quinlan, Charlotte-Eve Short, Benjamin H L Harris, Michael B Fertleman, Graham P Taylor, Nick Oliver, H. Sourij, Margarita Dominguez-Villar
          </td>
          <td>2025-12-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/679a7b822ce567d8ac2ac1c2ea01dd417c348cfe" target='_blank'>
              The SARS-CoV-2 nucleocapsid protein induces microglia senescence-mediated cognitive impairment via Glycolysis.
              </a>
            </td>
          <td>
            Nan-Shi-Yu Yang, Han-Xi Sha, Chen-Yu Zhang, Hui Chen, Yu-Biao Liu, Jian-Bing Xiong, J. Duan, Jun Zhang, Cha-Xiang Guan, Yong Zhou, Feng Su, W. Zhong
          </td>
          <td>2025-12-12</td>
          <td>Molecular medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Since the onset of the COVID-19 pandemic, obesity has been consistently associated with worse clinical outcomes. In 2020, we hypothesized that adipose tissue (AT) might serve as a viral reservoir and amplifier of immune responses in SARS-CoV-2 infection. Five years on, accumulating evidence supports this hypothesis. Recent autopsy and in vitro studies support that SARS-CoV-2 disseminates to and may replicate within human adipocytes. While several studies have detected SARS-CoV-2 RNA and proteins in AT, the recovery of infectious virus from this tissue has not yet been demonstrated. This remains a critical gap in our understanding of SARS-CoV-2 viral tropism and replication within adipocytes. Viral entry is mediated via angiotensin-converting enzyme-2 and neuropilin-1 receptors. Infected AT exhibits immune cell infiltration and cytokine activation, implicating it in systemic inflammation. Persistent viral RNA in AT correlates with prolonged metabolic dysfunction. These findings highlight the dual role of AT as a potential viral reservoir and immunometabolic organ. Understanding these mechanisms is critical to mitigating the long-term impact of COVID-19 and guiding responses to future pandemics involving metabolically active tissues.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/77a113aee7203a484ecb443a20ff11990516bad4" target='_blank'>
              Adipose Tissue in SARS-CoV-2 Viral Tropism, Viral Replication, and the Concept of a Viral Reservoir: An Update.
              </a>
            </td>
          <td>
            Liam Charles Maher, Paul M. Ryan, Noel M. Caplice
          </td>
          <td>2025-11-24</td>
          <td>Obesity</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="A comprehensive understanding of host-virus interactions during persistent foot-and-mouth disease virus (FMDV) infection is essential for elucidating the mechanisms that underpin disease causation by this highly contagious pathogen. This understanding necessitates the development of stable in vitro models. In this study, we established a model of persistent FMDV serotype O infection in Madin-Darby bovine kidney epithelial cells followed by integrated multiomics analyses. These analyses revealed that host cells adapt to persistent viral infection by reprogramming mitochondrial metabolism. This reprogramming is accompanied by alterations in mitochondrial structure and function, as well as the suppression of the apoptotic response in host cells. In particular, bystander cells, which are devoid of active viral replication, display enhanced proliferative capacity and possess a distinct microenvironmental signature that potentially increases viral susceptibility, facilitating sustained virus persistence within the cell population. Moreover, persistent viruses have evolved enhanced replicative fitness. Our findings elucidate the biological characteristics of FMDV-infected cell populations that persistently harbour the virus, reveal host-virus coadaptation, and highlight the critical role of bystander cells in sustaining persistent FMDV infection. These discoveries establish the foundation for further mechanistic studies of FMDV persistence maintenance. Supplementary Information The online version contains supplementary material available at 10.1007/s00018-025-05997-y.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f717c7343d691b2f665717d1011e75b567875353" target='_blank'>
              Integrated multiomics reveals host-virus coadaptation in persistent foot-and-mouth disease virus infection
              </a>
            </td>
          <td>
            Shuang Wang, Zhihui Zhang, Sumin Wei, Guoliang Huang, Shuanghui Yin, Suyu Mu, Hu Dong, Shiqi Sun, Huichen Guo
          </td>
          <td>2025-11-24</td>
          <td>Cellular and Molecular Life Sciences: CMLS</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Background T-cell responses are crucial in SARS-CoV-2 immune-control; however, limited data exist from African populations. We assessed interferon-gamma (IFN-γ) release by T cells among Tanzanian adults (18–70 years) previously infected with or without SARS-CoV-2 vaccination, using the ELISpot assay. We also characterized background plasma IFN-γ levels in this population. Methods Peripheral blood mononuclear cells (PBMCs) from 143 individuals, sampled 1–12 months post SARS-CoV-2 exposure, were stimulated with overlapping peptides spanning the Spike and Nucleocapsid proteins. T-cell responses were measured by ELISpot assay, and plasma IFN-γ concentrations by ELISA. Associations with participant characteristics were analyzed using gamma linear and modified Poisson regression models (p < 0.05 considered significant). Results We found high background T-cell IFN-γ release in 73.4% (105/143) of participants, leaving 38 (26.6%) with detectable responses above background; (38/38;100%) to Spike and (36/38;94.7%) to Nucleocapsid peptides. T-cell response magnitude did not differ by symptomatic/asymptomatic infection or vaccination status. However, each one-year increase in age was associated with a 1% decline in mean T-cell response (p = 0.029). Moreover, among participants with high background responses, 43/105;41% had elevated plasma IFN-γ, and 5/105; 4.8% showed cytokine storm-level concentrations. Alcohol consumption was significantly associated with elevated plasma IFN-γ (p = 0.041). Conclusion Strong and possibly cross-reactive T-cell responses to SARS-CoV-2 were detected in Tanzanian individuals following infection with/without vaccination. Moreover, high plasma IFN-γ levels were detected, especially among participants who consumed alcohol. We recommend for modifications of the ELISpot T-cell assays to optimize the evaluation of pathogen-specific T-cell responses among African residents given the high background IFN-γ release.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/54f3e9b40a7457b0ee1b6ea368c711e316371b03" target='_blank'>
              T-Cell Interferon Gamma Responses to SARS-CoV-2 Following Infection with/Without Vaccination in a Tanzanian Population
              </a>
            </td>
          <td>
            Lilian Nkinda, Godfrey Barabona, Mark Ndubi, C. Motozono, Emmanuel Nkuwi, Doreen Kamori, F. Msafiri, Posian Kunambi, Elisha Osati, Benson Kidenya, Harrison Chuwa, F. Hassan, Juma Kisuse, S. Mfinanga, Mbazi Senkoro, Takamasa Ueno, E. Lyamuya, Emmanuel Balandya
          </td>
          <td>2025-12-01</td>
          <td>Infection and Drug Resistance</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ebd7c1c95a72fa42446be74525f1dfe8c58ae064" target='_blank'>
              Decoding acute neuroinflammatory states from the 3D architecture of in vitro microglia
              </a>
            </td>
          <td>
            Anthoula Chatzimpinou, Johanna Huber, Xenia Podlipensky, J. Cairns, Ayse Erozan, Jian-Hua Chen, V. Loconte, M. Le Gros, Carsten Hopf, Carolyn A. Larabell, V. Weinhardt
          </td>
          <td>2025-12-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="ABSTRACT Long-term non-progressors (LTNPs) represent a valuable model to investigate immunological features associated with non-progression in chronic HIV infection. In this study, single-cell RNA sequencing was performed on peripheral blood mononuclear cells obtained from 12 individuals, including 4 LTNPs, 4 typical progressors (TPs), and 4 healthy donors (HDs). Compared with TPs, LTNPs exhibited a higher percentage of naive T cells, whereas TPs showed a higher percentage of CD8+ Effector-GNLY cells. LTNPs also exhibited lower gene-expression scores related to T-cell activation, cytotoxicity, inflammation, and interferon-alpha response across multiple effector-state T-cell subsets. GO enrichment analysis showed that compared with HDs and TPs, LTNPs exhibited downregulation of migration, translation, and antiviral response pathways in both CD4+ and CD8+ T cells, with upregulation of stress/inflammatory response and differentiation programs in CD4+ T cells and of immune differentiation/activation pathways in CD8+ T cells. High-dimensional weighted gene co-expression network analysis (hdWGCNA) further revealed higher module eigengene expression of innate and myeloid-related modules and lower expression of B-cell and cytotoxicity-related modules in LTNPs compared with TPs. Additionally, HIV-1 RNA+ cells were detected more frequently in TPs than in LTNPs and predominantly identified within CD4+ T cells. Together, these findings reveal a transcriptionally balanced and favorable immunological profile associated with non-progressive HIV infection and inform the design of immune-based strategies toward a functional HIV cure. IMPORTANCE Understanding molecular traits associated with natural control in LTNPs is critical for advancing HIV remission and cure strategies. Using single-cell RNA sequencing, we found that LTNPs had more naive T cells and fewer CD8+ effector-GNLY cells than typical progressors, along with lower activation, cytotoxicity, inflammation, and IFN-α scores across effector-state T-cell subsets. Differential expression and GO analyses showed predominant downregulation of migration, translation, and antiviral pathways, while preserving early activation markers. Co-expression network analysis revealed higher innate/immune-regulatory module activity and lower B-cell and cytotoxicity modules in LTNPs. HIV-1 RNA+ cells were detected less frequently in LTNPs and mainly detected in CD4+ T cells. These findings highlight balanced immune programs in LTNPs, which may inform strategies toward a functional HIV cure. Understanding molecular traits associated with natural control in LTNPs is critical for advancing HIV remission and cure strategies. Using single-cell RNA sequencing, we found that LTNPs had more naive T cells and fewer CD8+ effector-GNLY cells than typical progressors, along with lower activation, cytotoxicity, inflammation, and IFN-α scores across effector-state T-cell subsets. Differential expression and GO analyses showed predominant downregulation of migration, translation, and antiviral pathways, while preserving early activation markers. Co-expression network analysis revealed higher innate/immune-regulatory module activity and lower B-cell and cytotoxicity modules in LTNPs. HIV-1 RNA+ cells were detected less frequently in LTNPs and mainly detected in CD4+ T cells. These findings highlight balanced immune programs in LTNPs, which may inform strategies toward a functional HIV cure.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a6171a97ed7fcf5c1b6659f49943539558df22b4" target='_blank'>
              Single-cell transcriptome profiling reveals immunological fitness of HIV long-term non-progressors
              </a>
            </td>
          <td>
            Minjuan Shi, Rongfeng Chen, Tongjin Wu, Yu Liao, Tongxue Qin, Ziyu Wen, Junqi Liu, Xiu Chen, Beibei Lu, Chunxing Yi, Li Ye, Hao Liang, Caijun Sun, Junjun Jiang
          </td>
          <td>2025-11-24</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/17ca45251dca60eb19783c9a6d4ef6ec1d61fb90" target='_blank'>
              Single-cell RNA sequencing of cerebrospinal fluid immune cells in relapsing–remitting multiple sclerosis: insights into cellular composition and immune dynamics
              </a>
            </td>
          <td>
            Xue Yang, Fanju Li, Jingtian Zhe, Zhimian Zhang, Zhenzhen Hu, Chenchang Zhang, Fenqi Wan, Qinfang Xie, Xiaoling Li
          </td>
          <td>2025-11-19</td>
          <td>Journal of Neurology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Viral infections impose a substantial threat to human health, characterized by a wide range of pathogens, clinical manifestations, and complex immune responses. Single-cell multi-omics technologies have revolutionized the study of antiviral immunity by resolving cellular heterogeneity, transcriptional reprogramming, and clonal dynamics. However, no resource has yet comprehensively integrated such datasets in the context of viral infections. Here, we present scMOVIR, a single-cell multi-omics database for human viral infections and immune responses. The database systematically integrates transcriptomic, proteomic, and immune receptor repertoire profiles at single-cell resolution, compiling 8532 human samples across 114 viral species, subtypes, and strains. These datasets span 59 well-defined disease states, including acute and chronic infections, virus-associated malignancies, and immune-related disorders, and extend across >30 tissue types. In addition, these datasets incorporate vaccination cohorts, therapeutic interventions, and time-course models of infection. To ensure consistency and interoperability, all datasets undergo standardized preprocessing, including batch correction and unified cell-type annotation, with metadata harmonized using authoritative ontologies. scMOVIR provides user-friendly interfaces for dataset exploration and interactive visualization of cellular dynamics and molecular profiles, offering a high-resolution reference for investigating virus-host immune interactions and supporting antiviral research. The database is freely accessible at https://pgx.zju.edu.cn/scmovir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/130c5b82f9725db7d1697918120f36ba3e49fd02" target='_blank'>
              scMOVIR: a single-cell multi-omics database for human viral infections and immune responses.
              </a>
            </td>
          <td>
            Xue Zhang, Shounan Yang, Xiaobin Xu, Yitao Lin, Huaicheng Sun, Bangyu Zhu, Wenyi Zhao, Binbin Zhou, Yan Lou, Xinyu Wang, Shuqing Chen, Qiaojun He, Feng Zhu, Zhan Zhou
          </td>
          <td>2025-11-13</td>
          <td>Nucleic acids research</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of COVID‐19, has caused widespread morbidity and mortality worldwide. SARS‐CoV‐2 infection triggers innate and adaptive immune responses, but excessive cytokine release can drive hyperinflammation, acute respiratory distress syndrome and poor clinical outcomes. Although serological and molecular assays, such as ELISA and RT‐qPCR, remain central to COVID‐19 diagnostics, they have limited capacity to reveal host–pathogen interactions at the tissue level. Therefore, profiling the human lung proteome offers a powerful strategy to identify molecular signatures associated with viral pathogenesis and disease severity. This review emphasises emerging technologies that advance lung proteome profiling during SARS‐CoV‐2 infection. Novel strategies include phage display for high‐throughput identification of antibody–antigen interactions, yeast two‐hybrid for mapping virus–host protein interactions and lateral flow immunoassays for rapid, point‐of‐care detection. Conversely, omics‐based technologies such as single‐cell RNA sequencing, microarrays and mass spectrometry are transforming our understanding of the lung proteome by revealing patterns of gene expression, protein abundance and immune heterogeneity. Therefore, comparing these conventional diagnostic assays with innovative approaches, we highlight their unique contributions to lung proteome research. These tools not only improve diagnostic precision but also hold the potential to uncover biomarkers for early risk stratification and therapeutic targeting. Prioritising integrative proteome‐focused strategies may ultimately guide personalised interventions and enhance preparedness for future viral outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bbbfd30116540e19ec56315bbd933a000cc82f6f" target='_blank'>
              Novel Strategies to Profile SARS‐CoV‐2 and Human Lung Proteome: Inflammatory Pathways in the Spotlight
              </a>
            </td>
          <td>
            E. Mankayi, T. E. Chiliza, N. Mvubu
          </td>
          <td>2025-01-01</td>
          <td>BioMed Research International</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0df155cef961a4919322a6e793a6b887b5332168" target='_blank'>
              Evolutionary rewiring of host metabolism and interferon signalling by SARS-CoV-2 variants
              </a>
            </td>
          <td>
            Riaz-Ali Somji, Jonathan C. Brown, Shahid Rowles-Khalid, Tukur Abdullahi, Dongsheng Luo, Natalie Barthel, Michael Mülleder, M. Ralser, Wendy S. Barclay, C. Rallis, E. S. Giotis
          </td>
          <td>2025-11-28</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Viruses, like influenza and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remain major causes of upper respiratory tract infections worldwide, with symptoms ranging from asymptomatic to lethal outcomes. While antivirals and vaccines have helped ameliorate disease morbidity and mortality, these infections still pose significant challenges. Probiotics, including Lactococcus lactis strain plasma (LC-Plasma), have recently shown antiviral effects by activating plasmacytoid dendritic cells (pDCs), though their detailed mechanism remains unclear. In this study, we stimulated peripheral blood mononuclear cells (PBMCs) collected from healthy participants with LC-Plasma and conducted immunological analyses to investigate the immunomodulatory mechanisms of LC-Plasma. The supernatant derived from LC-Plasma-stimulated PBMCs (LCP Sup) exhibited dose-dependent inhibition of replication in Influenza A virus subtype H1N1 (H1N1) and SARS-CoV-2. LCP Sup significantly reduced the SARS-CoV-2 viral load in Huh-7 cells. However, in the H1N1 antiviral assay using A549 cells, LCP Sup was required at a higher concentration against H1N1 in A549 cells compared with SARS-CoV-2 in Huh-7 cells. Treatment with LCP Sup significantly upregulated interferon-stimulated genes (ISG) expression, particularly MxA, in A549 cells. While MxA showed the most notable increase, other ISGs also exhibited elevated expression levels compared with the negative control. Other cytokines, chemokines, and growth factors were also induced by LC-Plasma and CpG-DNA stimulation, and the effects of LC-Plasma were much higher than those of CpG-DNA. These results provide in vitro evidence of the antiviral mechanisms of LC-Plasma via upregulation of interferon-α (IFN-α) and related ISGs for host defense against respiratory viruses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/54c1e93f06d05aceebdf2e0d94bd475aa2743cdf" target='_blank'>
              Stimulation of Peripheral Blood Mononuclear Cells with Lactococcus lactis Strain Plasma Elicits Antiviral Effects Against H1N1 and SARS-CoV-2
              </a>
            </td>
          <td>
            Zhao Xuan Low, Owen Woo, Osamu Kanauchi, P. Hassandarvish, V. Tiong, Sazaly AbuBakar
          </td>
          <td>2025-11-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d82b0101e16002e72922cc003dc674661bb12d26" target='_blank'>
              Ischemic injury triggers a protective microglial phenotype in models of Aβ pathology
              </a>
            </td>
          <td>
            Michael Candlish, Jan Hofmann, Desirée Brösamle, Annika Haessler, Murphy DeMeglio, Angelos A. Skodras, Georgi Tushev, Eloah S. De Biasi, Stefan Günther, R. Wiegandt, Heidi Theis, Elena De Domenico, Nina Hermann, K. P. R. Nilsson, Marc Beyer, Mario Looso, M. Windbergs, Sigrun Roeber, Jochen Herms, J. Neher, Andreas G. Chiocchetti, Jasmin K. Hefendehl
          </td>
          <td>2025-12-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="As primary immune sentinels of the central nervous system (CNS), microglia respond rapidly to acute brain injury and engage in dynamic crosstalk with infiltrating peripheral immune cells. This interplay critically shapes the neuroinflammatory microenvironment—a key determinant of secondary brain injury (SBI) following intracerebral hemorrhage (ICH). Fatty acid-binding protein 4 (FABP4), an adipokine associated with metabolic disorders, is recognized as a pivotal modulator of inflammatory responses; however, its role in ICH-induced SBI remains undefined. To investigate the pathogenic functions of FABP4 in microglia after ICH, elucidate its molecular mechanisms, and develop targeted therapeutic strategies. Blood and brain tissue samples from ICH patients were analyzed to evaluate the relationships between FABP4 expression and prognosis. Behavioral tests, Nissl staining, and Golgi-Cox staining were used to quantify neuronal damage. Immunofluorescence and flow cytometry were used to assess microglial activation and immune cell infiltration. Transcriptomic, proteomic, co-immunoprecipitation, western blotting, and ChIP‒qPCR analyses were used to examine the FABP4 regulatory network. Brain-targeted nanoparticles were engineered to deliver FABP4-specific siRNA. Clinical analyses revealed microglia-specific FABP4 upregulation in ICH patients, correlating with poor neurological outcomes. Microglial Fabp4 knockout in mice attenuated neuronal loss, ameliorated cerebral edema, and enhanced functional recovery after ICH. Mechanistically, FABP4 promoted lipid droplet accumulation and inhibited the ubiquitin–proteasome-mediated degradation of S100A9 in microglia, synergistically amplifying neuroinflammation. Moreover, the activity of FABP4 in microglia facilitated neutrophil transendothelial migration into the brain parenchyma, exacerbating injury via the release of neutrophil extracellular traps (NETs). Finally, pharmacological FABP4 inhibition using brain-targeted nanoparticles conferred significant neuroprotective effects in ICH models. This study establishes that FABP4 acts as a novel orchestrator of post-ICH neuroinflammation through dual enzymatic and nonenzymatic pathways. We also demonstrate a targeted nanotherapeutic strategy to suppress FABP4 and improve neurological outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cbd6afea19f2780d62b43438f150276eb07542a8" target='_blank'>
              Fatty acid-binding protein 4 drives microglia-mediated neuroinflammation through promoting S100A9 expression and lipid droplet accumulation after intracerebral hemorrhage
              </a>
            </td>
          <td>
            Jiaqing He, Zijuan Qin, Haixiao Liu, Yaning Cai, Hao Wu, Tinghao Wang, Qing Hu, Yanni Xu, Pan Yang, Xun Wu, Yan Qu, Wei Guo
          </td>
          <td>2025-11-07</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Introduction Despite extensive research, the pathogenesis and predispositions underlying long COVID (long-term coronavirus disease 2019) remain poorly understood. Methods To address this, we analyzed the immunological landscapes of 44 patients with long COVID and 44 matched convalescents using single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) and validated the findings with plasma cytokine measurements via Luminex technology. Results While the immune cell compositions showed minimal quantitative differences only among natural killer (NK) cells, the transcriptome analyses identified distinct gene expression patterns, particularly in classical monocytes: patients with long COVID exhibited downregulation of the inflammation-associated genes, including IL1B and CXCL2. Imputation of the transcription factor activity hinted at a reduced inflammasome activity (via SNAI1) and an impaired monocyte differentiation (via ATF2) in long COVID. The RNA velocity data supported the presence of immature classical monocytes in these patients. Discussion These findings show that monocytes might be dysregulated and/or exhausted in patients with long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3892a0439deb222191d646b042b2e39ae2bf0fef" target='_blank'>
              Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients
              </a>
            </td>
          <td>
            Florian Fricke, Franz Mai, Christine Wossidlo, Felix Steinbeck, Wendy Bergmann-Ewert, Marcel Kordt, Karin Kraft, Britta Müller, Emil C. Reisinger, Brigitte Müller-Hilke
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially infects airway epithelial cells. This infection is mediated by the binding of SARS-CoV-2 spike (S) protein to ACE2 expressed on target cells. Patients with allergic (type-2) asthma have been reported to be less susceptible to coronavirus disease 2019 (COVID-19), but these effects are controversial and mechanistically unclear. We previously showed lower expression of ACE2 mRNA in airway epithelial cells from type-2 asthmatics compared to healthy donors. Moreover, we and others demonstrated that the type-2 cytokine interleukin 13 (IL-13) suppresses ACE2 expression and SARS-CoV-2 infection in human epithelial cells. To better understand the relationship between type-2 inflammation, ACE2 expression, and SARS-CoV-2 infection, we investigated the effects of IL-13 on critical steps of epithelial cell infection by SARS-CoV-2: S protein-mediated binding to ACE2 on epithelial cells, and ACE2-mediated SARS-CoV-2 entry into these cells. Recombinant IL-13 significantly inhibited both these processes. This inhibition appeared to be mediated by IL-13-induced suppression of ACE2 transcription because IL-13 failed to affect S protein-mediated viral entry into cells that express ACE2 under the control of an IL-13 unresponsive heterologous promoter. We propose that IL-13 protects epithelial cells from SARS-CoV-2 infection largely by inhibiting ACE2 expression and ACE2-mediated downstream events that allow the virus to access its cellular targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df8083f73ae8478fb1031798b020e6d2348e4b62" target='_blank'>
              IL-13 protects epithelial cells from SARS-CoV-2 infection by inhibiting ACE2-mediated virus binding and cell entry
              </a>
            </td>
          <td>
            Vadim Pivniouk, Oksana Pivniouk, J. Uhrlaub, Seongmin Hahn, Allyson Molzahn, Hiroki Kimura, Mari Numata, H. Chu, J. Ledford, Monica Kraft, J. Nikolich, Donata Vercelli
          </td>
          <td>2025-11-24</td>
          <td>ImmunoHorizons</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f06caba0f4cc503c8b0aa1aadbc7d5f878826110" target='_blank'>
              GPR34 regulation of disease-associated microglial states and responses to physiological stimuli
              </a>
            </td>
          <td>
            Ana Geller, Min Jee Kwon, Sean K Simmons, Qihong Xu, William E. Martenis, Jordan L. Doman, Sahana Natarajan, Katherine J. Stalnaker, Jixiang Zhang, Xian Adiconis, Trang Nguyen, Matthew Demers, Donovan L. Batzli, Antia Valle-Tojeiro, Christy Biji, Sameer Aryal, Horia Pribiag, Constanze Depp, Nader Morshed, Deeksha Misri, Diana Bohannon, Elena Longhi, Hasmik Keshishian, Steven A. Carr, David McKinney, Alexandra E.Gould, Evan P Lebois, M. Weïwer, Matthew Johnson, Joshua Z. Levin, Yan-Ling Zhang, Morgan Sheng, Prabhat S. Kunwar
          </td>
          <td>2025-12-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Mpox re-emerged globally in 2022 with atypical clinical features and efficient human-to-human transmission, which underscores the need to better understand host immune responses. We conducted an integrative transcriptomic analysis of mpox virus (MPXV) infection in nonhuman primates by leveraging RNA-Seq datasets from whole-blood and skin. We applied the Generalized Linear Model with Quasi-Likelihood F-test and Magnitude-Altitude Score (GLMQL-MAS), a method that combines rigorous statistical testing with a ranking metric to identify and prioritize differentially expressed genes (DEGs), and the Cross-Magnitude-Altitude Score (Cross-MAS) gene selection strategy, which integrates results across multiple time points to identify reproducible signatures, to define compact and robust markers of infection. Longitudinal analysis of whole-blood revealed a staged immune trajectory: early induction of interferon-stimulated genes (IFI27, ISG15) was followed by proliferative and hematopoietic programs and later enrichment of adaptive immune signatures, including B cell activation and TNF signaling. A minimal six-gene panel (IFI27, ISG15, MYO7B, HEY1, VASH1, CNTD2) distinguished infected from control animals with 100% accuracy in both training and independent held-out test sets. In contrast, skin transcriptomes showed upregulation of keratinocyte-related genes (KRT10, KRT1, SOSTDC1) and downregulation of immune mediators (IL1B, CXCL8, S100A8, ISG15), which suggests epithelial remodeling with limited local immune activation. Cross-tissue comparisons revealed that under stringent criteria (BH-adjusted p-value < 0.05 and |log₂FC|> 1), only 10 genes were commonly significant between whole-blood and skin, and all (100%) exhibited opposite regulation. When thresholds were relaxed for exploratory purposes (unadjusted p-value < 0.05 and |log₂FC|> 1), 58 common significant immune-related genes were identified from the curated nCounter® Host Response Panel, of which 74.1% were oppositely regulated. Shared immune genes such as ISG15, MX1, IFIT2, and OAS2 were upregulated in blood but suppressed in skin, and Reactome enrichment of discordant genes highlighted interferon and cytokine signaling pathways. These contrasts suggest that MPXV may trigger systemic interferon activation while suppressing local antiviral responses in lesions; however, because they are derived from independent secondary datasets in different species, they should be regarded as hypothesis-generating signals that require confirmation in matched, longitudinal studies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f42e167ab73e8ee0f1b9da83613dfa3150236874" target='_blank'>
              Opposite regulation of immune genes in blood and skin highlights tissue-specific dynamics of mpox virus
              </a>
            </td>
          <td>
            Mostafa Rezapour, Sean V. Murphy, D. Ornelles, Patrick M. McNutt, Anthony Atala
          </td>
          <td>2025-11-07</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4edc78ea59897eb7bd96425cec0afc43cf52263b" target='_blank'>
              Interferon-stimulated gene GALNT2 restricts respiratory virus infections.
              </a>
            </td>
          <td>
            Wei Ran, Jinghong Yang, Shi Yu, Qingtao Hu, Yuqi He, Shengjun Wang, Cheng Wei, Jing Sun, Airu Zhu, Fang Li, Lu Zhang, Pengfei Li, Huina Hu, Ruangang Pan, Yanying Yu, Yanqiu Yuan, Lingyu Sun, Yanqun Wang, Zhaoyong Zhang, Zhao Chen, Donglan Liu, Qihong Yan, Dong Wang, Kuai Yu, Yiliang Wang, Jianfen Zhuo, Zhuan Zhen, Hua Tao, Qiuhui Zeng, Kaixin Zhou, Feng Chen, Wenxuan Tang, Yuzheng Zhou, Rong Bai, Yonghao Xu, Na Li, Jun Dai, Hongyu Zhao, Jung-Eun Park, Tao Wang, Qiang Ding, Stanley Perlman, Jingxian Zhao, Yang Mao, Shaobo Wang, Jincun Zhao
          </td>
          <td>2025-12-12</td>
          <td>Nature microbiology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Background Immunocompromised hosts (ICHs) face elevated risks of severe respiratory infections and mortality. Glucocorticoids, commonly used to treat underlying conditions in ICHs, may further impair immune defenses, but the underlying mechanisms remain unclear. Methods Retrospective analysis of peripheral blood immune cell profiles was conducted in pneumonia patients with ICHs. Prospective immunophenotyping of PBMCs by Cytek flow cytometry was performed to compare immune cell subsets in survivors versus deceased patients. To explore glucocorticoid effects on ICH immune mechanisms, we used a murine model of severe pneumonia (MRL/lpr mice) and an in vitro ICH infection mimic model. Glucocorticoid effects on immune cell populations and function were examined in these models. Results Focusing on key immune cells, we observed that ICH patients with severe pneumonia exhibit a reduction in classical monocyte subsets. Mechanistically, glucocorticoids downregulated CCL2 expression in the lung via GR/STAT3, thereby inhibiting the PA-LPS/TLR4/PI3K/AKT/STAT signaling pathway and diminishing pulmonary CCL2 and Ly6C+CCR2+ monocyte levels. Importantly, exogenous recombinant CCL2 administration restored monocyte function, reduced lung injury, and enhanced survival. Conclusion These findings uncovered a critical immunosuppressive mechanism by which glucocorticoids, via GR/STAT3-mediated suppression of the CCL2-CCR2 axis, impair monocyte-driven antibacterial responses in severe pneumonia, highlighting the need for targeted immunomodulation in ICH patients. Supplementary Information The online version contains supplementary material available at 10.1186/s12931-025-03437-w.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d9b4bf1673b01f4644488331e3a225c1f792b5eb" target='_blank'>
              Glucocorticoid-mediated suppression of the CCL2-CCR2 axis drives monocyte dysfunction in severe pneumonia among immunocompromised hosts
              </a>
            </td>
          <td>
            Zhongshu Kuang, Yue Luo, Yao Chen, Yilin Yang, Chen Chen, Feixiang Xu, Yumei Chen, Yannan Zhou, Yongqi Shen, Li Yuan, Hua Su, Chaoyang Tong, Zhenju Song
          </td>
          <td>2025-11-26</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Introduction The long-term dynamics of T-cell immunity following SARS-CoV-2 vaccination, essential for durable protection, remain incompletely understood. This study, therefore, aimed to investigate the kinetics and persistence of spike-specific T-cell responses in vaccinated healthcare workers. Methods Within the framework of the ORCHESTRA Project, we conducted a longitudinal study on the kinetics and persistence of CD4+ and CD8+ T cell immunity in healthcare workers (n=305) from four hospitals and public health centers across two European countries who received either 2 or 3 doses of an mRNA vaccine, with or without prior SARS-CoV-2 infection. Specifically, the anti-spike adaptive immune cellular response was evaluated, focusing on its crosstalk with the B cell response as measured by serology. Circulating cellular adaptive immune cells were extensively analyzed using flow cytometry to assess pro-inflammatory cytokine production (TNF-α, IFN-γ, IL-2), functional activation (CD154), and memory differentiation (CD45RO). Results Our findings show that anti-spike T cell reactivity is not influenced by age, with the only exception of a weak positive correlation with spike-specific CD8+CD45RO+ T lymphocytes (Spearman’s rho = 0.34, p<0.001), and an equally weak negative correlation with CD8+TNF+ (Spearman’s rho = -0.23, p<0.01). Other variables, such as gender and job category, did not significantly impact the vaccine-induced, anti-spike T cell immune response. Discussion No distinct relationship between CD4+ and CD8+ T cell subsets was observed post-vaccination. However, specific dynamic changes in vaccine-induced T cells were identified showing clear dose- and time-dependence. Finally, the median level of CD8+CD154+ lymphocytes, indicative of activated T cells, was significantly associated with infection incidence and may represent a reliable predictive biomarker. This study provides evidence that the vaccine-induced anti-spike cellular immune response should be considered when making vaccination decisions, as it has predictive value for infection risk.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07ae26ae5551412fdb1a4df495b2f7c4fe3ee344" target='_blank'>
              A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project
              </a>
            </td>
          <td>
            S. Ugel, Akshita Gupta, Gianluca Spiteri, P. Marchetti, F. De Sanctis, Shari Wouters, Angelina Konnova, M. Monaco, A. Carta, M. Pezzani, F. Liviero, S. Pavanello, M. dell’Omo, Eleonóra Fabiánová, Jana Bérešová, F. Larese Filon, Marcella Mauro, Giuseppe Verlato, Vincenzo Bronte, Samir Kumar-Singh, S. Porru
          </td>
          <td>2025-11-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Clinical observations suggest that obstructive sleep apnea (OSA) and Alzheimer’s disease (AD) pathology may be linked; however, causal mechanisms and relationships are unclear. To investigate the potential interaction between amyloidosis and intermittent hypoxia (IH), a hallmark of OSA, starting at 4 months of age 5XFAD mice were exposed to chronic IH (CIH) consisting of 20 episodes per hour of hypoxia for 12 h/day, daily for 4 months (males) or 6 months (females). CIH did not induce significant changes in amyloid burden or the number of astrocytes in males or females, but there was a slight decrease in the number of microglia observed in the cortex of 5XFAD mice of both sexes. To further explore this effect, we performed bulk RNA sequencing on isolated microglia. In WT mice, the most robust gene changes induced by CIH were identified in male microglia, many of which were pro-inflammatory. In microglia from 5XFAD mice, compared to normoxia (NX), CIH exposure induced comparatively more DEGs in males. Further, in genes that were upregulated by CIH in WT vs 5XFAD mice of both sexes, there was an enrichment of pathways associated with oxidative phosphorylation, aerobic and cellular respiration, and ATP synthesis. These changes indicate that CIH has a more robust effect on the microglial transcriptome in 5XFAD mice than in WT mice, suggesting that the synergy between AD and OSA pathologies may be driven by metabolic changes in the microglial transcriptome. These observations are particularly interesting given the known sex differences in OSA and AD pathology in human disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8727e54e7992921c8779ef401d96df0e163a6576" target='_blank'>
              Chronic Intermittent Hypoxia Exposure Induces a Unique Microglial Transcriptome in 5XFAD Mice
              </a>
            </td>
          <td>
            Kaitlyn M. Marino, Andrea C. Ewald, Jaidynne N. Lash, Erin C. McCann, Shibani Ram, Phinea Z. Romero, Tao Wang, Abby Watters, A. Radcliff, Daniel C. Shippy, Tracy L. Baker, Tyler K. Ulland, Jyoti J. Watters
          </td>
          <td>2025-11-19</td>
          <td>Molecular Neurobiology</td>
          <td>1</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d5581192995f28d24b781c1e7c2e69bf2aa53d8" target='_blank'>
              Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial
              </a>
            </td>
          <td>
            E. Maestri, W. J. Kwon, H. Zheng, T. Prestwood, H. Hedlin, J. W. Liang, H. McCann, B. Shaw, L. Tian, B. Jones, R. Lu, G. Wiley, E. Haraguchi, O. Wirz, J. Afaghani, B. Lam, D. F. D. Mahmood, N. A. Phillips, M. M. S. Sim, J. P. Wood, J. R. Heath, S. D. Boyd, J. Guthridge, U. Singh, H. Bonilla, P. Jagannathan, P. Utz, L. Geng, P. Khatri
          </td>
          <td>2025-12-05</td>
          <td>None</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71b827598caa3b92c66b1747f1e4d291bdfd16d5" target='_blank'>
              Multi-omics Analysis of Human Blood Cells Reveals Unique Features of Age-associated Type2 CD8 Memory T cells
              </a>
            </td>
          <td>
            Hiroyuki Matsui, Marlene Cervantes, Mir M. Khalid, Alan Tomusiak, Varun B. Dwaraka, Jorge Landgrave-Gomez, Prasanna Vadhana Ashok Kumaar, Qingwen Chen, Jesica Lasky-Su, Jake Stone, Ritesh Tiwari, Ryan Kwok, Shuntaro Ichikawa, Benjamin D. Ambrose, Rebeccah Riley, G. Hormazabal, Ariel Floro, Andreea Cristina Alexandru, Ryan Smith, B. Schilling, Herbert Kasler, Eric Verdin
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Organ transplant recipients are at high risk of developing chronic infection when exposed to hepatitis E virus (HEV), which can rapidly progress to liver fibrosis and cirrhosis. Macrophages play a key role in the response to the infection and disease progression. However, the interactions amongst immunosuppressants, macrophages, the course of HEV infection and activation of inflammatory response remain unclear. In this study, we generated M0, M1 and M2 macrophages from the human THP‐1 cell line. These macrophages were then infected with HEV and treated with different immunosuppressants. We visualised viral infection using laser confocal microscopy, and quantitatively analysed viral replication and inflammatory responses by bulk sequencing, RT‐qPCR, ELISA and Western blotting. We found that the M1 inflammatory macrophages exhibited the highest, while M2 macrophages had the lowest levels of viral RNA. Genome‐wide transcriptome analysis indicated that viral, inflammation and immunity‐related pathways were predominantly upregulated by HEV infection. Dexamethasone exerted potent inhibitory effects on inflammatory response in macrophages. Mycophenolic acid (MPA) demonstrated inhibitory effects on viral replication, IL‐1β and TNF‐α expression, whereas mTOR inhibitors had the opposite effects, and tacrolimus showed no clear effect. In conclusion, immunosuppressants can differentially affect HEV replication and the subsequent inflammatory responses in macrophages.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eac70274038702e260d9f4da11346625f1871599" target='_blank'>
              The Differential Effects of Immunosuppressants on Hepatitis E Virus Replication and the Triggered Inflammatory Responses in Macrophages
              </a>
            </td>
          <td>
            Jiahua Zhou, Kuan Liu, P. Boor, Qiuwei Pan, I. Ayada
          </td>
          <td>2025-12-16</td>
          <td>Journal of Viral Hepatitis</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c67902287b707e2a864fa94a99930bc5171cdb8e" target='_blank'>
              Susceptibility of Human Neural Stem Cells to SARS-CoV-2: Entry Mechanisms and Glycocalyx Influence
              </a>
            </td>
          <td>
            Ann Song, Cori Zuvia, P. Talbot
          </td>
          <td>2025-11-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="In the context of neurodegeneration, activated microglia facilitate inflammation via secretion of TNF-α, IL-1α, and C1q. Astrocytes exposed to this signaling array polarize to a reactive inflammatory phenotype, termed A1 or A1-like. Astrocytes are essential for neuronal survival, synaptic support, and blood–brain barrier (BBB) function, but A1-like astrocytes upregulate inflammatory gene expression, downregulate neurotrophic factors, and secrete neurotoxic signals. The consequences of A1-like polarization on BBB function are unknown but may have etiological implications for some diseases. Frequently identified by upregulation of complement component 3 (C3), A1-like astrocytes have been characterized in neurodegenerative disorders like Alzheimer’s disease, with polarization correlated with disease progression and severity. However, the role of A1-like astrocytes in neurodegeneration associated with chronic viral infections, like HIV-1-associated neurocognitive disorder (HAND), remains unclear. An in vitro system using primary human astrocytes, as well as a BBB model featuring primary human brain microvascular endothelial cells (BMECs) co-cultured with astrocytes, was used to elucidate cellular and molecular consequences of chronic astrocyte activation. As measured by whole transcriptome analysis and protein expression assays, repeated treatment with TNF-α, IL-1α, and C1q induced A1-like polarization of astrocytes both in monoculture and in a BBB model, resulting in increased secretion of pro-inflammatory signals. No substantial change to BBB permeability was observed. In contrast, exposure to HIV-1 viral protein Tat did not independently induce A1-like polarization. Ongoing investigations into the effect of astrocyte polarization on BBB integrity and treatment with pathogenic proteins may provide insights into the role of neurotoxic astrocytes in neurovirologic pathologies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33a034aeaf82d86cd18ab74f1a0b8c466df7ff53" target='_blank'>
              Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat
              </a>
            </td>
          <td>
            Jill M. Lawrence, W. Dampier, J. Mell, Diehl R. De Souza, Kayla Schardien, Kyle Yeakle, R. J. Barnett, Bhaswati Sen, Azad Ahmed, Michael Bouchard, Brian Wigdahl, Micheal Nonnemacher
          </td>
          <td>2025-12-04</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="The placenta possesses several structural and immunological barriers against viral infections, the SARS-CoV-2 detection in placental tissues has raised concerns regarding possible alternative viral entry mechanisms beyond the canonical ACE2/TMPRSS2-mediated pathway. In this context, the present study evaluated the immunohistochemical expression patterns of ADAM17, Cathepsin L, Clathrin, ACE-2, Furin, NRP-1, and TMPRSS2-molecules involved in SARS-CoV-2 placental entry pathways - as well as the detection of viral RNA by RT-qPCR in paraffin-embedded samples. The study included 75 paraffin-embedded placental samples (decidua and villi) collected after spontaneous placental delivery at birth from patients who tested positive for COVID-19 (COVID-19 Group), and 19 paraffin-embedded control placental samples collected prior to the COVID-19 pandemic (NON-COVID-19 Group). A statistically significant reduction in NRP-1 expression was observed in the COVID-19 group decidua (p < 0.001), including in RT-qPCR - positive samples (p = 0.001), regardless of comorbidities or underlying conditions. A statistically significant reduction in Clathrin expression was also found in the decidual samples of the COVID-19 group and in RT-qPCR - positive samples (p = 0.05and 0.013, respectively), while Cathepsin L expression was significantly increased in the placental villi of the COVID-19 group (p < 0.001) and in RT-qPCR - positive samples (p = 0.005). These findings may contribute to a better understanding of the mechanisms underlying SARS-CoV-2 interaction with the placenta, possibly through auxiliary and/or endocytic entry pathways, and may support future investigations into the impact of these alterations in the context of maternal SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bf129d03af40a7a9e20aecd51a08fd5d6af1eee7" target='_blank'>
              Placental infection by SARS-CoV-2: exploring alternative entry pathways.
              </a>
            </td>
          <td>
            Carolina Lumi Tanaka Dino, Barbara Maria Cavalli, Carolline Konzen Klein, Felipe Paes Gomes da Silva, Nicolas Henrique Borges, Ana Catharina Joaquim, Thiago Rodrigues Dos Santos, Natan de Araújo, Lucas Baena Cartens, Ana Clara Simões Flórido Almeida, Seigo Nagashima, Caroline Busatta Vaz de Paula, Cleber Machado-Souza, Lúcia de Noronha, Meri Bordignon Nogueira
          </td>
          <td>2025-11-30</td>
          <td>Tissue barriers</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="A hallmark of COVID-19 patients is the reduction of the lymphocyte population accompanied by activation, senescence, and exhaustion markers. We investigated patients admitted to hospital wards who either recovered after a short hospitalization or progressed to critical illness. Patients (n=48) were recruited between May and September 2020; 19 healthy volunteers were enrolled as controls. Blood samples were collected on days 0, 3, and 7 of hospitalization and around 30 days after discharge (convalescence sample, CS30). Lymphocyte counts and extended immunophenotyping were performed by flow cytometry and analyzed using conventional and stochastic methods. At D0 and D7, total lymphocytes, natural killer cells, T cells, TCD4 cells, and TCD8 cells were lower in patients than in volunteers but were restored at CS30. The stochastic analysis identified 11 distinct clusters of lymphocytes, nine of them with significant differences between patients and healthy controls. Clusters of TCD8+ memory cells showing activation, senescence, and exhaustion were increased in patients during hospitalization and in the convalescence samples. In contrast, clusters 5 (TCD4+ Central Memory exhausted activated) and 7 (TCD4+ Central Memory exhausted) were decreased in patients during the disease compared to healthy controls. Overall, the conventional flow cytometry analyses corroborated the findings from the stochastic analysis, showing that effector memory (EM) and TEMRA subsets exhibited sustained markers of exhaustion and senescence, particularly in TCD8+ cells. Our findings reinforce lymphopenia, T cell activation, senescence, and exhaustion as essential immunological features of COVID-19; while cell counts fully recovered, lymphocytes remained dysfunctional in convalescent samples.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ccf36a0bfe213bfeb842f9d7a3a65163a5e63e4c" target='_blank'>
              Tracking immune dysregulation in COVID-19: lymphocyte dynamics from hospitalization to recovery
              </a>
            </td>
          <td>
            G.S. Eburneo, M.B. Sousa, M. Brunialti, S. Santos, J.G.D. Silva, P. Ferreira, N.C.J. Bellei, J.S.O. Arakaki, Giuseppe G F Leite, R. Salomão
          </td>
          <td>2025-11-14</td>
          <td>Brazilian Journal of Medical and Biological Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c515ee3e9e86703752ec072206a806bfdf0f76b3" target='_blank'>
              SLAMF1-peptide mediated epigenetic priming reprograms innate immune responses in sepsis
              </a>
            </td>
          <td>
            Sindre Ullmann, Birgitta Ehrnström, Jørgen Stenvik, S. Pinto, Yashwanth Subbannayya, Victor Boyartchuk, I. Mestvedt, Mahamaya Dhaware, Siddhesh S. Kamat, L. Ryan, Hilde Vagle, T. Dahl, B. Halvorsen, J. K. Damås, T. Espevik, Maria Yurchenko
          </td>
          <td>2025-12-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>71</td>
        </tr>

        <tr id="Acute viral infections are usually cleared by an efficient anti-pathogen immune response, following which immune homeostasis is restored. Occasionally, such pathogen-induced immune response fails to abate despite clinical recovery, but how this occurs in humans has not been thoroughly investigated. Here, we perform a detailed analysis of T cell homeostasis following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which reveals persistent activation and dyshomeostasis of CD4+ and CD8+ T cells for 6–12 months after acute infection. Compared to steady-state and unlike T cell responses following vaccination, interleukin (IL)−2 receptor and IL-7 receptor expression remains altered on both SARS-CoV-2-specific and bystander T cells for 6–12 months after acute infection. These alterations correlate with increased IL-7 and IL-15 serum levels and are reproduced by in vitro stimulation by IL-7 and IL-15, but surprisingly not by IL-2. Collectively, our study demonstrates prolonged T cell dyshomeostasis driven by dysregulated homeostatic cytokine signals following acute viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4b30b34de10d73c9f922bb678272c07c41f6fdb9" target='_blank'>
              Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans
              </a>
            </td>
          <td>
            Laura Ceglarek, Patrick Taeschler, Alp Inci, Yves Zurbuchen, Sarah Adamo, Carlo Cervia-Hasler, M. E. Raeber, O. Boyman
          </td>
          <td>2025-11-27</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>63</td>
        </tr>

        <tr id="Host factors influencing susceptibility to rhinovirus-induced asthma exacerbations remain poorly characterized. Using organotypic bronchial epithelial cultures from well-characterized children with asthma and healthy children, this study investigated viral load kinetics and resultant host responses by bulk and single-cell transcriptomics and targeted protein analyses. Bronchial epithelium from exacerbation-prone children exhibited greater rhinovirus replication and a cascade of exaggerated downstream interferon (IFN), inflammatory, epithelial stress, and remodeling responses. These transcriptional patterns were confirmed and further refined using single-cell transcriptomics, revealing cell type-specific contributions-particularly from non- ciliated cell populations including secretory immune response, tuft, and basal cells. We observed that these post-infection differences were associated with lower pre-infection IFN- stimulated gene (ISG) expression and protein levels of the ISG CXCL10. Prophylactic IFN-β treatment reduced viral replication and normalized downstream responses, supporting low baseline (pre-infection) IFN tone as a modifiable causal determinant of host susceptibility to adverse rhinovirus-induced responses in exacerbation-prone children with asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cfd5fb2b94ca4d7dd630610e6106619f4fa60c8d" target='_blank'>
              Bronchial Epithelial Transcriptome Reveals Dysregulated Interferon and InflammatoryResponses to Rhinovirus in Exacerbation-Prone Pediatric Asthma.
              </a>
            </td>
          <td>
            Naresh Doni Jayavelu, Basilin Benson, P.C. Dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, C. Gates, Andrew J Nagel, M. White, Nyssa B. Samanas, Kourtnie Whitfield, T. Hallstrand, Steven F. Ziegler, Matthew C. Altman, Jason S. Debley
          </td>
          <td>2025-11-11</td>
          <td>JCI insight</td>
          <td>1</td>
          <td>45</td>
        </tr>

        <tr id="Abstract Traumatic brain injury (TBI) leads to intracerebral inflammation involving resident microglial cells and astrocytes as well as invading peripheral dendritic cells (DCs), monocytes, and neutrophils. However, the profile of immune blood cells activated by TBI remains poorly defined. Several animal models showing invasion of circulating classical dendritic cells type 2 (cDC2s) to the traumatically injured brain have been found, resulting in exacerbated neurological outcomes. In TBI patients, increased levels of chemokine CCL2, attracting cDC2 cells, have been linked to poor recovery. In the present study, blood samples from healthy blood donors (n = 11) were compared with blood from TBI patients (n = 15) at day 1 and day 3 after admission for neurointensive care stored in two tested freezing media (eight patients using Cytodelics, seven patients using CryoStor CS10) for analyses by flow cytometry. Reference blood was collected from random healthy blood donors (7 with Cytodelics, 4 CryoStor CS10). Flow cytometry excluded T-cells, B-cells, and natural killer cells by a panel of CD3, CD19, CD20, and CD56 antibodies. To identify DCs and inflammatory monocytes, antibodies to CD11c, CD1c, CD141, HLA-DR, and CD14 labeled with specific fluorochromes were added to the thawed blood samples. Neutrophils were analyzed by separate runs of flow cytometry using a CD66b antibody. Despite some differences depending on the freezing medium used, the percentage of classical DCs type 2 (cDC2; CD14-, CD11c high, CD1c+) remained unchanged from healthy controls at day 1 after admission but increased significantly (p = 0.014) from day 1 until day 3 after TBI. In contrast, levels of classical DCs type 1, inflammatory monocyte-derived DCs, or neutrophils were not altered. Thus, our preliminary data, in addition to previous animal model data, suggest a role for circulating cDC2 cells contributing negatively to the pathophysiology of TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8cd1a641c0c11041df618dbcdfb35d2ef3403d97" target='_blank'>
              Blood Levels of Dendritic Cell Populations in Patients with Moderate to Severe Traumatic Brain Injury
              </a>
            </td>
          <td>
            Patrik Fridh, Ebba Katsler, N. Marklund, Sara Mangsbo, Ted Ebendal
          </td>
          <td>2025-01-01</td>
          <td>Neurotrauma Reports</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="ABSTRACT In the context of COVID-19, macrophages are primarily responsible for sensing and responding to the virus, significantly influencing disease outcomes. They are involved in early pathogen recognition, immune activation, and tissue repair. Heterogeneity and phenotypic plasticity of macrophages are dynamically shaped by microenvironmental cues, including metabolites, hypoxia, and pathogen-derived signals. Notably, emerging evidence underscores that cellular metabolism, particularly in macrophages, dictates immune responses to viral infection. This metabolic-immune crosstalk critically determines COVID-19 severity, ranging from viral clearance to hyperinflammation or fibrosis. In this review, we systematically dissect how cell-intrinsic metabolic nodes and extrinsic factors modulate macrophage effector functions, while illustrating the complications associated with macrophage metabolic dysregulation in SARS-CoV-2 infection. These mechanistic insights provide a rational foundation for therapeutic strategies targeting macrophage metabolism to rebalance immune responses and mitigate COVID-19 complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a2e1bb8d0dab5824b185f810e0cd5ef78deac45" target='_blank'>
              Metabolic control of macrophages in coronavirus disease 2019
              </a>
            </td>
          <td>
            Li An, Houxi Xu, Qiaoling Fan, MengJiang Lu, Dongdong Sun
          </td>
          <td>2025-12-23</td>
          <td>Virulence</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Long- and post-COVID-19 syndromes have emerged as a significant global health challenge, with millions of individuals experiencing persistent or the development of new symptoms after a long period of an initial SARS-CoV-2 infection. These symptoms are multisystemic and may indicate changes in the respiratory, neurological, cardiovascular and gastrointestinal systems, in addition to prolonged fatigue. Vaccination has played a crucial role in reducing severe disease and mortality, but the impact of the different vaccine combinations on the development and resolution of Long COVID remains a topic of debate. This review synthesizes current evidence on how different vaccine platforms, dosing strategies and booster doses influence the immunological response, protection, incidence, severity, and persistence of Long COVID symptoms. We discuss key immunological mechanisms by which vaccination may modulate and protect post-COVID syndrome outcomes, including its effects on viral clearance, immune response reprogramming, inflammation, and autoimmunity, seeking to combat misinformation and concepts spread by fake news. The review also highlights controversies and research gaps, such as variability in vaccine response among different populations and the role in the selection of more transmissible and virulent SARS-CoV-2 variants, as well as the potential differences between vaccine-induced and infection-induced immunity, and the role of pre-existing immune conditions in this scenario.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1877f162e92139adf77d3156392d030444bf043" target='_blank'>
              Vaccination and COVID-19: impact on long-COVID
              </a>
            </td>
          <td>
            Gustavo N. Guimarães, N. S. Brunetti, D. G. de Lima, J. Proença-Módena, Alessandro S Farias
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="AIMS
Patients with cardiovascular disease (CVD) have an increased risk of developing severe respiratory infections, including COVID-19. However, the underlying molecular mechanisms are not completely understood. It has been previously shown that cardiovascular disease predisposes to an altered responsiveness to subsequent inflammatory triggers by an imprinted epigenetic memory in innate immune cells. Therefore, we hypothesized that patients with preexisting atherosclerotic cardiovascular disease (ASCVD) and COVID-19 display a dysregulated inflammatory response compared to patients without ASCVD due to epigenetically altered immune cells leading to increased disease severity.


METHODS AND RESULTS
Single-cell RNA sequencing revealed a dysregulated myeloid immune response with hyperinflammatory and immunosuppressive features in patients with ASCVD and moderate COVID-19. Assay for Transposase-Accessible Chromatin sequencing and in-vitro experiments with isolated monocytes infected with SARS-CoV-2 showed epigenetic priming of monocytes from patients with ASCVD towards increased expression of inflammatory mediators and type I interferon signalling. In a German nationwide cohort (NAPKON), using multiplex cytokine assays, enzyme-linked immunosorbent assays, and bulk-RNA-sequencing, we confirmed that patients with ASCVD display an exaggerated inflammatory response during moderate COVID-19.


CONCLUSIONS
This study demonstrates that patients with ASCVD show a dysregulated myeloid immune response in moderate COVID-19 disease. Mechanistically, epigenetic imprinting sensitizes myeloid cells of patients with ASCVD to an exaggerated type I interferon-associated immune response.


TRANSLATIONAL PERSPECTIVE
This study evaluates the underlying molecular mechanisms of worse outcomes of patients with atherosclerotic cardiovascular disease during respiratory infections, specifically COVID-19. Patients with atherosclerotic cardiovascular disease present with a dysregulated hyperinflammatory, type I interferon-driven immune response already during moderate COVID-19. This not only explains a major risk factor for severe COVID-19 but might also enable targeted therapies for this specific risk group.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/417901a925ab6ef7f438ab3c6409b92a5127c60d" target='_blank'>
              Atherosclerosis licenses for an exceeding immune response in COVID-19 disease by interferon priming in circulating myeloid cells.
              </a>
            </td>
          <td>
            J. Leberzammer, W. Abplanalp, Katharina Grikscheit, Emmanouil G. Solomonidis, S. Glaser, B. Schuhmacher, Maximilian Merten, Gligorije Jeremijev, A. Wilken-Schmitz, Lara Korth, David John, S. Günther, C. Kuenne, Mario Looso, C. Valasarajan, V. Beneš, Ferris Jung, Vivianne Niehaus, Gabriele Anton, Christoph Stellbrink, C. Römmele, S. Göpel, Soni S Pullamsetti, J. Vehreschild, M. Vehreschild, S. Ciesek, David M. Leistner, Andreas M. Zeiher, S. Dimmeler, S. Cremer
          </td>
          <td>2025-12-13</td>
          <td>Cardiovascular research</td>
          <td>0</td>
          <td>159</td>
        </tr>

        <tr id="Inflammation and excess cytokine release are hallmarks of severe COVID-19. While programmed cell death is known to drive inflammation, its role in SARS-CoV-2 pathogenesis remains unclear. Using gene-targeted murine COVID-19 models, we here find that caspase-8 is critical for cytokine release and inflammation. Loss of caspase-8 reduces disease severity and viral load in mice, and this occurs independently of its apoptotic function. Instead, reduction in SARS-CoV-2 pathology is linked to decreased IL-1β levels and inflammation. Loss of pyroptosis and necroptosis mediators in gene-targeted animals provides no additional benefits in mitigating disease outcomes beyond that conferred by loss of caspase-8. Spatial transcriptomic and proteomic analyses of caspase-8-deficient mice confirm that improved outcomes are due to reduced pro-inflammatory responses, rather than changes in cell death signalling. Elevated expression of caspase-8 and cFLIP in infected lungs, alongside caspase-8-mediated cleavage of N4BP1, a suppressor of NF-kB signalling, indicates a role of this signalling axis in pathological inflammation. Collectively, these findings highlight non-apoptotic functions of caspase-8 as a driver of severe COVID-19 through modulation of inflammation, not through the induction of apoptosis. During SARS-CoV-2 infection caspase-8 fuels harmful inflammation independent of apoptosis. Genetic loss of caspase-8 reduces cytokine levels, lowers viral load and mitigates disease severity, revealing non-apoptotic caspase-8 as a key driver of severe COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5fdd57c7d51f242c164bb60fdb057ec943038a10" target='_blank'>
              Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Stefanie M. Bader, Lena Scherer, Reet Bhandari, Allan J. Motyer, James P. Cooney, Liana Mackiewicz, Merle Dayton, Dylan Sheerin, David V. L. Romero, Jan Schaefer, J. Pang, Siqi Chen, Kael Schoffer, Le Wang, Xinyi Jin, D. Batey, Raymond K. H. Yip, Ishrat Zaman, P. Rajasekhar, Matthew J. Gartner, Stephen Wilcox, Lachlan L Whitehead, S. R. Georgy, Ana Maluenda, Kathryn C. Davidson, C. Allison, R. Bowden, Kerstin Brinkmann, M.-L. Asselin-Labat, B. Phipson, Maria C. Tanzer, Marco J. Herold, A. Samson, J. Vince, Andreas Strasser, Marc Pellegrini, Marcel Doerflinger
          </td>
          <td>2025-11-13</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>51</td>
        </tr>

        <tr id="Introduction & Aims: Optimal neural activity in the central nervous system relies on the myelin sheath formed by oligodendrocytes. During demyelination, changes in the microenvironment can activate oligodendrocyte precursor cells (OPCs) and induce them to generate new oligodendrocytes. However, different demyelination models employ distinct pathways, targeting different cells and cytokines; these, in turn, have varying effects on OPCs. Therefore, it is reasonable to assume that OPCs derived from different pathologic environment may exhibit functional differences. This study aims to investigate the influence of the pre-activation of OPCs, isolated from lipopolysaccharide (LPS)-induced and cuprizone (CPZ)-induced demyelination models, on their regenerative capacity. Methods: OPCs were isolated from mice subjected to LPS or CPZ-induced neurodegeneration. Characterization and activation assessment included immunostaining for PDGFRα, OLIG2, and ELISA analysis for IL-1, and SOX10 expression assessment. Then OPCs were intravenously transplanted into LPS-exposed mice. The migration patterns of transplanted OPCs were tracked using DiI labeling. After 7 days, spinal cords were assessed for myelin content and integrity (Luxol fast blue, Transmission electron microscopy, MBP and MOG analysis) and extracellular matrix changes (chondroitin sulfate proteoglycan—CSPG levels). Results: Transplantation of LPS-OPCs significantly enhanced their migration to the demyelinated spinal cord, correlating with increased myelin content and integrity and a reduction in CSPG levels compared to the CPZ-pre-activated OPCs and control groups. Conclusion: Our findings suggest that the pre-activation environment, determined by the source model, differentially affects the regenerative potential of transplanted OPCs.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e93beea2d77a03933c3d6ea3a815bd15f83e750d" target='_blank'>
              Pre-activation status impacts regenerative potential of oligodendrocyte progenitors in an LPS-exposed animal model
              </a>
            </td>
          <td>
            Farzane Rezaei Yazdi, P. Pasbakhsh, H. Akbari, I. Kashani
          </td>
          <td>2025-11-01</td>
          <td>International Journal of Immunopathology and Pharmacology</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Persistent, unresolved inflammatory processes disrupt the complex homeostatic state and lead to severe disease, ultimately resulting in organ failure, shock, and death. The mediators that monitor and control the programmed mechanisms in tissue homeostasis and repair remain elusive. A recently discovered group of endogenous proteins, termed neuronal guidance proteins (NGPs), has gained attention as important mediators of immunoregulation and tissue homeostasis through their role in the complex interplay between metabolic reprogramming and immunity. In murine peritonitis, the deficiency of the NGP Plexin C1 (PLXC1−/−) led to an increase in neutrophil and Ly6Chi monocyte recruitment to the injury site and a decrease in the phagocytosis rate. This was accompanied by a decrease in the endogenous biosynthesis of specialized proresolving lipid mediators (SPMs) such as Maresin-1 and Protectin DX and finally by a lengthening of the resolution interval. Peritoneal macrophages (MΦs)PLXC1−/− followed specific strategies to adapt their metabolism to catabolic conditions, by reducing fatty acid oxidation and oxidative phosphorylation, increasing aerobic glycolysis and activation of the pentose phosphate pathway, and disrupting the tricarboxylic acid cycle. The decreased MΦsPLXC1−/− citrate levels corresponded with a lipid mediator profile in which PGD2 and PGE2 were greatly decreased in murine PLXC1−/− peritoneal exudates, indicating a lesser effect on lipid mediator class switching and ultimately the formation of SPMs. Analysis of the related signaling networks indicated mTOR and AKT2 phosphorylation pathways are critical determinants of metabolic reprogramming in activated MΦsPLXC1−/−. These findings highlight a novel role for PLXC1 in regulating the crosstalk between immunometabolism and inflammation resolution programs in severe inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/142901da389dc4e201c184a92df6289f59bd6377" target='_blank'>
              Plexin C1 modulates metabolic programming for resolution of severe inflammation
              </a>
            </td>
          <td>
            Andreas Körner, Michael Koeppen, Jasvir Kaur, Julia C Fitzgerald, S. Kostidis, Torsten Kaussen, Christoph Trautwein, M. Giera, Tamam Bakchoul, Alice Bernard, V. Mirakaj
          </td>
          <td>2025-11-25</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Toxoplasma gondii is a globally prevalent intracellular parasite that infects ~40 million Americans. The murine immune response to Toxoplasma relies on both toll-like receptor (TLR) 11/12 and immunity related GTPase-mediated (IRGs) responses, which humans lack, making it unclear how the human immune response detects and responds to the parasite. We investigated whether human Vγ9Vδ2 T cells, which detect phosphoantigens through the BTN3A1 receptor, shape the early immune response to the parasite. Using primary human peripheral blood mononuclear cells (PBMCs), we show that Vγ9Vδ2 T cells are activated by Toxoplasma-infected cells in a BTN3A1-dependent manner leading to secretion of interferon gamma (IFNγ) and tumor necrosis factor-alpha (TNFα). Additionally, these T cells potentiate IFNγ production by natural killer (NK) cells, via TNFα and interleukin (IL)-12 produced during infection. Active parasite invasion is required to stimulate the IFNγ response, and inhibition of the host mevalonate pathway, which limits the synthesis of the phosphoantigen isopentenyl pyrophosphate (IPP), attenuates the cytokine response, indicating Toxoplasma infection increases host phosphoantigens leading to Vγ9Vδ2 T cell activation. Our findings identify Vγ9Vδ2 T cells as key effectors that potentiate NK cells in the early human immune response to Toxoplasma, bridging innate and adaptive immunity in the absence of TLR11/12 signaling.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6baec0197c59f767ac2b9af6c48776dd5b07acfc" target='_blank'>
              The early human interferon gamma response to Toxoplasma gondii is driven by Vγ9Vδ2 T-cell sensing of host phosphoantigens and subsequent NK-cell activation
              </a>
            </td>
          <td>
            Felipe Rodriguez, Jeroen P. J. Saeij
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Monkeypox, a zoonotic disease caused by the monkeypox virus (MPXV), has significant global public health implications. Inflammasomes serve as crucial components of the innate immune system, detecting pathogens and triggering cell death in infected cells to eliminate harmful agents. However, the precise molecular mechanisms governing the activation of inflammasomes during MPXV infection remain largely unclear. Using CRISPR-knockout cytosolic innate immune sensor screening, we identified AIM2 as the sensor for MPXV within the inflammasome, a trigger for inflammatory cell death. Mechanistically, AIM2 forms a complex with essential cell death molecules, including ASC and caspase-1 (CASP1), without interacting with RIPK3 or CASP8. Loss of ASC, CASP1, or gasdermin D (GSDMD) reduced cell death following MPXV infection, whereas loss of GSDME, CASP3, CASP6, CASP7, CASP9, RIPK3, or MLKL did not. Pyroptotic cell death was predominantly observed in infected cells, whereas apoptotic and necroptotic signaling pathways were primarily activated in uninfected bystander cells. Furthermore, we found that the transcription factor IRF1 serves as an upstream regulator of AIM2, controlling AIM2-dependent cell death. In experiments involving AIM2-deficient mice infected with MPXV, we observed a decrease in proinflammatory cytokines, multiple inflammatory cell death pathways, and leukocyte migration, culminating in increased viral spread. CAST/EiJ mice succumbed to high-dose MPXV infection within 8 days, whereas AIM2 inhibition increased survival, with 10% of the mice treated with an AIM2 inhibitor surviving the infection. In a low-dose infection model, AIM2 inhibition reduced IL-1β and IL-18 production, LDH release, and tissue pathology. These findings highlight the critical role of AIM2-mediated inflammasome activation, along with multiple programmed cell death pathways, in shaping the innate immune response to MPXV infection, offering valuable insights for developing therapeutic strategies targeting AIM2 and the broader innate immune response against monkeypox.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d9255f9c0757211efce272667e049b82cca5937f" target='_blank'>
              AIM2 drives inflammatory cell death and monkeypox pathogenesis
              </a>
            </td>
          <td>
            Jueun Oh, Yun-Ho Hwang, Jihye Lee, Cheong Seok, SuHyeon Oh, Hye Yoon Kim, Nabukenya Mariam, Jaeyoung Ahn, Gyoengju Yu, Jaewoo Park, Hayeon Kim, Suhyun Kim, Seyun Shin, Min-Chul Jung, Jinwoo Gil, Joo Sang Lee, Y. Choi, Dokeun Kim, Daesik Kim, You-jin Kim, SangJoon Lee
          </td>
          <td>2025-11-12</td>
          <td>Cellular and Molecular Immunology</td>
          <td>1</td>
          <td>9</td>
        </tr>

        <tr id="Viruses critically depend on host lipid metabolism to drive replication, assembly and immune evasion during infection and pathogenesis. While previous studies have demonstrated that certain viruses induce lipid droplet accumulation in infected host cells, lipid droplets have been reported to exert either proviral or antiviral effects across different research contexts. The present study investigates how porcine deltacoronavirus (PDCoV) regulates lipid droplet biogenesis and fatty acid synthesis in LLC-PK1 cells, with the aim of elucidating the potential molecular mechanisms and regulatory gene targets that govern lipid droplet homeostasis during infection. First, we characterized PDCoV’s impact on lipid droplet homeostasis in LLC-PK1 cells using immunofluorescence staining, lipidomic profiling and gene expression analysis. Subsequently, we investigated the molecular mechanisms governing lipid droplets’ antiviral effects against PDCoV, focusing on interferon (IFN) response pathway and endoplasmic reticulum (ER) stress signaling. Finally, we employed gene knockout (KO) strategy to study the regulatory gene of lipid metabolism that modulate the efficiency of PDCoV infection. PDCoV infection caused significant accumulation of lipid droplets in LLC-PK1 cells. Transcriptional and lipidomic analyses revealed a disruption in lipid metabolism, characterized by altered gene expression and elevated cellular triacylglycerol (TAG) levels. Lipid droplets exhibited co-localization with actively replicating virus, suggesting a potential proviral role of lipid droplets in PDCoV infection. However, excessive lipid droplets accumulation strongly suppressed PDCoV infection. This antiviral effect was linked to enhanced type I/III IFN responses and ER stress. We further identified the pan-coronavirus host factor TMEM41B as a key regulator of lipid droplet homeostasis. TMEM41B KO induced aberrantly enlarged lipid droplets and potently inhibited PDCoV infection. Re-expression of TMEM41B restored both lipid droplet morphology and PDCoV infection, underscoring its role in modulating infection through lipid metabolic regulation. This work delineates host factors and mechanisms governing the lipid droplet-PDCoV interplay, revealing an antiviral strategy via chemical or genetic modulation of lipid droplet homeostasis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb997a6629e0d4f9b9acbc8d0af66ffaafcce8b0" target='_blank'>
              Porcine deltacoronavirus infection promotes intracellular lipid droplet accumulation
              </a>
            </td>
          <td>
            Xiaohui Yang, Haiwen Zhong, Chuanzhao Yu, Jie Cheng, Huijie Jiang, Cuizhen Wang, Changxu Song, Huaqiang Yang
          </td>
          <td>2025-11-17</td>
          <td>Virology Journal</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Staphylococcal enterotoxins (SE) crosslink the MHC‐II on antigen‐presenting cells (APC) with the T‐cell receptor, inducing a polyclonal T‐cell response. Although APCs are the initial targets of SE and are critical in shaping subsequent T‐cell activation, the effects of SE on APC function remain poorly understood. This study investigates the immunomodulatory effects of staphylococcal enterotoxin A (SEA) on monocytes and their differentiation into monocyte‐derived dendritic cells (moDC) or macrophages (MDM). Transcriptomic analyses of human monocytes via RNA sequencing revealed SEA‐induced enrichment of gene pathways associated with inflammation, infection, and dermatitis, effects that were amplified in the presence of T cells. Phenotypic and functional characterization showed that SEA‐primed monocytes differentiated into MDM with an altered polarization, deviating from classical M1/M2 pathways. SEA‐primed MDM exhibited downregulation of key markers, including HLA‐DR, CD80, CD86, and PD‐L1. Functional assays demonstrated that SEA‐primed MDM pushed hyperinflammatory T‐cell responses, with significantly enhanced proliferation and IFN‐γ secretion. In contrast, following SEA‐priming, moDC retained robust antigen‐presenting capabilities and displayed enhanced expression of molecules involved in T‐cell interactions. These findings provide mechanistic insights into SEA‐mediated immune modulation, illustrating how SEA reprograms MDM functions and amplifies proinflammatory T‐cell responses. This advances our understanding of superantigen‐driven immune interactions, offering a foundation for developing therapeutic strategies to mitigate superantigen‐mediated immune conditions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31b8b3bf0438451c3b982c5f615c660d9c3ce361" target='_blank'>
              Staphylococcal Enterotoxin A Shapes Monocyte Transcription and Macrophage Polarization: Implications for Immune Responses in Infection and Inflammation
              </a>
            </td>
          <td>
            C. Arasa, Khaleda Rahman Qazi, David Brodin, Manuel Mata Forsberg, E. Sverremark-Ekström
          </td>
          <td>2025-12-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/077d61a2f5398bd9d9325e4f8f0c44e0a25878aa" target='_blank'>
              Flu Virus Infection in Juvenile Mice Leads to Lifelong Multi-Organ Damage and Parkinsonian Pathological Changes in Aging
              </a>
            </td>
          <td>
            Ruina You, Cuicui Liu, Xun Liu, Xinglian Wang, Zhuoya Xu, Qian Huang, Guolin Dong, Chaoqun Liang, Na Wang, Zhichao Miao, Taijiao Jiang, Dayan Wang, Lei Deng, Yousong Peng
          </td>
          <td>2025-12-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/374e623a09a6fc538a56807d5d61bb92b1f9f1a3" target='_blank'>
              Cellular Distribution of Pyruvate Kinase M2 After Spinal Cord Injury in Adult Rats
              </a>
            </td>
          <td>
            Alejandro Arriero-Cabañero, Natalia Díaz-Rubio, Cristina Talabán-Rocha, Lorenzo Romero-Ramírez, V. Buzoianu-Anguiano, Jörg Mey
          </td>
          <td>2025-11-29</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Post-COVID cardiac complications have emerged as a significant and persistent clinical concern, yet their underlying mechanisms remain poorly understood. Animal models can act as proxies to investigate the pathophysiology of the human, post-acute sequelae of SARS-CoV-2 infection (PASC). The aim of this experimental study was to evaluate the expression of inflammatory biomarkers in cardiac tissue 28 days after SARS-CoV-2 infection in a female hACE2 mouse model, with a focus on chemokine-mediated immune activation. Twelve female C57BL/6 hACE2 mice were infected with the Omicron variant (BA.1.17 lineage) of SARS-CoV-2, and eleven non-infected mice served as controls. Cardiac tissue was analyzed via Western blot for markers of innate immune activation (TLR4, MyD88, NF-κB) and pro-inflammatory cytokines (IL-6, IL-18, IL-1β, TNF-α, CD11d). Cardiac tissue injury markers (iNOS, PAI-1 and Connexin43) were also analyzed. Compared to non-infected mice, cardiac tissue from infected mice showed significantly higher expression of IL-6 (p = 0.028), indicating an inflammatory state, and CD11d (p = 0.016), suggesting an inflammatory stage accompanied by sustained activation of chemokine-mediated inflammatory signaling. No significant differences in TLR4 (p = 0.340), MyD88 (p = 0.410), NF-κB p65 (p = 0.780), IL-18 (p = 0.548), IL-1β (p = 0.455), and TNF-α (p = 0.125) expressions were observed Similarly, no changes in cardiac damage markers (iNOS: p = 0.4684; PAI-1: p = 0.5345; Connexin 43: p = 0.2879) were found. The results of this experimental study would support the hypothesis of persistent low-grade inflammation as a contributor to post-COVID cardiac sequelae in females that is not accompanied by severe tissue damage, as also observed in clinical studies. This study also reinforces the need for studies evaluating the functional and structural evolution of the myocardium after an acute SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8c71f525771ab829c5b8bbcdcdb88fac1b05cc46" target='_blank'>
              Cardiac Tissue Damage in a Female Animal Post-COVID Model: Relevance of Chemokine-Mediated Inflammation
              </a>
            </td>
          <td>
            Silvia Flaj-Prados, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Eva M. Sánchez-Robles, L. Arendt-Nielsen, C. Fernández‐de‐las‐Peñas, Visitación López-Miranda
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>87</td>
        </tr>

        <tr id="

 Multisystem inflammatory syndrome in children (MIS-C) is a severe condition that arises 4–6 weeks after SARS-CoV-2 exposure, marked by persistent fever, mucocutaneous symptoms, cardiac involvement, and shock. Natural killer (NK) cells are thought to contribute during the acute phase due to their antiviral and immunoregulatory roles, but their phenotype during recovery is not well defined. An expansion of TCR Vβ21.3+ T cells has been observed during acute MIS-C, though their long-term presence and significance remain unclear.



 Peripheral blood mononuclear cells (PBMCs) were collected from 4 healthy pediatric controls, 4 febrile (non-COVID) controls, 4 children with acute COVID-19, 9 with acute MIS-C, 8 MIS-C convalescents (6–12 months), and 6 long-term MIS-C convalescents (4 years). TCR Vβ21.3 expression was analyzed using a T cell panel (CD3, CD4, CD8, CD27, CD45RA, TCR Vβ21.3). NK cell phenotype was assessed after co-culture with K562 cells using markers including CD56, CD3, CD16, CXCR6, Ki67, NKG2D, NKG2C, and CD158.



 NK cells from acute MIS-C patients showed decreased CD57, CD158, and CD107a, along with increased NKG2D expression. Clustering analysis revealed a unique NK cell population exclusive to acute MIS-C, defined by absent CD107a and elevated CXCR6 and Ki67. Most alterations resolved within 6–12 months, except CD158, which remained low even after 4 years. TCR Vβ21.3+ T cells persisted for up to a year but were undetectable at 4 years.



 MIS-C triggers a transient NK phenotype marked by reduced cytotoxicity and increased activation, suggesting a hyperactivated or dysregulated immune profile. Persistent downregulation of the inhibitory receptor CD158 may indicate prolonged NK activation. TCR Vβ21.3+ T cells appear to be short lived. Further long-term studies with larger cohorts are needed to validate these findings.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1c63e6c5c161a67863c64ce2aea0e118e09c3073" target='_blank'>
              Tracking NK and Memory T Cell Dynamics in Children Affected by Multisystem Inflammatory Syndrome (MIS-C)
              </a>
            </td>
          <td>
            Natalia González, Camila Astudillo, Yazmin Espinosa, Paz Cerda-Castro, Juan Pablo Araya, Grace Ayleen Silva, Martín Felipe Hernández, M. C. Poli, Emma Rey-Jurado
          </td>
          <td>2025-12-22</td>
          <td>Journal of Human Immunity</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Abstract Background Peripheral inflammation is linked to neurodegeneration. Using Xenium spatial transcriptomics (Figure 1), we test the hypothesis that peripheral inflammation triggers transcriptional changes in microglia. Preliminary data show microglial transcriptional changes are detectable within days of the peripheral inflammatory event, and moreover, that these changes persist for months. How this impacts Aβ and tau pathology is unknown. Method 3xTg‐AD mice were exposed to a peripheral (does not directly infect the CNS) viral infection inducing systemic inflammation. At 7 days‐ and 2‐months post infection, the right and left hemispheres of the brain, respectively, were harvested for immunostaining and integrated analysis of Multiome sequencing (simultaneous single‐cell RNA‐seq and ATAC‐seq) with spatial transcriptomics. Circulating cytokine levels in the blood were measured via ELISA. Result At the 7‐day timepoint, spatial transcriptomics revealed 265 differentially expressed genes in microglia, with three unique microglial profiles present only in infected animals (Figure 2). Cluster features, such as downregulated Plcxd2 and Bhlhe40, have been associated with intracellular Aβ and pTau, as well as dysregulated lipid processing, respectively. Further, algorithmic cell sorting revealed overlap of microglia with glutamatergic neurons and endothelial cells, suggesting increased microglial engulfment of these cell types. Preliminary scRNA‐seq data at 2‐months post‐infection reveals a pro‐inflammatory microglial phenotype (Figure 3), as shown by increases in Ctss and Cd84. Genes critical for synaptic function and neuronal support (Snap25, Anks1b, Fam155a) were significantly downregulated, suggesting that microglia‐neuron interactions are influenced by peripheral inflammation. These changes correlated with global increased expression of Apoe and Psen1&2. Together, these findings show that peripheral inflammatory events induce significant deviations in microglia homeostasis. Conclusion Our preliminary findings suggest that viral‐induced peripheral inflammation alters microglia state and homeostasis in a 3xTg‐AD model. Despite the clearance of systemic inflammation, the transcriptional profile of microglia remains different in infected vs mock‐infected mice. The data suggest peripheral inflammatory stress events alter microglial transcriptional profiles and a “reset” to the original baseline profile is not immediate. The implications on neurodegeneration are being explored.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79f5f8c0e4dfe741508526e81fb59b5018895daf" target='_blank'>
              Multiomic Insights into Inflammation‐Driven Microglial Dysregulation in AD
              </a>
            </td>
          <td>
            Stella R Wroblewski, Sara Morris, Gabrielle Blahusiak, Vivianne E. Morrison, Elizabeth Engler-Chiurazzi, Kevin J. Zwezdaryk
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Besides its robust antiviral activity, type I interferon (IFN-I) also exerts immunomodulatory effects and can even drive pathology during chronic viral infections. Mechanisms that regulate IFN-I induction during virus infection, thus strongly affecting the outcome of disease, remain to be defined. Here, using the lymphocytic choriomeningitis virus (LCMV) Docile strain, we identified acid ceramidase (aCDase, Asah1) as a critical lipid-metabolic regulator of endosomal, nucleic acid-driven IFN-I responses and disease outcome during chronic virus infection. aCDase is highly expressed in plasmacytoid dendritic cells (pDCs) and required for robust early IFN-I production. aCDase deficiency resulted in ceramide accumulation, blunting IFN-α/β induction, impairing IFN-I-dependent upregulation of programmed death-ligand 1 (PD-L1) on antigen-presenting cells and preventing the exhaustion of virus-specific CD8+ T cells, leading to severe immunopathology. This pathology is abrogated by CD8+ T-cell depletion or by adoptive transfer of IFN-I-induced PD-L1-expressing macrophages. Conversely, limiting ceramide production in acid sphingomyelinase (Asm)-deficient mice prevented ceramide accumulation, and pDCs showed accelerated IFN-I induction. Mechanistically, ceramide abundance regulated IFN-I production by altering endosomal signaling microdomains. Collectively, our findings reveal ceramide homeostasis as a key determinant of IFN-I-driven CD8+ T-cell exhaustion and immunopathology during chronic viral infection and highlight aCDase as a potential therapeutic target.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3347a83451be199ba4cf611d6ba58e4cec09e11d" target='_blank'>
              Acid ceramidase regulates CD8+ T-cell exhaustion via type I interferon-mediated upregulation of PD-L1
              </a>
            </td>
          <td>
            Zhongwen Hu, Hossam Abdelrahman, Abdelrahman Elwy, F. Kuang, Swati Dhiman, Shafaqat Ali, Marcel Marson, Lisa Holnsteiner, Thamer A Hamdan, Justa Friebus-Kardash, Elisa Wiebeck, W. Hansen, S. Scheu, Erich Gulbins, P. Lang, K. Lang, Judith Lang
          </td>
          <td>2025-12-09</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="Long COVID has emerged as a major global health concern, yet the long-term trajectory of immune recovery and its contribution to persistent symptoms remain to be elucidated. Here, we conducted a three-year longitudinal follow-up of the 47 COVID-19 patients and applied single-cell RNA sequencing (scRNA-seq) and multiplex cytokine profiling to comprehensively characterize the peripheral immune landscape during convalescence. We observed persistent immune dysregulation up to three years post-infection, characterized by chronic inflammation and impaired restoration of naïve CD4⁺ T cells, naïve CD8⁺ T cells, and SLC4A10⁺ MAIT cells—features reminiscent of immunosenescence. Notably, Th17 cells, rather than monocytes, emerged as key drivers of chronic inflammation beyond one year. We identified two distinct Th17 subsets: RORC⁺ Th17 cells and LTB⁺ Th17 cells. While RORC⁺ Th17 cells were negatively correlated with inflammatory cytokine levels, LTB⁺ Th17 cells showed proinflammatory features and were positively associated with long COVID symptoms. Sustained elevation of S100A8 and IL-16 in follow-up patients may contribute to the persistent presence of LTB⁺ Th17 cells. Together, our study provides an in-depth longitudinal map of immune remodeling in COVID-19 convalescents, revealing key cellular and molecular drivers of sustained inflammation up to three years post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f682ef5df5972e318b0093c3cf2459508e92d089" target='_blank'>
              T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19
              </a>
            </td>
          <td>
            Tian Zheng, Ru Gao, Yiwei Liu, Ye-ming Wang, Chao Wu, Li Guo, Lan Chen, Xinming Wang, Yan Xiao, J. Zhong, Rongling Zhang, Ying Wang, Xianwen Ren, Bin Cao, Lili Ren, Jianwei Wang
          </td>
          <td>2025-11-20</td>
          <td>Immunity & Inflammation</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Background Severe COVID-19 is frequently associated with acute respiratory distress syndrome (ARDS) and prolonged pulmonary sequelae. Persistent immune activation, including dysregulated B cell responses and increased proinflammatory chemokines, has been linked to the post-acute sequelae of SARS-CoV-2 infection. However, the mechanisms linking these factors remain poorly defined. Methods Sixty patients were studied four months after acute COVID-19, including 34 who developed ARDS, 26 who did not develop ARDS, and 12 healthy controls. Clinical, computed tomography scan (CT), and diffusion capacity of the lungs for carbon monoxide (DLCOc) assessments were performed. Anti-SARS-CoV-2 IgM/IgG levels were quantified, circulating B cell subsets were characterized, and circulating cytokines and chemokines were measured. CXCR3 expression on B cells was analyzed by spectral flow cytometry. In vitro assays were performed to evaluate the effects of CXCL9 and CXCL10 on B cell activation, plasma cell differentiation, IgG production, and CD40L expression on CD4+ T cells. Associations between immunological markers and pulmonary sequelae were assessed. Results IgG, but not IgM, levels were significantly higher in patients with ARDS than in patients without ARDS. Both COVID-19 groups showed a reduction in CD19+CD20+ B cells and an increase in plasmablasts compared to controls. Serum levels of CXCL9 and CXCL10, but not other cytokines, positively correlated with IgG levels. In vitro, CXCL9 increased CD86 expression on B cells, while both chemokines promoted plasma cell differentiation (CD27+CD38+, CD138+) and increased total IgG secretion. CXCL9 also increased the expression of CXCR3 and CD40L on activated CD4+ T cells. Clinically, patients with combined CT abnormalities and reduced DLCO had the highest levels of IgG, CXCL9, and CXCL10. Conclusion Four months after COVID-19, patients with prior ARDS and persistent pulmonary sequelae exhibit sustained elevations of anti-SARS-CoV-2 IgG and chemokines CXCL9 and CXCL10. Both chemokines directly enhance B cell differentiation into IgG-secreting plasma cells in vitro, while CXCL9 also increases CD4+ T cell help, suggesting a mechanistic link between chronic inflammation, increased humoral responses, and long-term lung impairment. Targeting CXCL9/CXCL10–CXCR3 signaling could offer therapeutic potential to mitigate post-COVID pulmonary complications.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f87e4a08188abb1875547220225dd7d5712072b" target='_blank'>
              CXCL9 and CXCL10 support the exacerbated humoral response in recovered COVID-19 patients who developed acute respiratory distress syndrome by promoting plasma cell differentiation, whereas CXCL9 also induces CD40L and CXCR3 upregulation on T helper cells
              </a>
            </td>
          <td>
            R. Quiroga, Sergio Sanhueza, Catalina Sepúlveda, Bárbara Antilef, C. Munoz, Camilo Cabrera, M. Fraga, Faryd Llerena, L. Lamperti, M. I. Barria, Alicia Colombo, Gonzalo Labarca, Mario Henriquez-beltran, Luciano Ferrada, Estefanía Nova-Lamperti
          </td>
          <td>2025-12-04</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="This study investigated how prolonged aggression in male CD1 mice alters responses to chronic LPS (lipopolysaccharide)-induced inflammation. Experience of aggression induced pathological aggression in 36% of mice. Following LPS, aggressors resolved systemic inflammation within five days—evidenced by normalized locomotor activity, WBC (white blood cells), and lymphocyte counts—while controls remained inflamed. LPS did not alter established aggression or anxiety. Furthermore, aggressors demonstrated accelerated inflammation resolution in the brain, showing a higher proportion of resting microglia and a lower percentage of activated microglia following LPS-induced inflammation compared to control animals. Gene expression analysis revealed a more pronounced inflammatory response in the hypothalamus than in the nucleus accumbens. Aggressive mice exhibited a profile associated with inflammation resolution, indicated by increased expression of the Trem2 gene. These differential immune responses may be modulated by the dopaminergic system. Elevated Drd1 gene expression in the hypothalamus could possibly contribute to the anti-inflammatory signaling, while changes in nucleus accumbens dopaminergic activity, involving D2 receptor activation, appear linked to the development of pathological aggression. Thus, this study demonstrates that prolonged aggression induces persistent changes in behavioral, neuroimmune, and neuroendocrine systems in male CD1 mice. Aggressive animals develop a distinct neuroimmune phenotype characterized by accelerated resolution of both systemic and brain inflammation following LPS challenge.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e8af717818ae65429c337dd3a00e34367f6925bd" target='_blank'>
              Prolonged Aggressive Experience Accelerates Resolution of Inflammation in Blood and Microglia After Repeated LPS Treatment
              </a>
            </td>
          <td>
            Anastasia Mutovina, A. Sapronova, Kseniya Ayriyants, Yulia Ryabushkina, Julia Khantakova, Polina Mezhevalova, Polina Ritter, Natalya Bondar
          </td>
          <td>2025-12-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Salivary gland dysfunction and inflammation are common following SARS-CoV-2 infection. This study aimed to investigate the effects of SARS-CoV-2 spike and envelope proteins on glandular function in healthy C57BL/6 mice through direct intra-glandular injection into the submandibular glands. Local administration of spike protein significantly reduced salivary secretion, while the envelope protein had no measurable impact. Histological analysis revealed the presence of leukocyte foci in two-thirds of spike protein-treated mice, while none were detected in the vehicle- or envelope protein-treated groups. Furthermore, spike protein treatment led to a significant increase in total immune cells and B cells, and an expansion of the CD44high CD62Llow effector/effector memory subsets within CD4 T cells and B cells in the submandibular glands. Notably, serum antinuclear antibodies developed in one-third of spike-treated mice, consistent with the reported salivary gland pathology in COVID-19 patients that resemble autoimmune Sjögren’s disease. Moreover, spike protein treatment increased phospho-STAT3 levels and induced transcriptomic changes indicating impaired acinar compartment, heightened adaptive immune responses, and altered tissue remodeling activity. These findings show that SARS-CoV-2 spike protein alone is sufficient to initiate significant salivary gland pathology in the absence of intact virus or ACE2 interaction, providing evidence for a novel mechanism by which SARS-CoV-2 induces salivary gland dysfunction and pathology with autoimmune features.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0ed181b81ada91ccc763c713a424a697626f932b" target='_blank'>
              SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice
              </a>
            </td>
          <td>
            Fernanda Aragão Felix, Yuqiao Jiang, Jing Zhou, Dongfang Li, Victoria Zhou, Sílvia Ferreira de Sousa, Kevin Matthew Byrd, Qing Yu
          </td>
          <td>2025-11-21</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Multiple sclerosis (MS) progresses through brain region-specific inflammation and degeneration, with poorly defined mechanisms. In individuals with MS, we identified increased expression of formyl peptide receptor 1 (FPR1) in central nervous system (CNS)-resident microglia and CNS-infiltrating macrophages. Blood amounts of N-formylated peptides, which are endogenous agonists of FPR1, correlated with disease progression in patients with MS. In MS mouse models, signaling through FPR1 promoted microglial mitochondrial dysfunction, causing axonal loss and apoptosis. FPR1-expressing microglia sustained the clonal expansion of myelin-reactive CD4+ T cells in the CNS. A CNS-penetrating small molecule FPR1 antagonist, T0080, mitigated autoimmune responses and axonal degeneration. Our study identifies FPR1 signaling as a potential mechanism for MS progression and suggests antagonizing FPR1 as a therapeutic approach.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7a44a96cf4db06bcdae090e3c2f4a120de5e7d1f" target='_blank'>
              Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration.
              </a>
            </td>
          <td>
            Yulin Li, Zhiguo Li, Pei Zheng, Shuzhen Guan, Yan Li, Nan Yao, Zhihui Qi, Xueyu Zhang, Lei Su, Jing Jing, Siting Wu, Xue Zhao, Meng Wang, C. Böttcher, Hans-Gustaf Ljunggren, F. Paul, L. Van Kaer, Alexej Verkhratsky, F. Shi
          </td>
          <td>2025-11-13</td>
          <td>Science</td>
          <td>1</td>
          <td>72</td>
        </tr>

        <tr id="Alcohol use disorder (AUD) is associated with significant neuroimmune dysregulation, with microglia emerging as a potential pathological driver of neurotoxicity. However, the molecular landscape driving this alcohol-induced reactivity has yet to be uncovered, especially in the context of human microglia. Here, we comprehensively characterized global-scale molecular changes of human stem cell-derived microglia (iMGLs) after exposure to ethanol and inflammatory mediators lipopolysaccharide (LPS) and TNFα using mass spectrometry-based proteomics. KOLF2.1J hiPSCs were differentiated to iMGLs utilizing commercially available kits and treated with multiple ethanol exposure paradigms, LPS, and TNFα. Proteomic profiles were assessed by data-independent acquisition (DIA) mass spectrometry, followed by a Luminex cytokine assay and a functional phagocytosis assay. Ethanol produced distinct, temporally dependent proteomic changes that differed markedly from the robust proinflammatory responses induced by LPS and TNFα. Cytokine measurement confirmed an overall lack of proinflammatory responses of iMGLs treated with ethanol in contrast to the elevated levels in LPS- and TNFα-treated cells. However, Ingenuity Pathway Analysis and flow cytometry revealed an increase in phagocytosis of iMGLs treated with ethanol for 48 hours. Our findings demonstrate that ethanol exposure induces distinct and temporally dependent molecular phenotypes in human iMGLs, which differ markedly from the robust proinflammatory responses elicited by LPS and TNFα. The novel pathways identified in this study will provide new insights into the human-specific response to ethanol and emphasizes the importance of utilizing human-specific models for neuroimmune interactions in AUD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/243231cde6c0b823c9ec42396c1fb1a29f3ae249" target='_blank'>
              Deep Proteomic Profiling of Human Stem Cell-Derived Microglia: Insights Into Inflammatory and Alcohol-Induced Reactivity
              </a>
            </td>
          <td>
            Tiara Wolf, Jessica Wohlfahrt, Jennifer Guergues, Stanley M. Stevens
          </td>
          <td>2025-11-17</td>
          <td>Research Square</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="ABSTRACT Biological sex significantly influences susceptibility to tuberculosis (TB), with males typically experiencing a greater disease burden than females. However, the mechanisms underlying sex-specific immune regulation during TB pathogenesis remain incompletely understood. In this study, we examined sex-based differences in pulmonary immune cell composition, inflammatory signaling pathways, and macrophage transcriptomic responses in C57BL/6 mice infected with the Mycobacterium tuberculosis (Mtb) HN878 strain during the sub-acute stage of infection. Our results show that female mice had significantly lower pulmonary Mtb burdens and enhanced protein kinase B (AKT)–interferon gamma (IFN-γ) signaling, which is associated with autophagy, lysosomal activation, and effective intracellular bacterial clearance. In contrast, male mice exhibited higher bacterial loads and elevated IL-6 signaling, a pathway linked to exacerbated inflammation and impaired pathogen control. Histological analysis revealed greater lymphocytic aggregation in female lungs, despite comparable levels of pulmonary macrophages between sexes. Importantly, transcriptomic profiling of lung macrophages uncovered distinct sex-specific gene expression patterns, wherein female macrophages upregulated genes involved in tissue remodeling, phagocytosis, autophagy/lipophagy, and cell survival, whereas male macrophages showed enrichment of genes related to pro-inflammatory and adaptive immune responses. Notably, male macrophages expressed higher levels of Ighg1 (Immunoglobulin Heavy Constant Gamma 1), suggesting a potential sex-dependent modulation of humoral immunity during TB. Together, these findings demonstrate that biological sex shapes immune cell programming and host-pathogen interactions during TB, underscoring the importance of incorporating sex as a biological variable in TB research and therapeutic development. IMPORTANCE Men and women often respond differently to diseases like tuberculosis (TB), with men typically facing more severe illness, though the underlying reasons are unclear. To this end, our study investigated how male and female mice combat TB infection at a cellular and molecular level. We discovered that female mice controlled TB more effectively, as their immune systems activated specific pathways to break down and clear bacteria efficiently. Conversely, male mice showed higher bacterial loads and triggered more inflammatory, yet less effective, immune responses. Crucially, despite similar numbers of key immune cells (macrophages) in the lungs, their functional responses differed significantly by sex. These findings underscore that biological sex profoundly impacts the immune system’s fight against TB, paving the way for more personalized treatments and improved outcomes for all. Men and women often respond differently to diseases like tuberculosis (TB), with men typically facing more severe illness, though the underlying reasons are unclear. To this end, our study investigated how male and female mice combat TB infection at a cellular and molecular level. We discovered that female mice controlled TB more effectively, as their immune systems activated specific pathways to break down and clear bacteria efficiently. Conversely, male mice showed higher bacterial loads and triggered more inflammatory, yet less effective, immune responses. Crucially, despite similar numbers of key immune cells (macrophages) in the lungs, their functional responses differed significantly by sex. These findings underscore that biological sex profoundly impacts the immune system’s fight against TB, paving the way for more personalized treatments and improved outcomes for all.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a4287a0838a97c49b64dc2f6538c24df65cefe80" target='_blank'>
              Sex-specific transcriptional regulation in lung macrophages during sub-acute Mycobacterium tuberculosis infection
              </a>
            </td>
          <td>
            D. Dhanyalayam, Hariprasad Thangavel, Kezia Lizardo, Jigar V. Desai, J. Nagajyothi
          </td>
          <td>2025-11-12</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Background
Little information is available on the immune signaling pathway that drives severe COVID-19 in asthma. Our study evaluates the association between immune dysfunction and progression to severe COVID-19 in asthma using single-cell RNA sequencing.


Methods
Four patients with asthma and eight patients without asthma from three centers in South Korea were used for this analysis. For each patient, samples were collected over three-time points: at the time of COVID-19 infection, one week later, and two weeks later.


Results
They were classified into four groups according to the presence or absence of asthma and COVID-19 severity; non-asthma/mild COVID-19 (n=5), non-asthma/severe COVID-19 (n=3), asthma/mild COVID-19 (n=3), and asthma/severe COVID-19 (n=1) groups. A high-quality scRNA-seq dataset composed of 155,565 cells was generated that characterized peripheral immune cells. When the proportion of cell type was analyzed by time points, a decrease in T-cells was shown at the second time point in asthma/severe COVID-19 group compared to other groups. When the proportion of T-cell subtype was analyzed by time points, an increase in the proportion of CD8+ T cell was shown at the second time point in asthma/severe COVID-19 group than in other groups: in DEG analysis, notably, we observed relatively higher levels of cytotoxicity-related genes in asthma/severe COVID-19 compared to other groups.


Conclusion
Our study provides new insights into the mechanisms underlying the progression of COVID-19 infection in patients with asthma. A reduction in the proportion of T cells while expanding cytotoxic CD8+ T cell proportion was associated with severe COVID-19 presentation in asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/024d563473f02b1257c1b2dc0e7510521f7669e6" target='_blank'>
              T cell immune dysfunction and progression to severe COVID-19 in asthma revealed by single-cell RNA sequencing.
              </a>
            </td>
          <td>
            B. Kim, Youlim Kim, Sang Hoon Lee, Siyoung Lee, Minjun Choi, Byeongchan Lee, Jae Seok Jeong, Sang-Heon Kim, Hyun Lee, Kwang Ha Yoo
          </td>
          <td>2025-11-18</td>
          <td>Tuberculosis and respiratory diseases</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Parkinson’s disease (PD) is increasingly recognized as a multisystem disorder involving pathological α-synuclein (α-syn) accumulation and widespread neuroimmune dysregulation. Microglia, the resident immune cells in the central nervous system (CNS), are pivotal mediators of the bidirectional communication between the CNS and peripheral systems. In addition to sensing neuronal injury and α-syn pathology, microglia dynamically respond to peripheral immune signals, including circulating cytokines, immune cell infiltration, and microbial metabolites, through pattern recognition receptors such as Toll-like and NOD-like receptors. Furthermore, microglia regulate blood–brain barrier integrity, modulate peripheral immune cell recruitment, interact with meningeal lymphatic vessels, and contribute to the propagation of α-syn within the CNS and along the gut–brain axis. However, a comprehensive framework encompassing their diverse roles in peripheral–central immune crosstalk remains underdeveloped. This review synthesizes recent advances elucidating how microglia link the CNS to peripheral immune and metabolic signals in PD. We further highlight microglial contributions to α-syn propagation along the gut–brain axis and discuss how their functional states influence disease progression. A deeper understanding of microglial involvement in this complex neuroimmune interface may inform the development of effective and system-level therapeutic strategies for PD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40b4787f9c236f2822ea4097343456b74122cbca" target='_blank'>
              Microglia in the crosstalk between peripheral and central nervous systems in Parkinson’s disease
              </a>
            </td>
          <td>
            Tianbai Li, Tao Qiu, Fei Jiang, Huaibin Cai, Weidong Le
          </td>
          <td>2025-12-01</td>
          <td>Translational Neurodegeneration</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Considerable attention has been recently devoted to the involvement of immune cells in the central nervous system (CNS) during infections with neurotropic viruses, such as SARS-CoV-2, HIV-1, and ZIKV. These viruses are capable of infecting astrocytes and microglia, the main glial cells in the CNS, responsible for regulating neuronal activity. Here, we discuss how viral infections lead to metabolic reprogramming toward aerobic glycolysis in these cells, enhancing pro-inflammatory pathways, such as inflammasome activation, resulting in the secretion of inflammatory cytokines that favor the development of neuroinflammation. In this mini review, we discuss the pivotal interplay between metabolism and immunity towards viral pathogenesis in the CNS, pointing out the relevance of therapeutic strategies targeting both metabolic and immunological pathways to enhance antiviral and neuroprotective responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c603076d92448698be2b3b34d399b974e9d4c131" target='_blank'>
              Viral reprogramming of glial metabolism as a driver of neuroinflammation
              </a>
            </td>
          <td>
            Tamara Rodrigues, Gabriel Salles Beltrão, Heloísa Girardi, Aguinaldo R. Pinto
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="The effects of antiretroviral therapy (ART) and treatment interruption on myeloid cell egress from the central nervous system (CNS) during human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection remain poorly defined. We hypothesized that CNS macrophages normally traffic out of the CNS, accumulate during viral infection and inflammation, and are released as inflammation resolves. To test this, we administered intracisternal (i.c.) injections of two different colored fluorescent superparamagnetic iron oxide nanoparticles (SPION) to SIV-infected macaques either early in infection (12–14 dpi) or 30 days before necropsy. SPION are preferentially taken up by perivascular, meningeal, and choroid plexus macrophages, enabling us to track macrophage turnover, infection, and migration. In non-infected macaques, SPION+ macrophages trafficked from the CNS to peripheral sites including the deep cervical lymph node (dCLN), lumbar lymph nodes, spleen, and dorsal root ganglia (DRG). With SIV infection, these cells accumulated in the CNS and showed reduced peripheral trafficking. ART decreased the number of SPION+ perivascular macrophages, and to a lesser extent, meningeal or choroid plexus macrophages. After ART interruption, SPION+ perivascular and choroid plexus macrophage numbers remained stable, whereas SPION+ meningeal macrophages increased. ART eliminated SIV-RNA+ perivascular macrophages, leaving few- scattered SIV-RNA+ cells in the meninges and choroid plexus. Following ART interruption, perivascular macrophages remained virus-negative, but scattered viral RNA+ meningeal macrophages persisted. In non-infected macaques, SPION+ macrophages trafficked to the dCLN, spleen, and DRG, but this trafficking diminished with SIV infection and AIDS with SIVE. Importantly, SIV-RNA+ SPION+ macrophages that exited the CNS were cleared by ART and did not reappear after treatment interruption. Using two differently colored SPION to assess establishment of CNS viral reservoirs, we observed higher numbers of early-labeled macrophages within and outside the CNS in animals with AIDS and SIVE, ART treatment, and ART interruption. These findings support a model in which SIV-infected perivascular macrophages seed an early CNS viral reservoir, while the meninges and choroid plexus undergo continual viral seeding during infection. ART reduces trafficking of infected macrophages out of the CNS and clears the perivascular macrophage reservoir, but SIV-RNA+ meningeal macrophages can persist, in low numbers, and can rebound after ART interruption.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/978817c1cd51902524161c071846dc82c1a681a8" target='_blank'>
              Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS
              </a>
            </td>
          <td>
            Zoey K. Wallis, C. Midkiff, Miaoyun Zhao, P. Autissier, Soon Ok Kim, Addison Q. Amadeck, Yiwei Wang, M. Jakubowski, Tricia H Burdo, Andrew D. Miller, Qingsheng Li, Xavier Alvarez, Robert V. Blair, Kenneth C. Williams
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Mycobacterium tuberculosis (Mtb) persists within macrophages, yet how different host species shape bacterial state remains poorly understood. Here, we directly compared the intracellular transcriptome of Mtb during infection of human and mouse macrophages, revealing distinct host-imposed microenvironments that drive the pathogen into separable metabolic states. Lipid metabolism and regulatory circuits were prominently remodeled, with mouse macrophages inducing iron- and oxidative-stress responses while human macrophages promoted fatty acid import programs. Using fluorescent fatty acid tracing, we uncovered a striking species-specific phenotype: Mtb forms intracellular lipid inclusions (ILIs) in murine macrophages but not in human macrophages. This phenotype was independent of culture media, macrophage ontogeny, or host antimicrobial factors such as nitric oxide and itaconate. Access of Mtb to host-derived lipids required the ESX-1 secretion system and was inversely correlated with host triacylglycerol (TAG) synthesis. Inhibition of TAG formation in human macrophages partially restored Mtb ILI formation, revealing a metabolic gate that governs lipid flow between host lipid droplets and intracellular Mtb. Together, these findings establish a cross-species framework for decoding host-driven bacterial metabolic states and identify a key barrier limiting Mtb’s access to host lipid stores in human macrophages.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8455ca23c679ae25863ebe15850f9b46faecf1b3" target='_blank'>
              Systems analysis reveals alternate metabolic states adopted by Mycobacterium tuberculosis across species
              </a>
            </td>
          <td>
            Jonathan Padilla-Gomez, Rachel McGinn, Yisha Liang, Kendra Libby, Alison E Ringel, Charles Evavold, Bryan D. Bryson
          </td>
          <td>2025-11-15</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Tumor-specific CD8+ T lymphocytes play a critical role in anticancer immunity but frequently become dysfunctional and exhausted within the immunosuppressive tumor microenvironment. Although immune checkpoint inhibitors can restore T-cell activity, resistance to these treatments remains a significant challenge. Therefore, understanding the transcriptional and regulatory mechanisms underlying CD8+ T-cell exhaustion is crucial for the development of effective therapies. We developed two murine models of acquired immune checkpoint inhibitor resistance through prolonged anti-PD1 treatment. To gain insight into CD8+ T-cell exhaustion, we performed single-cell multiomics analysis, including both scRNA-seq and scATAC-seq, to capture gene expression profiles and chromatin accessibility. Moreover, we collected three external datasets to validate the results in silico. We further assessed the therapeutic potential of Runx2 through marker expression and cytotoxicity assays. Our single-cell analysis revealed distinct T-cell subsets, including early and terminally exhausted populations, along with their exhaustion trajectories. Runx2 was identified as a key transcription factor associated with CD8+ T-cell exhaustion in both models and correlated with immunotherapy response in clinical data. Additionally, functional marker expression and cytotoxicity assays demonstrated that inhibiting Runx2 improved CD8+ T-cell cytotoxicity. These findings highlight the role of Runx2 as a crucial regulator of CD8+ T-cell exhaustion in the context of prolonged immune checkpoint inhibitor treatment. Targeting Runx2 may provide a novel strategy to overcome immune checkpoint inhibitor resistance and enhance therapeutic efficacy, offering promising avenues for combination therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4efed637bde0b584b5806d223ee2a3f6b51d5e91" target='_blank'>
              Transcriptional dynamics of CD8+ T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution
              </a>
            </td>
          <td>
            Tzu-Yang Tseng, Ching-Hung Hsieh, Hsuan-Cheng Huang, Yu-Ching Wu, Chiun Hsu, Chia-Lang Hsu, D. Ou, Hsueh‐Fen Juan
          </td>
          <td>2025-12-01</td>
          <td>Molecular Cancer</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3f01d95c795a60414e85a7e266ae96dd44e6c777" target='_blank'>
              NLRP3 Inflammasome Activation Contributes to Seizure Susceptibility in Anti-NMDAR Encephalitis: Evidence from Patients and a Mouse Model
              </a>
            </td>
          <td>
            Hanyu Luo, Jiaxin Yang, Yuhang Li, Honghong Song, Xiaoyue Yang, Ziyao Han, Dishu Huang, Li Cheng, Jiannan Ma, Li Jiang
          </td>
          <td>2025-11-11</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/548c76c2b47dc431062da4b50df1f61b2f054fb1" target='_blank'>
              Molecular Mechanisms of Priming Innate Immunity by Small Extracellular Vesicles Released during Infection with Gram-negative Bacteria
              </a>
            </td>
          <td>
            Adam Fleming, Heather E. Hobbs, Graham Matulis, Weidong Zhou, Valerie Calvert, Hunter G. Mason, Samson Omole, Shivam A. Gaikwad, Cameron C Ellis, Emanuel F. Petricoin, Igor C. Almeida, R. Hakami
          </td>
          <td>2025-12-31</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Introduction Zika virus (ZIKV) infection has been associated with neurological syndromes, particularly during outbreaks caused by Asian lineage strains. However, experimental models suggest that African strains may exhibit an equal or more virulent profile. Neuroinvasion by systemic viruses often requires crossing the blood–brain barrier (BBB), which disruption amplifies viral dissemination and neuropathology. Type I interferons (IFNs) are key to restricting ZIKV replication, but their specific role in preserving BBB integrity remains poorly defined. Methods Here, we used human brain microvascular endothelial cells (HBMECs) as a simplified BBB model to compare transcriptional responses and IFN modulation following infection with either the African prototype strain ZIKVMR766 or the Asian epidemic strain ZIKVPE243. The role of endothelial cell–mediated IFN responses was further assessed in vivo by intravascular inoculation of mice with endothelial-specific IFNAR depletion using ZIKVMR766. Results and discussion Infection of HBMEC with ZIKVMR766 triggered a greater number and broader range of differentially expressed genes, especially ones associated with interferon signaling and translational pathways, whereas ZIKVPE243-infected samples clustered closer to non-infected ones. ZIKVMR766 infection also resulted in higher viral titers and faster dissemination across endothelial monolayers. Both strains induced IFN-β expression but suppressed downstream IFN signaling by reducing STAT1 phosphorylation and promoting STAT2 degradation, with these effects being more pronounced for ZIKVMR766. Despite these evasion mechanisms, neutralization assays revealed that endothelial cells-derived IFNs production and response partially restricted viral replication, preserved HBMEC viability, and protected against barrier disruption, with ZIKVPE243 showing greater sensitivity to IFN-β. Importantly, in vivo infection of mice lacking endothelial IFNAR signaling resulted in elevated CNS viral load and increased lethality following ZIKVMR766 infection, underscoring the pivotal role of endothelial IFN responses in viral control, maintenance of BBB integrity, and protection against neuroinvasion.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/56674b5024c412f991e7ef83dca244fa427476f0" target='_blank'>
              Distinct ZIKV strain signatures and type I IFN modulation reveal a protective role of brain endothelial interferon signaling in vitro and in vivo
              </a>
            </td>
          <td>
            Luan Rocha Lima, Y. M. Mustafá, Paula Luize Camargos Fonseca, S. V. A. Coelho, Pierina Lorencini Parisi, C. Simeoni, L. M. Meuren, Bruno Braz Bezerra, N. C. Mebus-Antunes, F. Matassoli, J. Proença-Módena, Renato Santana Aguiar, L. B. de Arruda
          </td>
          <td>2025-12-03</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="In a recent study published in Nature, Grippin and colleagues showed that SARS-CoV-2 mRNA vaccines can transiently reset the tumor – immune interface, converting immunologically “ cold ” tumors into those that respond to PD-1/PD-L1 blockade. This work supports COVID-19 mRNA vaccines as systemic immune modulators that, when timed appropriately around immune checkpoint inhibitors (ICIs), can sensitize tumors and improve survival across diverse cancer types. 1 In mouse tumors, spike mRNA lipid nanoparticles (RNA-LNPs) elicited IFNAR1-dependent innate activation that drove dendritic-cell priming and the expansion of cytotoxic CD8 ⁺ T-cell clones, accompanied by PD-L1 upregulation in tumor and myeloid compartments. Blocking type I interferon signaling abrogated both PD-L1 induction and synergy with anti-PD-1/PD-L1, pinpointing IFN-I as the mechanistic lynchpin and de ﬁ ning a short “ interferon window ” during which checkpoint blockade is maximally effective. To probe antigen speci ﬁ city, the authors replaced spike with the human cytomegalovirus antigen pp65, which is overexpressed in human glioma but not in the B16F0 model, and observed comparable antitumour activity, indicating that the checkpoint-sensitive state is largely driven by antigen-agnostic sensing of the mRNA – LNP platform rather than spike-speci ﬁ c priming. They further modi ﬁ ed the mRNA backbone, showing that replacing N1-methyl-pseudouridine with uridine in pp65 mRNA strengthened synergy with ICI, whereas the same change in spike mRNA conferred only modest numerical bene ﬁ t — evidence that RNA chemistry and structure, independent of the encoded antigen, can tune the magnitude of IFN-I – mediated tumor sensitization">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/774fa9aca5d2a2345b4788f1b81988c717440d52" target='_blank'>
              When vaccines reset tumors: SARS-CoV-2 mRNA shots create a transient checkpoint-sensitive state
              </a>
            </td>
          <td>
            Hao Chi, Michele Carbone, Youping Deng
          </td>
          <td>2025-12-31</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="The respiratory tract is particularly vulnerable to infections from various pathogens, often leading to severe illnesses. Co-infections involving multiple pathogens are commonly observed in respiratory diseases, although their underlying mechanisms remain poorly understood. Lung epithelial cells play a crucial role in the body’s defense and are primary targets for many pathogens, which exploit them for attachment and entry. This study investigates the molecular mechanism underlying co-infections of human enterovirus D68 (HEV-D68) and bacteria (Group A Streptococcus and Streptococcus pneumoniae) in lung epithelial cells. Cell viability and gene expression changes were assessed over a 24-hour period. The results revealed significant cytopathic effect and distinct gene expression patterns. HEV-D68 infection alone induced stronger upregulation of mucin genes (MUC2, MUC5AC) and immune markers (TNFα and p38) compared to co-infections. In contrast, co-infections led to downregulation of sialic acid biosynthesis genes (CMAS, GNE, NANS), suggesting impaired receptor restoration and altered host-pathogen dynamics. These findings contribute to a deeper understanding of epithelial responses and highlight potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3ee7e4af02ae26601a074b5457577a16c62421b3" target='_blank'>
              Human Enterovirus D68 infection – the intricate dance of cells, genes, and invading bugs
              </a>
            </td>
          <td>
            Hanne Lillerovde Ørstenvik, A. Tveten, Yanran Cao
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Dengue, also known as dengue fever (DF), is an infection spread by mosquitoes. It infects over 400 million people globally each year. Sometimes DF progresses to severe DF (sDF) for which patients suffer from life-threatening complications including internal bleeding, failure of cardiovascular systems and death. Although DF is a severe threat to human life, its diagnosis and therapeutic strategies have not yet reached a satisfactory level. In order to address these issues, at first, this study identified six key cell-types (myeloid dendritic cells (DCs), memory B cells, naive B cells, memory CD4 T cells, plasmacytoid DCs, and plasmablasts) associated with both DF and sDF by integrating two single-cell RNA-Seq (scRNA-seq) profile datasets (GSE220969 and GSE154386) and cell–cell communication (CCC) analyses. Top-ranked nine common host key genes (SYK, CYBB, SOCS3, HSPA5, IRF7, NFKB1, IL-6, ISG15, and TNFSF13B) were identified from the selected cell types through differential expression patterns and protein–protein interaction (PPI) network analyses, assuming their potential involvement in the development and progression of DF and sDF. The enrichment analysis of common host key-genes (chKGs) with gene ontology (GO) terms and KEGG-pathways disclosed molecular mechanisms about how chKGs are associated with the development and progression of DF to sDF. Finally, chKGs-guided three candidate drug agents (Entrectinib, Imatinib, and QL47) were recommended against dengue virus infection (DENVI) through molecular docking, drug-likeness screening, ADME/T analysis, DFT analysis. Therefore, the findings of this study may provide valuable insights for diagnosis and therapies against DENVI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e6ee9ef6a4c4d7e63a66a3e152f35e698f454882" target='_blank'>
              In-silico discovery of druggable molecular signatures that drive dengue fever to severe dengue fever highlighting common pathogenesis through single-cell RNA-Seq analysis
              </a>
            </td>
          <td>
            Md Al Noman, Md. Abdul Latif, Md. Foysal Ahmed, Md Shariful Islam, Md Al Amin Pappu, Md Sanoar Hossain, Md Bayazid Hossen, Tasfia Noor, Md. Manir Hossain Mollah, Md. Hadiul Kabir, Md. Nurul Haque Mollah
          </td>
          <td>2025-11-11</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/730bda77c6f77da1330b66ac6126520d39d7c77d" target='_blank'>
              Longitudinal gene expression analysis in COVID-19 sepsis highlights dynamic immune, cellular, and metabolic dysfunction in high severity patients.
              </a>
            </td>
          <td>
            Andy An, Arjun Baghela, Peter Zhang, Travis M. Blimkie, Jeff Gauthier, Daniel E Kaufmann, E. Acton, Amy H. Lee, Roger C. Levesque, Robert E. W. Hancock
          </td>
          <td>2025-12-19</td>
          <td>Scientific reports</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Greater than a hundred genetic risk factors for Alzheimer’s disease (AD) have been identified by genome-wide association studies (GWAS), many of which are primarily expressed in microglia. However, the pathogenic role for most of them remains unclear. We sought to assess at scale how AD GWAS hits influence human microglial inflammatory responses. Thus, we conducted CRISPR inhibition (CRISPRi) screens of 119 AD GWAS hits in hiPSC-derived microglia (iMGLs), with reactive oxygen species (ROS) produced in response to the viral mimic poly(I:C) as a readout. Top hits that either decreased or increased ROS in response to poly(I:C) when knocked down were then interrogated in CROP-seq experiments, where CRISPRi was combined with single cell RNA-sequencing (scRNA-seq). These analyses identified 9 unique microglial clusters, including a poly(I:C)-driven inflammatory cluster (2). Emerging evidence supports a pathogenic role of viral infections in AD and our scRNA-seq showed significant overlap with AD-relevant microglial clusters. Knockdown (KD) of two hit genes, MS4A6A and EED, which lead to high levels of ROS in the presence of poly(I:C), increased the proportion of inflammatory cluster 2 cells and led to functionally related changes in gene expression. In addition, KD of MS4A6A reduced the proportion of iMGLs in the disease-associated microglia (DAM) cluster under all conditions, suggesting that MS4A6A may modulate the DAM response. In contrast, KD of hit genes, INPP5D or RABEP1 which led to low levels of ROS in the presence of poly(I:C), did not significantly affect the proportion of cells in inflammatory cluster 2 but rather shaped the inflammatory response. This included upregulation of a poly(I:C)-independent HLA inflammatory cluster (6) by INPP5D KD under all conditions. Despite INPP5D or RABEP1 being involved in disparate biological processes, their perturbation led to similar changes in gene expression, which included changes in genes related to metabolism such as oxidative phosphorylation, suggesting a shared conversion point by which AD GWAS hits affect cell state. Overall, our data begin to elucidate the functional roles played by various AD GWAS hits, including how they regulate and shape inflammatory responses such as those observed in AD. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03562-9.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/497cdf48270eb7ac4fe84bee351f4625ecdcfd71" target='_blank'>
              High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease
              </a>
            </td>
          <td>
            Christopher L. Cardona, Lai Wei, Joonwon Kim, Ellen Angeles, Gunjandeep Singh, Shiye Chen, Ronak Patel, Nkechime Ifediora, Peter Canoll, A. Teich, Gunnar Hargus, Alejandro Chavez, Andrew A. Sproul
          </td>
          <td>2025-12-03</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Influenza A virus (IAV) is a prevalent pathogen that causes severe respiratory infections worldwide. Currently, the incidence of coinfections between IAV and Gram-negative bacteria has been steadily increasing, and the synergistic interaction between IAV infection and bacterial exposure represents a pivotal risk factor for disease exacerbation. Lipopolysaccharide (LPS), a major Gram-negative bacterial virulence factor, is hypothesized to regulate IAV-induced immune response intensity and disease severity by reshaping the pulmonary immune microenvironment. Here, we established an in vivo coadministration model via intratracheal instillation of low-dose LPS and H1N1 to dissect their synergistic pathogenesis. LPS exposure potentiated H1N1-induced severe lung injury, manifested as persistent neutrophil and monocyte infiltration, elevated levels of cytokines (e.g., CXCL1, CCL2, and IL-6), and alveolar damage without affecting viral replication. Mechanistically, LPS triggered immune hyperactivation through early neutrophil recruitment, neutrophil extracellular trap (NET) formation, and a self-sustaining positive feedback loop. Intervention experiments revealed that the degradation of NETs by DNase I or neutrophil inhibition significantly alleviated lung damage and systemic inflammatory responses. This study establishes NET-driven innate immune amplification as a key mechanism underlying LPS-enhanced H1N1 pathogenicity, offers an immunomodulatory approach for severe bacterial-viral coinfections, and underscores the parity of immunomodulatory therapy with anti-infective treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a8204eba4e3f2c05f83c187d56985bc21d9c8f7" target='_blank'>
              Exposure to bacterial lipopolysaccharide aggravates H1N1-mediated lung immunopathology via neutrophil extracellular trap formation
              </a>
            </td>
          <td>
            Guiling Yan, Zhongwen Hu, Yuanyuan Peng, Yuqin Tu, Jingling Xie, Yuchao Zhong, Changchun Niu, Yang Luo
          </td>
          <td>2025-11-18</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV), a filamentous, enveloped, negative-sense, single-stranded RNA virus, is a common cause of respiratory infections in pediatric and elderly populations, often leading to severe inflammation and lung damage. To date, there is no effective treatment for RSV infection. Therefore, elucidating the antiviral mechanism in RSV infection is critical for identifying potential effective therapeutic targets. Type I interferons (IFN-Is), especially IFN-β, play a key role in the immediate immune response against viral infection by inhibiting viral load and spread. Current studies have shown that ARCN1 (archain 1), the δ subunit of the coat protein complex I complex, is involved in intra-Golgi trafficking and protein transport from the Golgi apparatus back to the endoplasmic reticulum. In this study, we demonstrate that ARCN1 suppresses the anti-RSV innate immune response by promoting E3 ubiquitin ligase STUB1-mediated K48-linked polyubiquitination and subsequent proteasomal degradation of IKKε. Mechanistically, ARCN1 recognizes and binds to the δL motif of STUB1 via its flexible MHD domain while interacting with IKKε. This finding provides a theoretical basis for the development of new antiviral treatment strategies targeting ARCN1.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/32c87ced4d49da7da6a4806fe632d757e2e9e8ee" target='_blank'>
              ARCN1 suppresses innate immune responses against respiratory syncytial virus by promoting STUB1-mediated IKKε degradation
              </a>
            </td>
          <td>
            Jiamin Cai, Yunfei Ye, Zhengrong Chen, Fei Xu, Xiaoping Li, Mengyun Wu, Ji Zhou, Yuanyuan Shao, Peijie Zhu, Jing Zhao, Jingjing Hu, Yufeng Wang, Cancheng Li, Xiaoyu Tian, Beibei Huang, Tian Xia, Wenjun Wang, Chuangli Hao, Yi Yang, Jinping Zhang
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="In nature, animals encounter diverse pathogens that trigger specific peripheral defense programs and elicit sickness behavior, a set of stereotyped physiological and behavioral changes thought to promote host fitness. Most studies to date have relied on one or a few mouse models of infection, limiting insights into pathogen-specific neuroimmune interactions that generate sickness. We hypothesized that different pathogens might elicit distinct sickness states by engaging different cell types and brain circuits. Using inflammatory models representing bacterial, viral, allergic, parasitic or colitis conditions, we assessed sickness across scales: organismal – behavior and physiology; cellular – brain-wide neural activity; and molecular – single-cell in situ transcriptomics in hypothalamus areas associated with social and homeostatic functions affected during sickness. Remarkably, immune challenges elicited unique repertoires of changes across all scales. Our findings reveal pathogen-specific sickness states encoded by the brain across scales, thereby broadening our understanding of how infections make us sick.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a973ce07eaa0ba52a5d26dc1ae4c7f5dadb199db" target='_blank'>
              Brain-immune interactions generate pathogen-specific sickness states
              </a>
            </td>
          <td>
            Zuri A. Sullivan, Bertrand J. Wong, Vikrant Kapoor, Paula Kathleen Vincze, Harris S. Kaplan, Pia Giraudet, Brianna R. Watson, Adel Misherghi, Sebastian Lourido, Jeffrey R. Moffitt, Catherine Dulac
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/067b711dad1b01bf4fc346e14734d26bf59c2c8a" target='_blank'>
              Differential regulation of p62-ubiquitin conjugates in neurons versus astrocytes during cellular stress
              </a>
            </td>
          <td>
            D. Sidibe, Erin M. Smith, Maeve L. Spivey, Maria C. Vogel, Sandra Maday
          </td>
          <td>2025-11-18</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Microglia play a pivotal role in inflammatory regulation through multifarious signaling pathways within the central nervous system, and mitigating microglial inflammation is considered a promising strategy to delay the progression of neurodegeneration. However, the role of biased receptor signaling in modulating microglial inflammation remains largely unexplored. In this study, the anti‐inflammatory effects and the underlying mechanism of muscarinic receptor agonists pilocarpine and iperoxo were explored. Our results showed that pilocarpine, rather than iperoxo, inhibited the expression of TNF‐α and IL‐6, as well as restored ramified morphology and physiological phagocytosis of over‐activated microglia. RNA‐seq revealed that pilocarpine‐treated BV2 exhibited transcriptional profiles more similar to the control group, with upregulation of anti‐inflammatory genes. β‐arrestin2 knockdown attenuated the anti‐inflammatory effect of pilocarpine by reversing the expression of inflammatory factors and activation of NF‐κB. Furthermore, through chemogenetic DREADDs, activation of Gαq, Gαi, or β‐arrestin pathways demonstrated that β‐arrestin, but neither Gαq nor Gαi, inhibited the inflammatory response in microglia. Our findings proved that pilocarpine could abate the microglial inflammatory response via biased activation of the β‐arrestin2 pathway, which could be considered a promising therapeutic approach for anti‐neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2adfe4a54058838439d7a435ca33dd6b137bff77" target='_blank'>
              Beta‐Arrestin2‐Biased Activation by Pilocarpine Suppresses Microglial Inflammatory Response
              </a>
            </td>
          <td>
            Yuanyuan Xie, Kaichun Wang, Shiqi Wang, Yunjin Yao, Dongxue Wang, Hongzhuan Chen, Lanxue Zhao, Jianrong Xu
          </td>
          <td>2025-12-01</td>
          <td>Journal of Neurochemistry</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4344a3caab5690ca285cfeeb41c13e886e533ceb" target='_blank'>
              Arsenic Trioxide Underpins Delayed Neuroinflammation and Impaired Synaptic Integrity involving Integrative Stress Response Signaling
              </a>
            </td>
          <td>
            J. Khan, Sazzad Khan, Himanshi Singh, Jianfeng Xiao, Daniel Johnson, Md Athar, Mohammad Moshahid Khan
          </td>
          <td>2025-12-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="This review aims to discuss the apparent reduction in pulmonary cancer incidence in the general population during and shortly after the COVID-19 pandemic from a biological and pathophysiological mechanistic point of view. While the epidemiological evidence points to a disruption in the early- and mid-stage diagnostic process, which causes a shift to late-stage lung cancer discovery with no impact on its actual prevalence, an alternative hypothesis based on the intersection of viral and cancer biology could have a real effect on lung carcinogenesis as an independent phenomenon. By weaving together population-level trends, mechanistic insights, and translational oncology, we discuss whether the pandemic-associated decline in lung cancer diagnoses reflects primarily a temporary diagnostic artifact or whether it also reveals biologically relevant intersections between SARS-CoV-2 and pulmonary oncogenesis. The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has exerted profound and multifaceted effects on global healthcare systems, altering patterns of disease detection, management, and outcomes across nearly all medical disciplines. These disruptions generated what has been termed a “diagnostic deficit”, producing a backlog of undetected cancers that have only partially been recovered in subsequent years. This phenomenon, sometimes described as a “COVID-19 debt” in oncology, is thought to contribute to excess late-stage diagnoses and potentially worse medium-term survival outcomes. Beyond the disruption of medical systems, the pandemic also raised a more speculative but biologically intriguing question: could SARS-CoV-2 infection itself, through direct or indirect mechanisms, influence lung cancer biology? Our review aims to critically synthesize the evidence across seven domains to address this dual hypothesis. (1) We examine the observed effects of the pandemic on cancer incidence, highlighting global registry and health-system data; (2) we review SARS-CoV-2 infection biology, including viral entry, replication, protein functions, and treatment implications; (3) we summarize the pathogenesis of lung cancer; (4) we explore the role of immune checkpoints in tumor immune evasion, followed by (5) analyses of immune dysregulation in acute infection and (6) in long COVID; and (7) finally, we evaluate proposed oncogenic mechanisms of SARS-CoV-2, integrating molecular virology with cancer immunology. We conclude that the “diagnostic deficit” phenomenon was a reality during and immediately post-pandemic. However, a definitive answer to the questions related to the impact of the infection as an independent phenomenon would require advanced research information covering the biology of the viral infection and lung cancer oncogenesis: processes that are not currently implemented in routine clinical laboratory investigations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d0bf5466dfce0bf8184f1ba8da30a22761eadbf2" target='_blank'>
              COVID-19 and Lung Cancer Interactions: A Literature Review
              </a>
            </td>
          <td>
            S. László, E. Ianoși, A. Văsieșiu, Mioara Szathmáry, M. Ianoși, Delia-Liana Rachiș, Gabriel Nistor, G. Jimborean
          </td>
          <td>2025-11-30</td>
          <td>Medical Sciences</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/272b851a5c06d7bc39f09b18cf6e2aebd07cc686" target='_blank'>
              An Integrated Single-Cell Atlas Reveals Hepatic Stellate Cell Heterogeneity and Spatiotemporal Dynamics after Liver Injury
              </a>
            </td>
          <td>
            Jiongliang Wang, Jiawang Tao, Cuicui Xia, Miaoxiu Tang, Andrei-Florian Stoica, Shengxian Yuan, Yinxiong Li, Lin Guo, Xiangqian Kong, Jie Wang
          </td>
          <td>2025-11-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Acute neuroinflammation rapidly activates brain immune responses, but its lasting effects on microglia are unclear. Using systemic LPS administration and LCMV-Armstrong infection, we found that blood–brain barrier disruption and cytokine shifts resolved within 30 days, yet microglial recovery was incomplete—marked by persistent numerical loss and an IFN-γ–low phenotype in the LPS model and reduced relative abundance in the LCMV model. Single-cell RNA sequencing revealed sustained transcriptional alterations, including disease-associated microglia (DAM) features and a distinct recovery-biased population. These acute signatures overlapped with profiles from Alzheimer’s model mice and were enriched in human microglia from multiple sclerosis, Alzheimer’s disease, and other neuroinflammatory conditions. Although our observation period was shorter than the chronic course of these diseases, the persistence of disease-like microglial states suggests that transient inflammation can prime the brain for long-term vulnerability. Targeting this primed state may offer new strategies to prevent or mitigate neurodegenerative pathology. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03572-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8721848b4335622c9d56e1c1301ae59339a8f8e0" target='_blank'>
              Acute neuroinflammation induces prolonged transcriptional reprogramming in microglia
              </a>
            </td>
          <td>
            Sehoon Moon, Cheol Gyun Kim, Young-Kwang Kim, Cheol-Heui Yun, Min-Kyoo Shin, Hyungseok Seo
          </td>
          <td>2025-12-10</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1486b2a0665ed52ccf9a17b86e0809646ad8755a" target='_blank'>
              Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
              </a>
            </td>
          <td>
            A. Popa, Elena Popa, Tatiana Dramba, Elena-Adorata Coman, Mihaela Poroch, M. Ungureanu, A. Bacușcă, Ana-Maria Slanina, Gema Bacoanu, V. Poroch
          </td>
          <td>2025-11-25</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Introduction The role of Regulatory T cells (Tregs) in severe COVID-19 remains unclear. Some authors reported that Tregs increased in peripheral circulation, while other investigators reported that these cells decreased in severe COVID-19 patients. The expression of FoxP3 in Tregs remains inconsistent and controversial. These observations have been made using immune phenotyping via flow cytometry and T-cell sequencing; however, none of these data provide a clear indication of what Tregs are doing in this chaotic hyperactivated immune response. Methods We conducted a comprehensive characterization of the Treg compartment in a longitudinal cohort of patients with acute COVID-19, including individuals with mild or severe disease. Using RNA-seq, we analyzed gene expression across the cohort, while flow cytometry enabled us to determine Treg phenotype and observe changes during disease progression. Furthermore, we assessed Treg activity through a suppression assay. Results Gene expression analysis revealed significant downregulation of genes involved in regulatory pathways supporting T regs' functional activities, consistent across the severe patients analyzed. In contrast, we found increased expression of these genes in patients with mild disease. This finding was further confirmed by phenotyping analysis, which showed significant differences in CD25+CD127- Treg cells between mild and severe patients, positively associated with CTLA-4 and PD-1 inhibitory markers. Surprisingly, these results did not correlate with FoxP3 expression. Furthermore, a high frequency of CD25+CD127- Treg cells was associated with young, mild patients. In contrast, a lower frequency of CD25+CD127- cells and a higher frequency of FoxP3+ cells were associated with elderly patients. Finally, a Treg functional assay showed a lower capacity for suppression in Tregs obtained from severe patients compared to those from mild patients in the acute phase of the disease. Discussion Our findings offer critical insights into the role of Tregs in SARS-CoV-2, with implications that extend beyond this viral infection. Understanding how Tregs contribute to immune responses in COVID-19 could inform therapeutic strategies to modulate immune regulation in infectious diseases more broadly.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/375e622ef27c7342cf0c8ff5baa1cafe0077df24" target='_blank'>
              Longitudinal immune profiling uncovers regulatory T cell signatures associated with the progression of COVID-19
              </a>
            </td>
          <td>
            Camila Kossack, Felipe Bravo, Francisco Fuentes-Villalobos, Claudio Quevedo, Matias A. Medina, Raúl Riquelme, M. Rioseco, Mario Calvo, Karina Pino-Lagos, Felipe Aguilera, M. I. Barria, J. Garrido
          </td>
          <td>2025-12-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6f9c933a473e49313c32514553adbf6d9c17d2eb" target='_blank'>
              IFNγ-associated immune–metabolic remodeling drives serotonin–kynurenine imbalance with cortical vulnerability in lupus-prone mice
              </a>
            </td>
          <td>
            Karim Matmat, R. Guéant-Rodriguez, Emmanuel Darcq, Okan Baspinar, J. Alberto, J. Guéant, A. Mensah-Nyagan, Hélène Jeltsch-David
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="Background Retinal neurodegenerative diseases, including diabetic retinopathy and age-related macular degeneration, are characterized by the slow, chronic degeneration of photoreceptors. We previously used a chronic low light (CLL) exposure to model slow photoreceptor degeneration in adult zebrafish. Here, we investigate transcriptional, morphological, and functional responses of microglia in the CLL model. Methods Microglia-specific gene expression analysis was mined from our previously reported 3′ RNA-seq data performed at 8 time points during 28 days of CLL exposure. Morphological changes were performed on retinas collected at various time points using immunohistochemistry. Microglial inhibition was accomplished pharmacologically with dexamethasone and genetically using the irf8−/− mutant fish. Finally, we returned the CLL-treated fish to normal light/dark conditions to test whether photoreceptors could recover in the context of chronic stress. Results CLL induced dynamic, time-dependent upregulation of microglia-specific genes consistent with pro-inflammatory and pro-resolving function. Dexamethasone treatment reduced microglial numbers and exacerbated rod and cone outer segment damage, whereas irf8−/− mutants exhibited partial protection against photoreceptor damage. Notably, despite prolonged stress and damage during the CLL exposure, photoreceptor outer segments returned to near-baseline morphology after 28 days of normal light/dark recovery conditions. Discussion Overall, these findings suggest that microglial function in chronic retinal injury is context-dependent as pharmacological and genetic methods of inhibition produced contrasting outcomes depending upon microglial polarization.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3e38a1a439a93a8994094db441f7361b6b9879be" target='_blank'>
              Microglia response and function in a chronic model of photoreceptor damage
              </a>
            </td>
          <td>
            Deepa Raghavan, Olivia Jeakle, Yasmeen Berry, Majd Victor, Ryan Thummel
          </td>
          <td>2025-12-16</td>
          <td>Frontiers in Cell and Developmental Biology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Abstract Background Alzheimer's disease (AD) is a neurodegenerative condition with etiology firmly rooted in immune dysregulation. While genetic risk is increased in microglia, the brain's resident myeloid cell, myeloid cells throughout the body show high enrichment for disease risk genes as well. The role of peripheral immune cells in AD pathogenesis is relatively unknown, however, and may play important roles in waste clearance. Leveraging a cohort of idiopathic normal pressure hydrocephalus (iNPH) patients from which we have paired brain, cerebrospinal fluid (CSF), and peripheral blood monocytes (PBMCs), we have investigated cross‐compartment transcriptional changes to better understand how peripheral immune function is altered in AD. Method We have performed scRNA‐seq on paired samples (blood PBMCs, brain biopsy, and CSF, n = 100), from iNPH patients, ∼40% of which have early stage AD, to understand neuroimmune changes. We have further performed a large‐scale integrative analysis across previously published CSF scRNAseq datasets (>200 patients and 400,000 cells). Result Our analysis has found a unique population of macrophages present in the CSF that are distinct from CNS microglia and border macrophages, and peripheral monocytes. These cells are abundant in the CSF of all samples. Strikingly, we find that these cells exhibit enrichment of polygenic Alzheimer's disease heritability, including very high expression of the two most significant AD genetic variants, APOE and TREM2. Furthermore, we find that these macrophages display altered gene expression profiles in patients with AD pathology or clinical AD diagnosis, underscoring the importance of understanding these enigmatic cells. To deepen our understanding of CSF macrophages, we have also performed large‐scale integrative analysis with previously published CSF scRNA‐seq datasets. We identify this macrophage population across all datasets, and are working now to understand disease‐specific variations in CSF macrophage state. Conclusion By profiling the immune cells present in the CSF and comparing them to immune cells in the blood, we have identified a population of CSF macrophages that are unique to the CSF that show heritability enrichment for AD risk genes. These immune cells may play critical scavenging and clearance roles in disease and future work will clarify their role in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3bc0a153888f2b0e5ad0041bcf1fe1f80d60abc5" target='_blank'>
              Single Cell Transcriptomics of Paired CSF and Blood Immune Populations Reveals Unique Macrophage Population with Relevance to Alzheimer's Disease
              </a>
            </td>
          <td>
            Beth Stevens, S. Marsh, Rebecca Fulthorpe, Sarah Murphy, Tushar Kamath, Vahid Gazestani, David J. Lieb, T. Eisenhaure, Vishal Sarsani, Miguel Reyes, J. Gobom, C. Clish, H. Zetterberg, V. Leinonen, Evan Macosko, N. Hacohen
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>117</td>
        </tr>

        <tr id="The COVID-19 pandemic, caused by SARS-CoV-2, has had a profound global impact. Diabetes mellitus is a major comorbidity associated with higher infection risk, severe disease, and mortality in COVID-19 patients. This review examines the bidirectional relationship between COVID-19 and diabetes, focussing on immunometabolic mechanisms, post-COVID metabolic effects, and therapeutic implications. A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science for articles published until May 2025 using the terms "COVID-19," "SARS-CoV-2," "diabetes," and "immunometabolism." Peer-reviewed studies addressing clinical, molecular, or therapeutic interactions between the two diseases were included. Evidence shows that SARS-CoV-2 infection aggravates metabolic dysfunction through immune dysregulation, cytokine-mediated inflammation, and β-cell injury. Hyperglycemia promotes viral replication and inflammatory damage, creating a vicious cycle that worsens outcomes. Reports also indicate an increased risk of new-onset and post-COVID diabetes. Certain antidiabetic agents, such as metformin and GLP-1 receptor agonists, may improve prognosis via anti-inflammatory and metabolic effects. Diabetes significantly amplifies the severity of COVID-19 through intertwined metabolic and immune mechanisms. Understanding these interactions provides new insights into disease management and supports the development of targeted immunometabolic therapies for improving outcomes in diabetic patients affected by COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80e954bc39ab4c596e3acc382fff9dbe2db6d37d" target='_blank'>
              COVID-19 in Diabetic Patients: Mechanisms, Risks, and Therapeutic Considerations.
              </a>
            </td>
          <td>
            Rania Hamdy, Amal Z Barakat, Eman J Abuzaid, Tasneem Elsayed, M. Husseiny
          </td>
          <td>2025-12-04</td>
          <td>Reviews in medical virology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="SARS-CoV-2 disrupts cellular homeostasis, including the autophagy-lysosome pathway (ALP), a critical component of innate immunity and viral clearance. By subverting autophagy, SARS-CoV-2 proteins such as ORF3a, ORF7a, and NSP6 inhibit autophagosome-lysosome (APG-L) fusion, generating “incomplete autophagy” that permits viral persistence and drives hyperinflammation. Transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, has emerged as a central player in the host response to coronavirus infection. TFEB orchestrates the expression of genes required for lysosomal function and autophagic flux while also shaping immune processes, including cytokine production, interferon-stimulated gene expression, and inflammasome clearance. This mini review synthesizes current knowledge on the TFEB-ALP axis in COVID-19 pathogenesis, highlighting its influence on acute immunopathology and its potential contribution to post-acute sequelae (Long COVID). Restoring TFEB activity and autophagic flux may counteract SARS-CoV-2 evasion strategies and restrain aberrant inflammatory responses. Harnessing the TFEB-autophagy pathway as a host-directed therapeutic strategy could help rebalance immune homeostasis, limit tissue damage during acute infection, and mitigate persistent inflammatory sequelae in Long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/16fa03377df001310b096f5bc84f1cdb14cf36a8" target='_blank'>
              Dysregulated TFEB–autophagy-lysosome pathway links acute COVID-19 immunopathology to Long COVID sequelae
              </a>
            </td>
          <td>
            Magdalena Gabig-Cimińska
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Severe Coronavirus disease 2019 (COVID-19) is associated with abnormal innate and adaptive immune responses, as well as systemic alterations, including a shift in lipid network. A case–control study was conducted to describe the systemic lipidomic profile in COVID-19 according to disease severity. Selected polyunsaturated fatty acids (PUFAs), oxylipins, and endocannabinoids were analysed using a targeted liquid chromatography coupled to mass spectrometry in tandem method. Multivariate receiver operating characteristic curve-based model evaluation was performed to define a lipidomic signature for the disease. A total of 135 hospitalized COVID-19 patients, of whom 85 had severe form, and 134 healthy individuals were included. Patients exhibited increased levels of free PUFAs, proinflammatory and pro-resolving oxylipins, and endocannabinoids compared to controls. A combination of five lipid mediators, i.e., prostaglandin D2, prostaglandin E2, thromboxane B2, lipoxin B4, and 2-archidonylglycerol, discriminates patients from control individuals with excellent accuracy [AUC, 0.977 (0.950–0.995)]. The severe form is characterized by an imbalance between proinflammatory and pro-resolving oxylipins and increased endocannabinoids. COVID-19 is associated with a lipid storm that conditions disease severity. Targeting lipid mediators-related metabolic and signalling pathways could be an interesting therapeutic option in severe forms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a5fb8bf52683c50e4277c9e8f4f3b1e200f52531" target='_blank'>
              COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia
              </a>
            </td>
          <td>
            A. Bouabdallah, M. K. Ben-Fradj, Mohamed Bessem Hammami, Rim Abdelmalek, H. Sanhaji, T. Klopfenstein, Moncef Feki
          </td>
          <td>2025-11-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a860b1f890cd6919e6ed4f49c16018a6906fcd8a" target='_blank'>
              Exaggerated IFN-I Response in Long COVID PBMCs Following Exposure to Viral Mimics.
              </a>
            </td>
          <td>
            Bart Humer, J. Berentschot, C. V. van Helden-Meeuwsen, L. Bek, Maaike de Bie, Tobias M Defesche, Chantal A Boly, Manon Drost, M. Hellemons, W. Dik, M. Versnel
          </td>
          <td>2025-12-10</td>
          <td>Journal of clinical immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="SARS-CoV-2, the virus responsible for COVID-19, disrupts human cellular pathways through complex protein–protein interaction, contributing to disease progression. As the virus has evolved, emerging variants have exhibited differences in transmissibility, immune evasion, and pathogenicity, underscoring the need to investigate their distinct molecular interactions with host proteins. In this study, we constructed a comprehensive SARS–CoV–2–human protein–protein interaction network and analyzed the temporal evolution of pathway perturbations across different variants. We employed computational approaches, including network-based clustering and functional enrichment analysis, using our custom-developed Python (v3.13) pipeline, BioEnrichPy, to identify key host pathways perturbed by each SARS-CoV-2 variant. Our analyses revealed that while the early variants predominantly targeted respiratory and inflammatory pathways, later variants such as Delta and Omicron exerted more extensive systemic effects, notably impacting neurological and cardiovascular systems. Comparative analyses uncovered distinct, variant-specific molecular adaptations, underscoring the dynamic and evolving nature of SARS-CoV-2–host interactions. Furthermore, we identified host proteins and pathways that represent potential therapeutic vulnerabilities, which appear to have co-evolved with viral mutations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/69099fff2803ece73e94ac8189f87993409fb26a" target='_blank'>
              Temporal Profiling of SARS-CoV-2 Variants Using BioEnrichPy: A Network-Based Insight into Host Disruption and Neurodegeneration
              </a>
            </td>
          <td>
            Sreelakshmi Kalayakkattil, Ananthakrishnan Anil Indu, Punya Sunil, Haritha Nekkanti, Smitha Shet, Ranajit Das
          </td>
          <td>2025-12-05</td>
          <td>COVID</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Bats are recognized for harboring a diverse array of viruses without manifesting disease symptoms. In this study, we explored the single-cell atlas of wild Rhinolophus affinis (R. affinis) using Viral-Track and identified transcript expression of eight viral species in the R. affinis lung and three viral species in the kidney. Within the R. affinis lung, these viruses were detected across all cell types except ciliated cells. Compared to uninfected cells, virus-infected cells exhibited activation of pathways associated with protein synthesis, tissue repair, and immune responses, as evidenced by increased expression of corresponding genes. Ligand-receptor based analysis revealed that viral infection reshapes intercellular communication networks in the bat lung, with infected fibroblasts and infected proliferative T cells exhibiting enhanced signaling linked to tissue remodeling and immune activation. Through gene module analysis, we identified an immune cell activation-related module by high expression of CD14, CD74, and MRC1, as well as an antiviral related module by elevated expression of SAMHD1, SLC11A1, TYROBP, and IL18 in R. affinis pulmonary macrophages. Additionally, a cross-species single-cell transcriptomic comparative analysis demonstrated that R. affinis pulmonary macrophages exhibit elevated expression of pro-inflammatory genes (IRF9, DDX5, IL6ST and ITGA4), which are associated with antiviral activity and immune activation, and anti-inflammatory genes (IRF2, PTPRE and GPR65), which play critical roles in mitigating excessive immune responses. Compared to the other species, R. affinis pulmonary macrophages exhibited upregulation of genes enriched in pathways related to vacuolar acidification and negative regulation of response to external stimulus. These findings suggest that the R. affinis lung possesses a unique immune system that enables it to balance immune responses during viral infections, thereby preventing excessive immune damage and maintaining lung tissue homeostasis. Our study provides valuable insights into the viral infection risk organs in R. affinis and their distinctive antiviral immune responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d2a7dd5aaaef9bd6ef26a081f64e45724d701050" target='_blank'>
              Single-cell analysis of intermediate horseshoe bat (Rhinolophus affinis) organs reveals viral infections and antiviral immune signatures
              </a>
            </td>
          <td>
            Tianhang Lv, Jianhui Zhang, Zhiwan Zheng, Xiaohui Fan
          </td>
          <td>2025-11-07</td>
          <td>BMC Genomics</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="The devastating clinical, psychological, and economic impact of the COVID‐19 pandemic, caused by global spread of the second Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV‐2), has engendered a massive response from the scientific community to rapidly understand the biology of SARS‐CoV‐2 and to develop interventions to prevent infection or progression to life‐threatening disease. Angiotensin converting enzyme‐2 (ACE2) and its interaction with the SARS‐CoV‐2 Spike glycoprotein, which mediates fusion of the virion envelope with the target cell membrane, have emerged as a major pharmacological target, as disruption of the Spike‐ACE2 interaction prevents cells from becoming infected and hence from producing viral progeny. Moreover, the dysregulation of ACE2 that occurs in the context of SARS‐CoV‐2 infection may have broader implications for COVID‐19 pathogenesis. Here we summarize the role of ACE2 as a physiologic regulator of human health, as a facilitator of SARS‐CoV‐2 infection, as a factor in COVID‐19 disease, and as a target for pharmacological interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2e59f0d9c946db9a9c160b8605a6c2ca92d39a0" target='_blank'>
              The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions
              </a>
            </td>
          <td>
            M. McVoy, A. Kummarapurugu
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Abstract Background Alzheimer's Disease (AD) is characterised by the accumulation of aggregated β‐amyloid and neurofibrillary tangles, with the immune system being a key driver of AD pathology and progression. Systemic infections can worsen cognitive decline in patients, possibly due to cerebrovascular dysfunction and exaggerated neuroinflammation, but the underlying mechanisms are not fully understood. Modelling systemic infection in animal models has classically been carried out using lipopolysaccharide (LPS) to mimic a systemic bacterial infection. LPS activates the innate immune compartment of the immune system but does not accurately represent the chronic low grade inflammatory changes observed during a real bacterial infection. In this study, we investigate the inflammatory and vascular effects following exposure to a live, attenuated bacterial strain Salmonella Typhimurium in APP/PS1 and WT mice. Method APP/PS1 mice and WT littermates were infected with 1x106 CFU Salmonella Typhimurium (SL3261) or sterile saline control by intraperitoneal injection and tissue from perfused mice was collected at 7 and 28 days post‐infection. Liver and brain tissue were analysed for systemic inflammation, cerebrovascular dysfunction and neuroinflammation using immunofluorescence. Result We report that systemic infection with Salmonella Typhimurium induces fibrin(ogen) deposition in the liver accompanied by the formation of FcγRI and CD11b positive inflammatory lesions. Cerebrovascular activation, measured by increased expression levels of VCAM and ICAM, is observed 7 days post infection, which is accompanied by extravasation of fibrin(ogen) and IgG into the brain parenchyma. Microglial activation, measured by expression of MHC‐II and FcγRI, revealed an exaggerated microglial response in APP/PS1 mice when compared to WT littermates. The cerebrovascular dysfunction following exposure to Salmonella Typhimurium may have contributed to this exaggerated neuroinflammatory response. Conclusion This study shows that APP/PS1 mice with a systemic bacterial infection have exaggerated microglial neuroinflammatory response. The cerebrovascular dysfunction and fibrin‐ mediated activation of microglia following exposure to Salmonella Typhimurium may have contributed to this exaggerated neuroinflammatory response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/86a90de9ba1de1a8e1a7af0b9cbc74a9513897ea" target='_blank'>
              Systemic bacterial infection induces cerebrovascular dysfunction and exaggerated neuroinflammation in APP/PS1 mice
              </a>
            </td>
          <td>
            Matthew P Colley, A. B. Kantor, Jessica Teeling
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="ABSTRACT Enterovirus 71 (EV71) is a viral pathogen responsible for causing hand, foot, and mouth disease, which can lead to severe neurological complications. This study aims to elucidate the pyroptosis mechanism underlying brain injury induced by EV71 infection. EV71-infected BALB/c suckling mice exhibited characteristic symptoms, including weight loss, lethargy, and limb weakness. Notably, elevated levels of the inflammatory proteins IL-1β and IL-18 were detected in the brain tissue of the infected mice. Research findings indicate that EV71 infection activates the NLRP3 inflammasome, resulting in an increased release of IL-1β and IL-18. Furthermore, upregulation of the expression of Caspase-1, Caspase-11, and the pyroptosis-related protein GSDMD was observed in the context of EV71 infection. Importantly, the administration of inhibitors targeting Caspase-1 and Caspase-11 led to the downregulation of these protein expression levels and simultaneously reduced the severity of the inflammatory response in the brain tissue. These results highlight the critical regulatory role and cross-talk between Caspase-1 and Caspase-11 in EV71-induced brain injury, which involves inflammatory responses and pyroptosis. The significance of these findings enhances our understanding of the pathogenic mechanisms associated with EV71 infection and offers valuable insights for the development of new therapeutic strategies. IMPORTANCE This study elucidated the molecular mechanism underlying pyroptosis-mediated brain injury during EV71 infection in hand, foot, and mouth disease (HFMD), addressing a critical knowledge gap in neuroinflammatory pathogenesis. Using a BALB/c suckling mouse model, we demonstrated that EV71 infection induced a significant upregulation of the pro-inflammatory cytokines IL-1β and IL-18 in brain tissues. Mechanistically, the activation of the caspase-1/11-GSDMD axis was confirmed via Western blot analysis, which revealed an increase in cleaved GSDMD levels in the presence of EV71, indicating a definitive link between the virus and pyroptotic cell death, as supported by studies on GSDME’s role in EV71-induced cell pyroptosis. Specific inhibitors targeting caspase-1/11 have been shown to effectively suppress protein expression, reduce neuroinflammatory markers, and improve survival rates, as demonstrated in studies involving acute pancreatitis, EAE, and non-canonical cell death. These findings not only advance the understanding of EV71 neuropathogenesis but also identify caspase-1/11 as promising therapeutic targets for mitigating HFMD-associated brain injury. This study elucidated the molecular mechanism underlying pyroptosis-mediated brain injury during EV71 infection in hand, foot, and mouth disease (HFMD), addressing a critical knowledge gap in neuroinflammatory pathogenesis. Using a BALB/c suckling mouse model, we demonstrated that EV71 infection induced a significant upregulation of the pro-inflammatory cytokines IL-1β and IL-18 in brain tissues. Mechanistically, the activation of the caspase-1/11-GSDMD axis was confirmed via Western blot analysis, which revealed an increase in cleaved GSDMD levels in the presence of EV71, indicating a definitive link between the virus and pyroptotic cell death, as supported by studies on GSDME’s role in EV71-induced cell pyroptosis. Specific inhibitors targeting caspase-1/11 have been shown to effectively suppress protein expression, reduce neuroinflammatory markers, and improve survival rates, as demonstrated in studies involving acute pancreatitis, EAE, and non-canonical cell death. These findings not only advance the understanding of EV71 neuropathogenesis but also identify caspase-1/11 as promising therapeutic targets for mitigating HFMD-associated brain injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c322c9f621ed76545357fb58c7ef5e681afa5b13" target='_blank'>
              Enterovirus 71 infection induces pyroptotic brain injury via synergistic activation of classical inflammasome and viral gasdermin D cleavage
              </a>
            </td>
          <td>
            Tianrun Liu, Baixin Wang, Yingyu Li, Shuming Tian, Xinlong Gao, Yuhan Fan, Xiaomeng Zhang, Limin Yang, Rui Wu, Lei Liu
          </td>
          <td>2025-11-25</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="At a population level, evaluation of vaccine efficacy and of immunity in general focuses on measuring humoral immunity, especially antibody-mediated neutralization. However, antibody-dependent cell-mediated cytotoxicity (ADCC) and cellular immunity are key processes for pathogen clearance and often provide broader protection against emerging variants. More information on vaccine and infection-related determinants or markers of cell-mediated cytotoxicity is needed to inform design of standardized, high throughput tests assessing these processes. We previously showed that persons infected with SARS-CoV-2 prior to vaccination (hybrid immunity) had polyfunctional CD8+ T cells and robust ADCC against SARS-CoV-2 spike (S), while persons infected with Omicron after vaccination (breakthrough infection) had weak ADCC. In the current study, we investigated the impact of Omicron breakthrough infection on S-specific cellular immunity, including polyfunctional CD8+ T cell and cytotoxic T lymphocyte (CTL) levels of 28 previously uninfected individuals vaccinated either two or three times against SARS-CoV-2. In the group with three vaccinations, Omicron breakthrough infection significantly increased the frequency of circulating SARS-CoV-2 S-specific T cells, polyfunctional interferon-gamma and interleukin-2-producing SARS-CoV-2 S-specific CD8+ T cells and CTL after in vitro stimulation. Matrix testing with overlapping S peptides indicated recognition of one to two CTL epitopes per individual and revealed two previously unreported epitopes. Circulating S-specific cellular immune response magnitude neither correlated with, nor predicted CTL activity against SARS-CoV-2 S, but polyfunctional S-specific CD8+ T cell frequency seven days after stimulation and antibody reactivity against determinants indicating robust ADCC were both associated with day 10 CTL activity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cbb2a62c4bf2c7761ccd671a47fe0b9354dc0555" target='_blank'>
              Predictive Markers of SARS-CoV-2 Spike-specific Cytotoxic T Cell Activity Following Omicron Breakthrough Infection.
              </a>
            </td>
          <td>
            Kayla A. Holder, Danielle P. Ings, Keeley M. Hatfield, Kathleen E Fifield, D. A. Barnes, Keeley A Barnable, Debbie Harnum, Michael D Grant
          </td>
          <td>2025-12-09</td>
          <td>Emerging microbes & infections</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bce54efd110fde03077139b1afa9c1f4e6856c6b" target='_blank'>
              Single-cell analysis of B cell dysregulation in pediatric sepsis stratified by disease severity.
              </a>
            </td>
          <td>
            Fahd Alhamdan, Stefano Gianoli, Koichi Yuki, S. Koutsogiannaki
          </td>
          <td>2025-12-31</td>
          <td>Scientific reports</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Neurodegenerative diseases are a multifactorial problem for modern neurology, due to their unknown etiology, difficult diagnostics, and, consequently, the lack of causal methods of treatment. Rising life expectancy exacerbates the problem by increasing the number of patients, as most of them fall ill in older age. Recent research shows that inflammation, both peripheral and neuroinflammation, may take part in the pathogenetic pathways of disease development. Some studies suggest that the initiation of the process occurs outside of the nervous system and is causally related to the immune system. This review focuses on the role of basic peripheral immune cells, including lymphocytes and neutrophils, in the course of selected central nervous system pathologies and their potential use as a biomarker. Both types of leukocytes not only change their quantity, but, more importantly, their function. Furthermore, they interact with microglial cells that constantly surveil the central nervous system and respond to pathological factors. Their joint action, however, can be either neuroprotective or neurotoxic. This review highlights that the development of neurodegeneration is associated with a dysregulation of the balance between immune cell phenotypes and their interactions. The disturbed immune response does not allow for the organism to correctly control the disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ef5e62d571874de2ebc2fe74c74f57d6af4d6b8" target='_blank'>
              White Blood Cells in Neurodegenerative Diseases in the Context of Neuroinflammation
              </a>
            </td>
          <td>
            Agnieszka Wełnicka-Wesołowska, Monika Gołąb-Janowska
          </td>
          <td>2025-11-24</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d9fdff2c96c23d992f68887e5d8b5023f241d69" target='_blank'>
              Mycophenolate mofetil reduces the branching of microglial processes
              </a>
            </td>
          <td>
            Rin-ichiro Teruya, Kentaro Ueda, Takumi Taketomi, Takushi Yamamoto, Naoki Yamashita, Hana Konno, Fuminori Tsuruta
          </td>
          <td>2025-11-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Introduction SARS-CoV-2, the pathogen of COVID-19, disrupts the alveolar epithelial barrier and triggers exacerbation of airway inflammation. The envelope (E) protein plays a key role in promoting epithelial damage and sustaining inflammation. We previously identified a SARS-CoV-2 variant (F8) containing a 12-bp deletion in the E gene. Compared to the 8X strain, which possesses the wild-type E gene, F8 could induce a higher expression of inflammatory factors in Calu-3 cells. Methods This study analyzed the miRNA expression profiles in Calu-3 cells infected with either the F8 variant or the 8X strain. Quantitative Reverse Transcription Polymerase Chain Reaction (RT-qPCR) was employed to validate the differential expression of candidate miRNAs. Subsequent functional verification assays like ELISA were performed to elucidate the regulatory roles of these miRNAs in host signaling pathways, such as inflammatory responses. Results We discovered that F8 infection significantly upregulated miR-361-3p and downregulated let-7b-5p. Furthermore, miR-361-3p regulated the PI3K-Akt pathway by directly targeting and inhibiting TSPAN1, ultimately promoting PTEN expression. The downregulation of let-7b-5p might release the suppression on inflammatory cytokines (IL-6, IL-8, PTX3), and partially disorder ZO-1 expression in maintaining the barrier function. Discussion This study is the first to demonstrate that the SARS-CoV-2 E protein mutant F8 remodeled the host miRNAs network to coordinate the immune responses and barrier function. All findings provided valuable insights into the pathogenesis of SARS-CoV-2 variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8e3e728bf0af1f00a31c1d2eadcc47ca6aa1e2d4" target='_blank'>
              MicroRNA-mediated regulation of the immune response in Calu-3 cells infected with a SARS-CoV-2 E gene variant
              </a>
            </td>
          <td>
            Chenfan Sun, Fang Xu, Zhongji Pu, Hanping Zhu, Yu-dong Li, Hangjing Lu, Bei-Bei Wu, Yi-Sheng Sun, Ping-Ping Yao, Jian-Ming Jiang
          </td>
          <td>2025-12-15</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c18b6c3d94e0b245a2073ceeb35d02bd592fc6fc" target='_blank'>
              The compounding roles of gut-immune-brain axis and COVID19 in manifestation of idiopathic Parkinson’s disease
              </a>
            </td>
          <td>
            Ankita Das, Vani Vivek, P. Aich
          </td>
          <td>2025-11-08</td>
          <td>Discover Immunity</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Simple Summary Between 2021 and 2024, large segments of the population—including cancer patients—experienced multiple COVID-19 infections and received repeated doses of mRNA vaccines. The concomitant increase in newly diagnosed cancers or fast progression of cancers under treatment raised concerns about whether SARS-CoV-2 or the vaccines might play a role in these outcomes. While it appears extremely unlikely that SARS-CoV-2 and anti-COVID-19 mRNA vaccines can elicit genotoxic events causing neo-cancerogenesis in a short time, they could still cause non-genotoxic pro-carcinogenic effects. Indeed, multiple molecular, cellular, and systemic mechanisms, including disruption of the immunosurveillance and induction of inflammation in the tumor microenvironment, disruption of autophagy and of tumor suppressor pathways, and activation of signaling involved in cell proliferation and cell migration, could synergistically lead to the awakening and fast growth of dormant microtumors, particularly in vulnerable individuals exposed to both repeated infections and vaccinations over a short time frame.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/de3cfcddce3551466023c757b442fae429468eda" target='_blank'>
              SARS-CoV2 and Anti-COVID-19 mRNA Vaccines: Is There a Plausible Mechanistic Link with Cancer?
              </a>
            </td>
          <td>
            C. Isidoro
          </td>
          <td>2025-12-01</td>
          <td>Cancers</td>
          <td>0</td>
          <td>48</td>
        </tr>

        <tr id="Many studies have shown an association between herpes simplex virus type 1 (HSV-1) infection and the development of neurodegeneration processes later in life, such as Alzheimer’s disease. The Fas/FasL death pathway plays an important role in the complex regulation of the local inflammatory response and mounting of the specific antiviral response in HSV-1 infection. Here, we applied a mouse model of latent HSV-1 neuroinfection to Fas- and FasL-deficient mice (lpr and gld) to explore whether the lack of functional Fas/FasL pathway protects from inflammation-related neurodegeneration. The latently infected Fas- and FasL-deficient mice (lpr and gld) were not protected from virus replication despite the accumulation of virus-specific cytotoxic T cells. However, the lack of Fas/FasL pathway decreased neuroinflammation- and neurodegeneration-related markers, including cognitive impairment, amyloid-β protein, and tau hyperphosphorylation. The use of a glucocorticoid, dexamethasone, to decrease neuroinflammation in wild-type mice did not protect from cognitive impairment, despite the improved antiviral response. Our data indicate that excessive neuroinflammation via the Fas/FasL pathway during HSV-1 infection is associated with neurodegeneration. Furthermore, the administration of immunomodulatory agents to ameliorate the outcome of HSV-1 latent infection should be restricted to the peak of neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ae344fac498d71f5308786f29214c408bb4c753" target='_blank'>
              Lack of Fas/FasL Does Not Protect from Latent Herpes Simplex 1 Infection but Decreases Virus-Induced Neurodegeneration
              </a>
            </td>
          <td>
            Magdalena Patrycy, Agnieszka Kauc, Martyna Janicka, Aleksandra Osińska, Andrzej Kowalczyk, Katarzyna Skulska, Małgorzata Antos-Bielska, Marcin Chodkowski, Kristina Eriksson, Małgorzata Krzyżowska
          </td>
          <td>2025-12-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Neuroinflammation, a pervasive hallmark in many neurological and neuropsychiatric diseases, is largely dictated by the functional phenotypic dynamics of microglia, the immune system of the brain. Recent data illustrate that these phenotypic changes, from neuroprotective scavenging to neurotoxic pro-inflammatory effects, are intrinsically regulated by microglial metabolic repolarization. This review synthesizes understanding of discrete microglial metabolic phenotypes like the glycolytic reliance of pro-inflammatory (M1-like) microglia and the oxidative phosphorylation/fatty acid oxidation bias of anti-inflammatory/resolving (M2-like) microglia. We discuss how central metabolic sensors like AMPK, mTOR, and HIF-1α oversee these metabolic shifts in response to disease-targeted pathologies in Alzheimer’s, Parkinson’s, Multiple Sclerosis, ischemic stroke, and traumatic brain injury. Moreover, we review innovative therapeutic strategies directed toward microglial metabolism, involving pharmacological modulators (e.g., metformin, rapamycin, and ketone bodies), nutritional interventions (e.g., ketogenic diets), and modulation of gut microbiota. By tightly specific re-tuning of microglial cells’ bioenergetics, these approaches enable unprecedented opportunities to counteract neuroinflammation, enhance pathological clearance, and induce neuroprotection, paving the way for a new generation of disease-modifying therapies of neurodegenerative disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c8a37e2dcc6db354c333c276544357fb7b3b5ab0" target='_blank'>
              “Rewiring brain immunity: targeting microglial metabolism for neuroprotection in neurodegenerative disorders”
              </a>
            </td>
          <td>
            Mustafa M. Shokr
          </td>
          <td>2025-11-25</td>
          <td>Metabolic Brain Disease</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition emerging during the COVID-19 pandemic, strongly associated with prior SARS-CoV-2 infection. Characterized by systemic inflammation affecting multiple organs, MIS-C presents a complex clinical picture including fever, gastrointestinal distress, cardiac dysfunction, and neurological manifestations. Although its exact pathogenesis remains incompletely understood, immune dysregulation is recognized as a central mechanism. This review examines current understanding of MIS-C pathogenesis, focusing on immune dysfunction and viral triggers, particularly SARS-CoV-2. We analyze both innate and adaptive immune responses, cytokine storm dynamics, molecular mimicry, and virus-induced inflammatory cascades. Additionally, we discuss potential immunomodulatory therapeutic strategies and identify future research directions to improve MIS-C management and treatment outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb906afaca8efa1a4927662eab78d7c57c8c42b9" target='_blank'>
              MIS-C pathogenesis: immune dysregulation & viral triggers
              </a>
            </td>
          <td>
            Tiantian Xu, Jiamin Zhang, Xiangyuan Hou, Xinyu Xie, Junye Qi, Chang-bing Wang, Yuqing Yan, Lu Kuang, Bing Zhu
          </td>
          <td>2025-11-26</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="Dendritic cells (DCs) play a central role in both the development and maintenance of adaptive immunity by their ability to prime and regulate T cell function. These interactions between DCs and T cells are crucial to the pathogenesis of multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Myeloid differentiation primary response protein 88 (MyD88) signalling is pivotal in the pathogenesis of MS and EAE; however, its specific contributions across various cell types in the context of these conditions remain inadequately understood. In this study, we reanalysed single-cell RNA sequencing data from MS patients and revealed significant upregulation of MYD88 in DCs and CD4+ T cells isolated from PBMCs of MS patients. Single-cell RNA sequencing analysis revealed that during the peak phase of EAE, Myd88 is highly expressed in moDCs and pDCs compared to cDCs. Notably, the absence of Myd88 in DCs resulted in significantly reduced interactions with T cell clusters. Our in vivo and in vitro results showed that while MyD88 deficiency did not affect lymphocyte production in the thymus, it resulted in impaired Th1 and Th17 cell differentiation and diminished T cell activation. Mechanistically, MyD88-/- DCs exhibited impaired maturation and a reduced production of pro-inflammatory cytokines, such as IL-6, TNF-α, and IL-12, which may be linked to their role in directing Th1 and Th17 cell differentiation. Our findings suggest that MyD88 is essential for the priming of inflammatory T cells and the activation of DCs, and their interactions with T cells, underscoring its role in neuroinflammation. This study highlights the potential therapeutic implications of targeting MyD88 pathways in MS and related disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07143d3aea4af59d5ef86ee7d3bbbaf941891061" target='_blank'>
              MyD88 Deficiency Protects Mice From Experimental Autoimmune Encephalomyelitis by Influencing Both Dendritic Cells and T Cells.
              </a>
            </td>
          <td>
            Wen Si, Gaochen Zhu, Qianling Jiang, Xin Ma, Guan Yang
          </td>
          <td>2025-12-09</td>
          <td>Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="The systemic inflammatory response syndrome (SIRS) is a complex and multifactorial life-threatening reaction triggered by trauma or infection (sepsis). Since the dynamics of immune cells, cytokines and novel markers such as circulating extracellular vesicles (EVs) remain incompletely elucidated, we aimed to provide a comprehensive multiparametric characterization of this severe response, to identify potential prognostic and therapeutic targets. We conducted a multiparametric and sequential quantification of up to 25 immune cell circulating populations using next-generation flow cytometry, assessed plasma cytokine levels with Luminex technology, and the characterized and quantified EVs and their microRNA content. Peripheral blood samples were taken at 0, 24 and 72 h after SIRS onset from 25 patients with polytrauma-induced SIRS (PT group) and 25 developed SIRS from other origins, such as pulmonary or urinary infections (NP-denoting non-polytrauma group). Samples from 21 healthy donors (HD) were analysed as a control group. Statistical analyses were performed to compare experimental groups (PT, NP, HD) and to evaluate correlations between experimental findings and patients’ outcomes for potential prognostic markers discovery. SIRS patients exhibited increased leukocyte counts driven by neutrophil mobilization combined with a reduction of dendritic cells and lymphocytes early after the SIRS. The PT group showed an increase in classical monocytes, myeloid-derived suppressor cells (MDSCs), and mesenchymal stromal cells compared to HD. These dynamics occurred alongside substantial chemokine release, including IL-8, G-CSF, CCL2 in both SIRS groups, MIF in PT and CCL4 in NP. Both SIRS groups experienced a pronounced cytokine storm with simultaneous release of both pro- and anti-inflammatory cytokines, and increased of plasma EV levels. Our findings suggest that elevated IL-8 concentrations and increased counts of circulating monocytes and MDSCs are associated with worse prognosis and may serve as valuable prognostic indicators in SIRS patients. Our study demonstrates the dynamic kinetics of multiple cell subsets, cytokines and EVs during SIRS, highlighting differences between SIRS initiated by polytrauma versus non-polytrauma events and identifying correlations between biological findings and patient outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/678d0938855cd21885f7e9dce3eb4d79dc760ecc" target='_blank'>
              Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysis
              </a>
            </td>
          <td>
            Gerardo J. Martí-Chillón, S. Muntión, J. Flores-Montero, Javier González-Robledo, Luís Corchete, Julio Pozo, L. Osugui, S. Preciado, M. Gómez-Redondo, Juan F. Blanco, A. Navarro-Bailón, V. Sagredo, Julia Almeida, A. Orfao, F. Sánchez-Guijo
          </td>
          <td>2025-11-21</td>
          <td>Journal of Translational Medicine</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated not only with respiratory illness but also with profound vascular and coagulation disturbances. Long COVID (LC) is characterized by persistent symptoms such as fatigue, dyspnea, cognitive impairment, and palpitations. Mechanistically, SARS-CoV-2 induces direct endothelial injury, promotes a pro-inflammatory cytokine milieu, and activates platelets, leading to immunothrombosis and impaired fibrinolysis. Consequently, patients exhibit microthrombosis, elevated plasma D-dimer, fibrinogen dysregulation, and persistent hypercoagulability. Clinically, this translates into an increased risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, as well as arterial thrombotic events such as myocardial infarction and stroke, which may persist months after acute infection. Understanding the interplay between endothelial injury, inflammation, and coagulation is crucial for risk stratification and the development of preventive and therapeutic strategies. We conducted a systematic narrative review of the literature, including human clinical and mechanistic studies identified through PubMed, Scopus and Web of Science up to 30 September 2025. This review synthesizes current evidence on vascular complications in LC, highlighting endothelial dysfunction as a central pathophysiological nexus linking the acute phase of SARS-CoV-2 infection with chronic LC manifestations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f14dffbb63f077cbdc46f26a8295d84afd04c13d" target='_blank'>
              Vascular Complications of Long COVID—From Endothelial Dysfunction to Systemic Thrombosis
              </a>
            </td>
          <td>
            Maja Stojanović, Marko D Djuric, Irina B Nenadic, Suzana C. Bojic, Ana Andrijevic, Aleksa Popovic, Slobodan Pešić
          </td>
          <td>2025-12-31</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic, inflammatory condition characterized by neurodegeneration and lost myelin, or demyelination. This lost myelin may be regenerated in people with MS through a process called remyelination, that is prone to failure and is impaired with age. Remyelination is facilitated by microglia but our understanding of the microglial response during remyelination is incomplete. Here, we profile the microglial response during remyelination in the lysolecithin mouse model using single-cell RNA sequencing and find several distinct microglial states during the early stages of remyelination that coalesce into a resolved state defined by the presence of myelin transcripts, a state also present in MS brains. We also observe a delay in the appearance of several microglial states with age, in concordance with delayed remyelination. This multi-faceted microglial response during efficient remyelination provides the basis of multi-faceted microglia-specific targets for future MS therapies. Microglial states throughout remyelination are incompletely understood. Here, the authors show that microglia form several states during the early stages of remyelination that coalesce into a partially resolved state that is dysregulated with age.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/89f58ee42dc387c6b9d9bec82580a8d43e52f669" target='_blank'>
              Age-impaired remyelination is associated with dysregulated microglial transitions
              </a>
            </td>
          <td>
            Sameera Zia, Marianela E. Traetta, Charbel S. Baaklini, Brady P Hammond, Rebecca K. John, Katherine M. Souter, Niels Meijns, Larry K. A. Afun, Sharmistha P Panda, F. González Ibáñez, Mena K. Burr, Eva Dhupia, Abhisha M Rathod, Andre O. Faria, Dhruvish Zaveri, Sowmya Challa, Eugene Hahn, S. B. Manesh, Kelly V. Lee, Madelene F. S. Ho, Timothy N. Friedman, Aislinn D. Maguire, Arina Pang, Olivia Farkas, Bożena Szulc, Luiz Tenorio, Diya Vyas, Olivia R. La Caprara, W. Tetzlaff, Sarthak Sinha, G. Duncan, Anastassia Voronova, Bradley J. Kerr, Marie-Ève Tremblay, Jeff Biernaskie, G. Schenk, J. Plemel
          </td>
          <td>2025-11-12</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="SARS-CoV-2 accessory proteins (APs), particularly ORF3a and ORF9b, have emerged as key modulators of host-pathogen interaction and potential contributors to long COVID. Of the 13 predicted APs, only nine are expressed during infection – termed Infection-related APs – while the remaining are classified as Putative APs. Despite this distinction, extensive gene overlap among APs underscores the remarkable adaptability of SARS-CoV-2 viral genome. This review delves into the diverse roles of the original Wuhan APs and their Omicron counterparts in shaping host immunity, with an emphasis on their ability to suppress type I interferon (IFN-I) signalling, modulate cellular metabolism, and trigger inflammatory/apoptotic pathways. By integrating immunopathological insights with evolutionary dynamics and structural perspectives, this review provides a comprehensive understanding of the mechanism underlying Omicron’s reduced pathogenicity and highlights promising, yet unexplored, therapeutic targets within the SARS-CoV-2 accessory proteome.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6086782319f7c4f70392309ce0b182e4c6409aa6" target='_blank'>
              Hidden players of COVID-19: the evolving roles of SARS-CoV-2 accessory proteins
              </a>
            </td>
          <td>
            Miguel Padilla-Blanco, Tránsito García-García, Juozas Grigas, B. D. López-Ayllón, Juan J Garrido, María A. Oliva, María Montoya
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8602892f5a451d75b2917aa6aa3b1a249d99d98" target='_blank'>
              COVID-19-associated Autoimmune and Inflammatory Diseases: Molecular Mechanisms and the Role of IVIG Therapy
              </a>
            </td>
          <td>
            Sukanya Bordoloi, S. Singh, Jagadeesh Bayry
          </td>
          <td>2025-11-13</td>
          <td>Clinical Reviews in Allergy & Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Severe influenza is frequently associated with bacterial or viral co-infections. Although immune-mediated mechanisms have been extensively investigated, the cell-intrinsic responses of respiratory epithelial cells prior to immune engagement remain poorly characterized. To model co-infection in vitro, we pre-activated B16 melanoma cells using the TLR9 agonist CpG ODN, followed by infection with influenza A virus (IAV) strain FM1. Key molecular events, including STING expression and activation, were assessed by Western blotting and RT-qPCR. The in vivo relevance was assessed in a mouse model of intranasal CpG ODN pre-treatment and IAV challenge. RNA-seq was performed as a supplementary approach to explore possible cell death pathways. Pre-activation significantly enhanced IAV-induced cell death within a restricted vulnerability window (≤ 24 h), independent of viral replication or TLR9 signaling. This was associated with inflammatory priming and initial STING activation. However, IAV infection subsequently suppressed STING phosphorylation and elevated inflammatory cell death. Mice pre-treated with CpG ODN exhibited increased mortality and aggravated lung injury following IAV challenge. RNA-seq analysis suggested the potential involvement of pyroptosis. These findings demonstrate that cellular pre-stimulation exacerbates influenza severity by promoting inflammatory cell death, a process mechanistically linked to the subsequent suppression of STING activation. This study reveals a novel pathogenic cell-intrinsic mechanism in co-infection pathogenesis. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-28063-w.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3439ff28ee00f2494a3463487f23bdd0ebdcd631" target='_blank'>
              Pre-activation timing determines influenza severity and viral pathogenicity via STING Inhibition
              </a>
            </td>
          <td>
            Tong Zhu, Mengru Zhu, Feiyu Lu, Kuo Qu, Hong Wang, Shengnan Wang, Zhengyi Sun, Yongli Yu, Liying Wang, Chaoying Yan
          </td>
          <td>2025-12-24</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Since its emergence in late 2019, SARS-CoV-2 has evolved into multiple variants with distinct genetic and clinical features. Among them, the Omicron variant (B.1.1.529) and its sublineages BA.2.75, JN.1.8, and KP.2 have shown enhanced transmissibility and immune evasion, while generally exhibiting reduced lower respiratory tract pathogenicity compared to earlier variants, thereby continuing to pose significant challenges to public health. In India, these variants have significantly shaped the trajectory of the pandemic, necessitating focused evaluation of their biological and clinical impact. This review aims to provide a comprehensive study on the virology, pathophysiology, and systemic manifestations of Omicron and its emerging subvariants upto July 2025. We discuss their mechanisms of entry and replication, interaction with ACE2 and TMPRSS2 receptors, and evasion of host immune responses. Particular emphasis is placed on multi-organ involvement beyond the respiratory system, including neuro-respiratory dysregulation, cardiovascular complications, hepatic injury, gastrointestinal disturbances, and renal dysfunction. Furthermore, we evaluate the effectiveness of available vaccines, antiviral therapies, and diagnostic tools, alongside emerging clinical strategies such as vagus nerve stimulation, thermal modulation, and respiratory muscle training. By integrating molecular insights with clinical outcomes, this review highlights the multifaceted and systemic nature of Omicron-induced disease. We underscore the urgent need for variant-specific immunisation, early intervention strategies, and robust genomic surveillance to mitigate long-term sequelae and guide preparedness for future outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b2d3176f67a95b7b0b596b257cf88c32fab7bb85" target='_blank'>
              The virology of Omicron: pathophysiology, immune regulation, and clinical impact of SARS-CoV-2 sub variants
              </a>
            </td>
          <td>
            Nistha Mishra, Tanya Goel, Nisarg Gangani, Heerak Chugh, Bhavesh Kevadiya, Manisha Tiwari, Snigdha Singh, Jai Gopal Sharma, Ramesh Chandra
          </td>
          <td>2025-11-26</td>
          <td>Virology Journal</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Neurotropic viruses infect the central nervous system (CNS) and can cause severe neurological disorders. Theiler’s murine encephalomyelitis virus (TMEV) infection in C57BL/6 mice serves as a model for virus-induced encephalitis and hippocampal damage. C-type lectin domain family 12 member A (CLEC12A) is an inhibitory receptor, which modulates immune responses during inflammatory processes. However, the role of CLEC12A during neurotropic virus infections remains unclear. In this study, CLEC12A-deficient (CLEC12A−/−) and wild type C57BL/6 mice were infected with TMEV. Neuroinflammatory responses, viral load, and immune cell infiltration were analyzed using immunohistochemistry, RT-qPCR, and flow cytometry. CLEC12A−/− mice exhibited increased T cell sequestration in the brain, along with a higher expression of pro-inflammatory cytokine (TNF-α, IL-1β) and antigen presentation genes (CD11c, CD80, MHC-I) during acute infection. This led to an improved viral clearance in the hippocampus. CLEC12A deficiency also activates splenic CD4+ T cells and CD8+ cytotoxic T cells upon infection. Despite increased peripheral T cell activation and neuroinflammation, CLEC12A−/− mice displayed less hippocampal damage with improved neuronal and axonal integrity. In conclusion, CLEC12A signaling in C57BL/6 mice contributes to suppressive immune modulation, delaying viral elimination and exacerbating brain damage during acute neurotropic virus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c06a34914feb56293f8f56d9bcc2e6259a3943c" target='_blank'>
              CLEC12A signaling represses protective immune responses and contributes to hippocampal pathology in neurotropic picornavirus infection
              </a>
            </td>
          <td>
            M. K. Ameen, M. Stoff, S. Pavasutthipaisit, T. Ebbecke, M. Ciurkiewicz, T. Störk, J. Ruland, B. Lepenies, A. Beineke
          </td>
          <td>2025-11-10</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Abstract Background Recently approved Alzheimer's disease (AD) therapies leverage immunization strategies targeting amyloid‐β (Aβ). While most studies focus on microglial responses to these treatments, evidence suggests that sustained immune activity and Aβ clearance drive broader cellular changes. Astrocytes, which accumulate at microglia‐targeted Aβ plaques, may play a complementary role in clearance. This study examines how astrocyte phenotypes are altered by Aβ immunization and their contribution to Aβ clearance. Methods We performed single‐cell RNA sequencing and spatial transcriptomics on post‐mortem brain tissue from 16 AD patients—10 immunized (9 with AN1792 from the first active Aβ immunotherapy trial, 1 with lecanemab) and 6 non‐immunized controls. We identified astrocyte states enriched in immunized brains and analyzed their transcriptomic profiles. Additionally, we mapped astrocyte states localized at microglia‐targeted Aβ plaques. Results A distinct astrocyte population emerged following immunization with both AN1792 and lecanemab, characterized by upregulated CHI3L1 and other reactive astrocyte markers. Spatial analysis revealed these astrocytes preferentially localize at microglia‐targeted Aβ plaques post‐lecanemab treatment. Ongoing analyses aim to further define astrocyte phenotypes in terms of morphology, protein expression, Aβ uptake, and spatial relationships with Aβ pathology and microglia. Conclusion We identify a unique astrocyte phenotype induced by Aβ immunization in AD, marked by high CHI3L1 expression. This astrocyte state may be driven by microglia at Aβ plaques and contribute to plaque clearance. Our findings highlight distinct astrocyte responses to Aβ immunization, shedding light on their role in therapeutic outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc7159ce560d018f315b60c3e4c1c97a198abbee" target='_blank'>
              Distinct astrocyte phenotypes aid microglia‐mediated Aβ clearance in immunized Alzheimer's disease patients
              </a>
            </td>
          <td>
            Alex J. Edwards, Lily Camp, Anne V. Forsyth, Joshua Kuruvilla, Brooke Simonton, Pouya Jamshidi, Rudolph J. Castellani, James Ar Nicoll, Delphine Boche, Lynn van Olst, David Gate
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Neurocognitive impairment is a prevalent co-morbidity in virologically suppressed people living with HIV (PLWH), yet the underlying mechanisms remain elusive and treatments lacking. We explored use of participant-derived directly induced neurons (iNs) to model neuronal biology and injury in PLWH. iNs retain age- and disease-related donor features, providing unique opportunities to reveal important aspects of neurological disorders. We obtained primary dermal fibroblasts from six virologically suppressed PLWH (range: 27-64 years, median: 53; 83% Male) and seven matched people without HIV (PWOH) (range: 27-66, median: 55; 71% Male). iNs were generated using transcription factors NGN2 and ASCL1, and validated by immunocytochemistry, single-cell-RNAseq, and electrophysiological recordings. Transcriptomic aging analyses confirmed retention of donor age-related signatures. Bulk-RNAseq identified 29 significantly differentially expressed genes between PLWH and PWOH iNs. Of these, 16 were downregulated and 13 upregulated in PLWH iNs. Protein-protein interaction network mapping indicates iNs from PLWH exhibit differences in extracellular matrix organization and synaptic transmission. IFI27 was upregulated in PLWH iNs, complementing independent post-mortem studies demonstrating elevated IFI27 expression in PLWH-derived brain tissue. FOXL2NB-FOXL2-LINC01391 expression was reduced in PLWH iNs and negatively correlated with neurocognitive impairment. Thus, we identified an iN gene signature of HIV revealing mechanisms of neurocognitive impairment in PLWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ed7c586e77d0113c401ac4f4b8dda15f9a05841" target='_blank'>
              Transcriptional signature of induced neurons differentiates virologically suppressed people with HIV from people without HIV.
              </a>
            </td>
          <td>
            P. N. Ostermann, Youjun Wu, S. Bowler, Samuel Martínez-Meza, M. A. Siddiqui, David H Meyer, Alberto Herrera, Brandon A Sealy, Mega Sidharta, K. Ramnarine, Leslie St. Bernard, Desiree Byrd, R. Jones, Masahiro Yamashita, Douglas F. Nixon, L. Ndhlovu, Ting Zhou, Teresa H. Evering
          </td>
          <td>2025-11-25</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Circadian disruptions perturb the brain and immune system and increase the risk of developing Alzheimer’s Disease (AD), yet whether this involves dysregulation of brain immunity remains less clear. Here, we perform single-cell RNA sequencing of the brain immune compartment around the day-night cycle and identify brain border-associated macrophages (BAMs) as highly rhythmic cells. During the rest phase, we find that BAMs exhibit coordinated upregulation of endocytic genes and enhanced uptake of extracellular fluid-borne material including amyloid-beta (Aβ). Rhythmicity in BAM scavenging is regulated by the clock gene Bmal1, mediated by the endocytic receptor CD206, and perturbed with age. In a mouse model of AD, we show that deletion of Bmal1 in BAMs worsens perivascular and leptomeningeal Aβ plaque burden. Our results identify endocytosis as a specialized and rhythmic BAM function and identify perturbed timing of brain border immune functions as a potential mechanism by which circadian disruptions precipitate amyloidosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0c471e03c2aa28dba89ca368e4c1fb780adb456" target='_blank'>
              The circadian clock regulates scavenging of fluid-borne substrates by brain border-associated macrophages
              </a>
            </td>
          <td>
            Helena J. Barr, Sydney K. Caldwell, Justin M. Reimertz, Constanze Depp, Alec J. Walker, Samuel E. Marsh, Anushree S. Gupte, Maximilian Hingerl, Jasmin Patel, Sang-O Park, Sarah Ferraro, Jonathan Lipton, Beth Stevens
          </td>
          <td>2025-12-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Abstract Background We have recently established that microglia in the aged and AD human brain exist in discrete, transcriptionally defined states that have complex associations with clinicopathological features of AD (PMID: 33257666). This multifaceted relationship made it clear that we should develop approaches that allow for fine‐tuning of microglia population structure in order to achieve therapeutic benefit in AD. However, how Ad genes affect the cell intrinsic regulatory networks that shape human microglia phenotypes is yet unknown. To fill in this gap we investigated how AD genes affect the transcriptional regulatory networks that underlie microglia phenotypic specification. Method To achieve this goal, we utilized CROP‐seq, that enables pooled CRISPR screens with single‐cell transcriptome resolution. To assemble the guide RNA (gRNA) library for this study, we focused on nascent AD drug targets that were nominated by the National Institute on Aging's AMP‐AD consortium and TREAT‐AD centers and were expressed in microglia. gRNA library transduction was performed according to our recently published protocol (PMID: 38600587), and the cells were then submitted to a modified single cell RNA‐sequencing pipeline on the 10x Genomics Chromium platform. Result Generally, we found that genetic perturbation of AD genes in microglia resulted in changes in transcriptional regulatory networks associated with inflammation and lipid metabolism. More specifically, interestingly, the microglia subsets that were most affected by perturbations in AD genes were the previously described cluster 8 and cluster 9 microglia (PMID: 33257666). Previously we found cluster 8 microglia subset to be enriched in genes associated with metabolic changes while cluster 9 was characterized by genes involved cell proliferation. Both of these subsets had a negative association tau pathology in a large ROS/MAP transcriptomic dataset, suggesting that these microglia phenotypes might be protective in AD and that perturbations in AD genes might dysregulate the transcriptional regulatory networks involved in phenotypic specification of these subsets. Conclusion Our findings prioritize two human microglia subsets as being primarily affected by perturbations in AD genes, and identify transcriptional regulatory networks that could be targeted to modulate microglia population structure in a way that will potentially support the maintenance and/or restoration of tissue homeostasis in AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/eb1b2f817c2be7ae5aa9510c914b951f560502f1" target='_blank'>
              Identification of regulatory networks involved in microglia subset specification
              </a>
            </td>
          <td>
            Jason C. Ngo, Emily Lee, Nivedita Nimmagadda, Vilas Menon, Falak Sher, Marta Olah
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Enterovirus A71 (EV-A71) is a critical global pathogen, primarily causing Hand-Foot-and-Mouth Disease (HFMD) but frequently leading to severe neurological complications, including fatal neurogenic pulmonary edema (PE). This review elucidates the complex interplay between viral pathogenesis and the host immune response. EV-A71 utilizes receptors like SCARB2 and PSGL-1 for entry, while its proteases (2Apro, 3Cpro) efficiently evade innate immunity by cleaving key signaling adaptors (MAVS, TRIF), suppressing Type I IFN response. Critical to disease progression is the age-dependent vulnerability in infants and the subsequent shift toward immunopathology. Severe disease is driven by a systemic cytokine storm and T cell dysregulation, characterized by a loss of control from Treg cells and a profound Th17/Treg imbalance, resulting in high levels of pathogenic cytokines (e.g., IL-17A, IFN-γ). Clinical progression is predicted by specific biomarkers, including Treg depletion, monocyte exhaustion (PD-1/PD-L1), and suppressed regulatory signaling (low cAMP). These findings highlight that effective therapeutic strategies must target host-mediated damage through immunomodulation (e.g., by exploring interventions against key pathogenic axes like IL-6 and IL-1β) and call for the development of next-generation vaccines capable of eliciting balanced cellular immunity to prevent immunopathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c94423fb623958f352400377f15120efff0cd02" target='_blank'>
              The Host Immune Response to Enterovirus A71 (EV-A71): From Viral Immune Evasion to Immunopathology and Prognostic Biomarkers of Severe Disease—A Narrative Review
              </a>
            </td>
          <td>
            Anna Andronik, Dawid Lewandowski, Artur Sulik, Kacper Toczyłowski
          </td>
          <td>2025-11-25</td>
          <td>Viruses</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Aging is a major risk factor for increased morbidity and mortality following acute respiratory virus infections. To elucidate the immune determinants underlying viral pathogenesis and delayed lung repair in the aged lung, a comprehensive time-course study was conducted. Single-cell RNA sequencing (scRNAseq) and high-dimensional flow cytometry were utilized to compare lungs from young and aged mice infected with influenza A virus (IAV). Aged hosts displayed diminished alveolar macrophage (AM) and dendritic cell (DC) but elevated monocyte-derived macrophage (MoM) and interstitial macrophage (IM) presence following infection. Additionally, enhanced accumulation of adaptive immune cells, including CD4+ tissue-resident helper (TRH) cells, CD8+ tissue-resident memory (TRM) cells, and a B cell subset resembling age-associated B cells, was observed in the memory phase. Pathway analysis revealed that elevated type I and II interferon (IFNα/γ) signaling, especially in MoM/IM subsets, distinguished the aged hosts from the young. Inhibition of IFNα/γ signaling after viral clearance improved long-term respiratory outcomes and reduced both IM and TRH populations in aged mice. These findings highlight the pivotal role of IFNα/γ signaling, likely within MoM/IM subsets, in driving the exuberant persistence of adaptive immune cells and chronic immunopathology in the aged lung following acute viral infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79fbb4abcb1eeb6127549b886296b47a4c3b2fa0" target='_blank'>
              Temporal single-cell analysis reveals age-associated delay in immune resolution after respiratory viral infection
              </a>
            </td>
          <td>
            Yue Wu, Chaofan Li, Jinyi Tang, Xiaochen Gao, I. Cheon, Bibo Zhu, Ruixuan Zhang, C. Fain, S. Hu, H. Narasimhan, Gislane de Almeida Santos, K. Ayasoufi, Aaron J. Johnson, Hui Zong, Chongzhi Zang, Haidong Dong, Jie Sun
          </td>
          <td>2025-12-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Glaucoma is a neurodegenerative disease characterized by the progressive loss of retinal ganglion cell and optic nerve damage. Recent studies have highlighted the pivotal role of microglia in the onset and progression of glaucoma. This review aims to elucidate the key mechanisms of microglial activation in glaucoma and assess its potential as a therapeutic target for novel treatment strategies. Microglia activation in glaucoma is multifactorial, driven by biomechanical, metabolic, and inflammatory signals. Activated microglia contribute to both neuroinflammatory injury and neuroprotective responses. Their interaction with other kinds of cell establishes a dynamic inflammatory signaling network that exacerbates retinal ganglion cell loss. Furthermore, emerging evidence suggests that key targets in microglial activation, such as APOE, LGALS3, CX3CR1, etc. play critical roles in disease progression, revealing promising targets for therapeutic intervention. Microglia act as central regulators of the retinal immune microenvironment in glaucoma. Their dual role in neurotoxicity and neuroprotection is shaped by complex interactions with other kinds of cell. Targeting microglial activation state and restoring metabolic homeostasis represent promising strategies for the development of pressure-independent treatments for glaucoma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f0736f93a41203e022b21a0c724254c0beeb144f" target='_blank'>
              The role of microglia in glaucoma - trigger and potential target
              </a>
            </td>
          <td>
            Liugui Chen, Suyu Yang, Di Wang, Pingping Huang
          </td>
          <td>2025-11-11</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Background Rhinovirus (RV) is the most common trigger of viral-induced pediatric asthma exacerbations. The impact of IL-13-driven inflammation, common in pediatric asthma, on airway epithelial antiviral and inflammatory responses to RV remain unclear. Objective Determine how IL-13-driven T2 inflammation modulates pediatric bronchial epithelial cell responses to RV infection. Methods Bronchial epithelial cells (BECs) were collected from children with (n=50) and without (n=11) asthma. They were differentiated at an air-liquid interface for 21 days, pretreated with IL13 (10ng/mL) for 7 days to model T2 inflammation, then infected with RV-A16 (MOI 0.5). RNA sequencing of BECs was performed prior to and on days 2, 4, 7, and 10 post infection. Linear and generalized additive models partnered with pathway analysis identified differentially expressed gene clusters. Results RV infection, IL-13 stimulation, and their interaction each induced differentially expressed genes (7,808; 10,251; and 7,095 genes, respectively; FDR<0.05). IL-13 pretreatment did not alter RV load or a cluster enriched for interferon response and regulation genes, including IFNB1, IFNL1-3, STAT1/2, and CXCL10/11. In contrast, IL-13 reduced expression of distinct antiviral effectors (e.g. MX1/2, RSAD2, IFITM1-3; FDR=1.85×10⁻⁴) and increased a secondary proinflammatory response cluster enriched for IL-15, TNF, ER stress, and cell-death pathways (FDR=3.63×10⁻⁶). These clusters correlated with viral load in RV-infected cells, but IL13 pretreatment eliminated those associations. Conclusions IL-13 does not modify viral load or interferon induction but selectively suppresses epithelial antiviral effector programs and enhances secondary inflammatory pathways during RV infection. These findings provide mechanistic insight into how T2 inflammation contributes to viral-triggered asthma morbidity. Key Messages – IL-13 did not alter rhinovirus viral load or epithelial interferon induction but selectively suppressed antiviral effector programs. This indicates that T2 inflammation reshapes antiviral defenses downstream of interferon signaling rather than impairing interferon production itself. – IL-13 enhances a distinct secondary proinflammatory cluster enriched for IL-15, TNF signaling, ER stress, and cell-death pathways. These late-phase responses may contribute to the heightened airway inflammation and injury observed during viraltriggered exacerbations in T2-high pediatric asthma. – IL-13-driven changes decouple epithelial immune responses from viral load, revealing mechanisms that may persist even with anti-IL-4Rα/IL-13 therapy. These findings identify epithelial antiviral effector pathways and IL-15/TNF-associated inflammatory programs as potential therapeutic targets for patients who experience breakthrough viral exacerbations despite IL-13 blockade. Capsule Summary IL-13 did not alter rhinovirus load or epithelial interferon but selectively suppressed antiviral effectors and amplified secondary inflammatory pathways, revealing how T2-inflammation may worsen viral-triggered asthma exacerbations and contribute to breakthrough exacerbations despite IL-4Rα/IL-13-targeted therapy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8534d6df54bf150ef5da348dfd8ea2420fc6c8b1" target='_blank'>
              IL-13 Modulates Antiviral Effector and Proinflammatory Pathways in Rhinovirus-Infected Pediatric Bronchial Epithelium
              </a>
            </td>
          <td>
            P.C. Dela Cruz, Basilin Benson, N. Jayavelu, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, C. Gates, M. White, Nyssa B. Samanas, Kourtnie Whitfield, T. Hallstrand, Steven F. Ziegler, Gail H. Deutsch, Matthew C. Altman, Jason S. Debley
          </td>
          <td>2025-12-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Heart injury triggers a robust cellular response in zebrafish, characterized by neovascularization, immune cell activation, and the infiltration of proliferative cardiomyocytes that collectively lead to scarless regeneration. Upon injury, damage-associated molecular patterns are released by dying cells and injured extracellular matrix. These molecules bind to pattern recognition receptors on various cell types, promoting inflammation and immune cell recruitment by upregulating chemokines and pro-inflammatory cytokines. We previously identified the activation of injury-induced interferon signaling as a distinguishing feature between the regenerative zebrafish and non-regenerative medaka. Here, we establish interferon-Φ1 (IFN□1) as the primary driver of interferon signaling after zebrafish heart injury. IFN□1 expression is induced hours after injury and directs interferon-stimulated gene expression, which peaks at 72 hours post-injury. This response is lost in ifnphi1 mutants, which disrupt IFN□1 expression. ifnphi1 mutants have reduced neutrophil recruitment to the injured myocardium, while macrophages and neovascularization are unaffected. By studying later stages of regeneration, we find that ifnphi1 mutant hearts have a modest defect in scar resolution. Collectively, these findings uncover a critical early signaling cascade during the inflammatory response to heart injury and provide new insights into the mechanisms that choreograph zebrafish heart regeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/675164a06e9522cfc2bd5648b36fc42575e714a5" target='_blank'>
              Interferon signaling promotes early neutrophil recruitment after zebrafish heart injury
              </a>
            </td>
          <td>
            Alexis V. Schmid, James A. Gagnon
          </td>
          <td>2025-11-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Background/Objectives: Notwithstanding the declaration by the World Health Organization in May 2023 regarding the conclusion of the COVID-19 pandemic, new cases of this potentially lethal infection continue to be documented globally, exerting a sustained influence on the worldwide economy and social structures. Contemporary SARS-CoV-2 variants, while associated with a reduced propensity for severe acute pathology, retain the capacity to induce long-term post-COVID syndrome, including in ambulatory patient populations. This clinical phenomenon may be attributable to potential autoimmune reactions hypothetically triggered by antiviral antibodies, thereby underscoring the need for developing novel, universal vaccines against COVID-19. The nucleocapsid protein (N), being one of its most conserved and highly immunogenic components of SARS-CoV-2, presents a promising target for such investigative efforts. However, the protective role of anti-N antibodies, generated during natural infection or through immunization with N-based vaccines, alongside the potential adverse effects associated with their production, remains to be fully elucidated. In the present study, we aim to identify potential sites of homology in structures or sequences between the SARS-CoV-2 N protein and human antigens detected using hyperimmune sera against N protein obtained from mice, rabbits, and hamsters. Methods: We employed Western blot analysis of lysates from human cell lines (MCF7, HEK293T, THP-1, CaCo2, Hep2, T98G, A549) coupled with mass spectrometric identification to assess the cross-reactivity of polyclonal and monoclonal antibodies generated against recombinant SARS-CoV-2 N protein with human self-antigens. Results: We showed that anti-N antibodies developed in mice and rabbits exhibit pronounced immunoreactivity towards specific components of the human proteome. In contrast, anti-N immunoglobulins from hamsters showed no non-specific cross-reactivity with either hamster or human proteomic extracts because of the lack of autoreactivity or immunogenicity differences. Subsequent mass spectrometric analysis of the immunoreactive bands identified principal autoantigenic targets, which were predominantly heat shock proteins (including HSP90-beta, HSP70, mitochondrial HSP60, and HSPA8), histones (H2B, H3.1–3), and key metabolic enzymes (G6PD, GP3, PKM, members of the 1st family of aldo-keto reductases). Conclusions: The results obtained herein highlight the differences in the development of anti-N humoral responses in humans and in the Syrian hamster model. These data provide a foundational basis for formulating clinical recommendations to predict possible autoimmune consequences in COVID-19 convalescents and are of critical importance for the rational design of future N protein-based, cross-protective vaccine candidates against novel coronavirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/313d9d3a801fa8c844cca98ae433671df465c85a" target='_blank'>
              Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties
              </a>
            </td>
          <td>
            A. Rak, Y. Zabrodskaya, P. Wong, I. Isakova-Sivak
          </td>
          <td>2025-12-22</td>
          <td>Antibodies</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72f3e3fb83d6da5da12fbd024325e0282875f616" target='_blank'>
              Single-cell analysis identifies monocyte signatures of disease activity and clinical subtypes in Behcet disease
              </a>
            </td>
          <td>
            E. Carmona, R. Deniz, C. Bes, H. Direskeneli, A. Gul, A. H. Sawalha
          </td>
          <td>2025-12-27</td>
          <td>None</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Abstract Background Chronic inflammatory microglia is a key pathological hallmark of Alzheimer's Disease (AD) requiring high metabolic demand. Glucose is a key metabolite vital for microglia responses, and sustained hyperglycaemia is a significant risk for AD development. Understanding how microglia fuel their inflammatory responses is key to understanding how to modulate their behaviour in neurodegenerative diseases. Method Microglia were isolated from APP‐NL‐G‐F mice at different key time points in disease progression (1, 3 and 6 months, n = 4‐6 per time point) and interrogated using mass spectrometry and proteomic analysis. Result Proteomic analysis revealed by microglia massively upregulate their glycolysis machinery at 6 months coinciding with significant increases in inflammatory and disease associated protein expression. Interestingly, expression of glucose receptors were significantly decreased, yet increases in proteins involved in glycogen breakdown were increased. Acute (24hr) depletion of glucose in vitro also had no effect on microglia inflammatory responses to lipopolysaccharide (LPS) and glycolysis was maintained, yet longer (48hr) depletion significantly altered the microglia response. This suggests that microglia rely on glycogen reserves for metabolic flexibility and to fuel their inflammatory responses. Conclusion Microglia utilise their internal stores of glycogen to fuel their inflammatory responses to amyloid (in vivo) and to LPS (in vitro). Glycogen regulated microglia responses may represent a novel therapeutic strategy for targeting microglia inflammation in neurodegenerative diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/84417cd7c664f84a6a592673ab7bf61afa8669b4" target='_blank'>
              Investigating how Microglia Fuel their Immune Responses in Alzheimer's Disease
              </a>
            </td>
          <td>
            Amy F. Lloyd
          </td>
          <td>2025-12-01</td>
          <td>Alzheimer's & Dementia</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic obstructive pulmonary disease, asthma and bronchiectasis. Increasing evidence implicates respiratory viruses as predominant triggers, though the underlying immunopathogenic mechanisms remain poorly understood. Narrative This review synthesises current knowledge on the interplay between viral pathogens at the airway epithelial barrier, including structural and immunological mechanisms that may dysregulate antiviral immunity in chronic respiratory diseases. Furthermore, we discuss how perturbations in the respiratory microbiome, characterised by reduced microbial diversity, can modulate host antiviral immune defences. Conclusions Collectively, these interconnected factors create a permissive environment predisposing to viral infection and exacerbations in chronic respiratory diseases. Understanding the complex interactions between airway structure, interferon-mediated antiviral responses, inflammation and microbiota is essential for developing targeted therapies to effectively manage virus-induced exacerbations and reduce disease burden.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b8c32ceb7bc80ebe41ab7ed5118c911d3d8ae6b4" target='_blank'>
              Mechanisms driving immunopathogenesis of viral exacerbations in chronic respiratory disease
              </a>
            </td>
          <td>
            J. Mckenzie, Charlotte Carter, M. M. Jackson, Aran Singanayagam, Anand Shah
          </td>
          <td>2026-01-02</td>
          <td>Thorax</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Post-translational modifications (PTMs) are crucial chemical alterations occurring on proteins post-synthesis, impacting various cellular processes. During viral infections, PTMs are shown to play a multitude of roles in viral replication, host interaction, and immune evasion. Thus, these modifications can influence infectivity, with direct impact on the anti-viral host immune responses and potentially viral adaptation across species. This field is still scarcely explored, whilst understanding PTMs is not only important to advance the knowledge of virus pathology but also potentially to provide insights for vaccine development. In this review, we attempt to summarize the latest findings mainly published over the last 10 years, focusing on the roles of PTMs involved in virus infection and anti-viral immune responses, in the context of relevant human respiratory infections: influenza A virus (IAV), respiratory syncytial virus (RSV), and SARS-CoV-2. We decided to concentrate on these three viruses because they currently represent a global health problem due to recurrent outbreaks and pandemic potential. A deeper characterization of the PTMs may help in understanding virus–host interaction with possible implications on curative strategies. Further, we will report on cutting-edge technologies to study in vitro virus infection in different cellular-based systems. In particular, we describe and discuss the application of 2D and 3D lung organoid cell-culture systems as in vitro models to mimic respiratory environments and to study the PTMs in a controlled setting. Finally, we will discuss the importance of PTMs in the context of next-generation vaccine design, especially for their potential role to offer effective protection against respiratory viruses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c72b9eede6254de6ff7547a590df16f919d1f6ca" target='_blank'>
              Post-Translational Modifications in Respiratory Virus Infection: Recent Insights into the Development of In Vitro Models
              </a>
            </td>
          <td>
            Emna Ben Khlifa, Alessia Campese, Andrea Corsi, C. Bombieri, Maria Grazia Romanelli, M. Valenti, D. Zipeto, Matteo Castelli, Patricia Marie-Jeanne Lievens, Alessandra Ruggiero
          </td>
          <td>2025-12-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="This review article attempts to provide a unifying hypothesis to explain the myriad of symptoms and predispositions underlying the development of PASC (Postacute Sequelae of COVID), often referred to as Long COVID. The hypothesis described here proposes that Long COVID is best understood as a disorder of persistent immune dysregulation, with chronic macrophage activation representing the fundamental underlying pathophysiology. Unlike transient post-viral syndromes, Long COVID involves a sustained innate immune response, particularly within monocyte-derived macrophages, driven by persistent spike protein (peripherally in MAIT cells and centrally in Microglial cells), epigenetic imprinting, and gut-related viral reservoirs. These macrophages are not merely activated temporarily but also become epigenetically “trained” into a prolonged inflammatory state, as demonstrated by enduring histone acetylation markers such as H3K27acDNA Reprogramming. It is proposed that recognizing macrophage activation as the central axis of Long COVID pathology offers a framework for personalized risk assessment, targeted intervention, and therapeutic recalibration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5b5f2903ed6d3bcbf8e560a451808bb27c9205bb" target='_blank'>
              The Central Role of Macrophages in Long COVID Pathophysiology
              </a>
            </td>
          <td>
            Philip Mcmillan, Anthony J Turner, B. Uhal
          </td>
          <td>2025-12-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Dengue virus (DENV) is a major global health concern, with pathogenesis driven by complex interactions between the virus, host genetics, and immune responses. Key determinants of disease severity include antibody-dependent enhancement (ADE), cross-reactive T cells, anti-NS1 antibodies, autoimmunity, and genetic predisposition, with the NS1 protein and its antibodies strongly implicated in severe dengue. This review highlights recent advances in our understanding of how DENV impacts host immune responses at cellular, molecular, and genetic levels. We particularly focus on how the virus interacts with the host, alters immune responses, and escapes immune detection. These factors are crucial for disease progression and immune dysfunction. The host mounts both innate and adaptive immune responses involving interferon signalling, cytokine production, antigen presentation, and T-cell activation. However, DENV evades immunity by suppressing interferon pathways, disrupting antigen presentation, and leveraging antibody-dependent enhancement (ADE), leading to immune dysregulation, prolonged viremia, and severe dengue. Gaining insight into these host-pathogen interactions is essential for understanding dengue pathogenesis for designing safer and more effective therapeutics. Furthermore, integrating omics approaches with immune response models shows promise for identifying early, reliable markers that can predict disease severity and guide treatment. A deeper understanding of these processes will support the development of personalised treatment strategies and enhance preparedness for future dengue outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bf9b8ef3195ce4f7ad367bf4b707231f5b90da47" target='_blank'>
              Dengue Virus and the Host Immune System: A Battle of Immune Modulation, Response and Evasion
              </a>
            </td>
          <td>
            Anwesha Ghosh, Sudipta Mondal, Soumyodip Sadhukhan, P. Sadhukhan
          </td>
          <td>2025-11-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="This study examined the long-term transcriptomic reprogramming in peripheral blood mononuclear cells (PBMCs) of severe COVID-19 patients and its effects for cancer development. RNA sequencing was conducted on PBMCs obtained from healthy controls, COVID-19 patients without pneumonia, and COVID-19 patients exhibiting severe pneumonia one year post-infection. Differential gene expression analysis identified a sustained pro-oncogenic molecular signature, especially among severe COVID-19 patients. Functional enrichment analysis revealed a substantial enrichment of cancer-associated pathways, encompassing apoptosis, viral carcinogenesis, and transcriptional dysregulation. Notably, the autophagy-related gene SQSTM1/P62 was recognized as a distinctive hub gene within the severe COVID-19 patients, interacting with pivotal genes associated with inflammation, apoptosis, and cancer advancement. Survival analysis demonstrated that elevated expression of COVID-19-associated hub genes correlated with unfavorable prognosis in various cancer types, including adrenocortical carcinoma, bladder urothelial carcinoma, and brain lower-grade glioma. These findings indicate that severe COVID-19 infection may establish a systemic milieu favorable to cancer development or recurrence, highlighting the necessity of prolonged oncological monitoring in these patients. Finding specific molecular targets and pathways can help us understand how COVID-19 might be linked to a higher risk of cancer.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/09c3b7e4ee48aa0d27cd4639fd934da7bf0f81ea" target='_blank'>
              Long-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes
              </a>
            </td>
          <td>
            Pelin Duru Çetinkaya, Ozgecan Kayalar, Vahap Eldem, Serap Argun Barış, N. Kokturk, Selim Can Kuralay, Hadi Rajabi, N. Konyalilar, Deniz Mortazavi, S. Korkunç, S. Erkan, Gizem Tuşe Aksoy, Gul Eyikudamaci, Pelin Pınar Deniz, Oya Baydar Toprak, Pinar Yildiz Gulhan, Gulseren Sagcan, Neslihan Kose Kabil, Ayşegül Tomruk Erdem, F. Fakili, Onder Ozturk, I. Basyigit, H. Boyacı, Emel Azak, Tansu ULUKAVAK ÇİFTÇİ, I. Oguzulgen, H. Ozger, Pınar Aysert Yildiz, Ismail Hanta, O. Ataoglu, M. Erçelik, Ç. Çuhadaroglu, Hacer Kuzu Okur, M. Tor, Esra Nurlu Temel, S. Kul, Y. Tutuncu, O. Itil, Hasan Bayram
          </td>
          <td>2025-12-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Simple Summary Coronaviruses, including severe acute respiratory syndrome coronavirus 2, employ sophisticated strategies to evade the host innate immune system, which serves as the first line of defense against viral infections. These pathogens suppress antiviral responses by encoding proteins that interfere with pattern recognition receptors, inhibit mitochondrial antiviral signaling function, and disrupt interferon (IFN) production and signaling. Key mechanisms include downregulation of major histocompatibility complex class I molecules, conformational shielding of the receptor-binding domain to avoid immune detection, and exploitation of host proteases for viral entry. Additionally, non-structural proteins and accessory proteins (e.g., ORF6, ORF8) antagonize IFN pathways and impede nuclear translocation of immune signaling molecules. Understanding these escape mechanisms is critical for developing broad-spectrum antiviral therapies and vaccines that target conserved viral elements, enhancing our ability to combat coronavirus infections and mitigate future outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80e4a34d0664d51c2f82d8a17236e7f4824f8e83" target='_blank'>
              A Comprehensive View on the Mechanisms of Coronavirus Escaping Innate Immunity
              </a>
            </td>
          <td>
            Yichen Liu, Hao Lu, Jinyuan Li, Yuqing Xie, Gaowei Hu, Shengmei Pang, Siqi Lian, Jiaqi Liu, Guoqiang Zhu, Xueyan Ding
          </td>
          <td>2025-12-01</td>
          <td>Veterinary Sciences</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="ABSTRACT Microglia are the main innate immune cells residing in the brain parenchyma. Their activation and resulting neuroinflammation have emerged as major pathogenic mechanisms in neurodegenerative disorders, particularly in Alzheimer's disease (AD). The accumulation of amyloid‐β oligomers (AβOs) and microglia activation play crucial roles in the pathogenesis of AD. In a second vein, the development of innate immune memory in response to different stimuli is a vital mechanism that enables microglia to adjust their response to subsequent inflammatory challenges. While there is increasing evidence that repeated bouts of peripheral inflammation lead to training or tolerance in microglia, the impact of tolerance on the inflammatory response induced by AβOs remains to be determined. In this study, we investigated whether lipopolysaccharide (LPS)‐induced tolerance affects microglial responses to AβOs. For that, organotypic hippocampal cultures were repeatedly challenged with LPS before being exposed to AβOs. We measured cytokine levels and evaluated changes in microglial activation and morphology following exposure of cultures to AβOs. A significant decrease in cytokine production was observed when hippocampal slice cultures were repeatedly challenged with LPS. Interestingly, microglial activation and the resulting inflammatory response induced by AβOs were prevented when these cultures had been previously challenged with LPS. Moreover, the changes in microglial morphology and cytokine production resulting from repeated LPS stimulation were associated with reduced activation of nuclear factor kappa B (NF‐κB). These results indicate that preconditioning microglia with LPS induces a physiological immune tolerance response rather than pathological inflammation, which may have implications for developing therapeutic strategies for AD aimed at modulating innate immune memory.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f30b28f24e182dd29b261967df3617b845598fe7" target='_blank'>
              Innate Immune Tolerance Regulates Microglia Response to Aβ Oligomers
              </a>
            </td>
          <td>
            Rafaela Rodrigues Valerio, Áquila Rodrigues Costa Santos, Ana Helena Larangeira Nóbrega, Raquel Martins, F. D. De Felice, , Wilson Savino, Adriana Bonomo, Andressa Bernardi, R. Frozza
          </td>
          <td>2026-01-01</td>
          <td>Journal of Neurochemistry</td>
          <td>0</td>
          <td>57</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c98081e2d94c1f8f3d01731f5e992ad893a30f3e" target='_blank'>
              Acute systemic inflammation induces region-specific morphological remodeling of astrocytes and microglia concurrent with depression-like behavior
              </a>
            </td>
          <td>
            An-Qi Zhang, Meng-Meng Zhang, Ling-Jie Li, Mei-Xue Yuan, Rong-Yu Liu, Peng Chen, Chen-Wei Wang, Yu Wang, Jiang Zhou, Qing-Hong Shan, Xinya Qin
          </td>
          <td>2025-11-28</td>
          <td>Histochemistry and Cell Biology</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8b1f851971ca708410ff0c33c84532d4113e8c34" target='_blank'>
              The antiviral Interferon pathway drives astrocyte aging and motor decline
              </a>
            </td>
          <td>
            Lara Labarta-Bajo, Ayesha R. Thanawalla, Irene L Gutierrez, Su May Lei Soe, Brent Y. Chick, Ioanna Andritsogianni, Setareh Metanat, Diana C. Hargreaves, S. Kaech, Eiman Azim, Nicola J. Allen
          </td>
          <td>2025-11-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Early-life infections can produce durable changes in immune function and behavior. We propose a mechanistic hypothesis positioning the mechanistic target of rapamycin (mTOR) as the link between peripheral inflammation and central nervous system dysfunction in pediatric post-infectious syndromes. Based on clinical, translational, and experimental literature, we outline a stepwise pathway. First, sustained mTOR activation skews T-cell and macrophage differentiation toward pro-inflammatory and autoimmune states. Second, endothelial mTOR signaling weakens tight junctions and increases vesicular transport, compromising blood–brain barrier integrity. Third, cytokines and sometimes autoreactive cells enter the brain and engage mTOR in microglia and neurons, driving neuroinflammation, impaired synaptic maintenance and plasticity, and neurotransmitter disruption. This framework accounts for features observed in Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and pediatric acute neuropsychiatry syndrome (PANS/PANDAS) and yields testable predictions on pathway activity and barrier permeability. It also motivates targeted interventions that modulate mTOR-related processes in immune and endothelial compartments and within neural circuits in children. So, this article aims to outline a mechanistic framework linking infection-driven mTOR activation to post-infectious neuropsychiatric syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b2799fce36a305b1d54001a243bb97442880817" target='_blank'>
              Proposed Mechanistic Axis of Infections and mTOR Hyperactivation: A Multidisciplinary Review of Immune, Rheumatologic, and Psychiatric Links
              </a>
            </td>
          <td>
            Giovanni Fronticelli Baldelli, Danilo Buonsenso
          </td>
          <td>2025-11-25</td>
          <td>Children</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Survivors of COVID-19 can experience long-term lung complications (pulmonary sequelae), but the underlying mechanisms remain unclear. While most patients with COVID-19 lung injury eventually recover essentially completely, some experience significant residual damage. To investigate the underlying differences, we analyzed, using bronchoalveolar lavage fluid (BALF), the alveolar immune cell compartments of a group of patients with post-COVID-19 interstitial lung disease (ILD) six months after acute COVID-19. Patients were categorized into two groups, based on High-Resolution Computed Tomography (HRCT) evaluation a year later: those with persistent HRCT abnormalities compatible with fibrosis (persistent post-COVID-19 ILD, n=6) and those with resolved lung lesions (resolved post-COVID-19 ILD, n=13). Additionally, 6 patients with pre-existing ILD were included in the study, after recovery from COVID-19. Bulk RNA transcriptomics analyses of BALF cells revealed innate immunity and inflammation pathways of neutrophil and monocyte chemotaxis to be enriched in patients with persistent HRCT abnormalities post-COVID-19, consistent with an increase in monocyte-like cell recruitment in the lungs. Pro-fibrotic SPP1 gene expression was significantly upregulated similarly to other fibrotic lung diseases. Conversely, patients with resolved post-COVID-19 ILD showed enhanced BALF cell gene expression signatures indicative of adaptive immune response activation. BALF gene expression patterns of low T-cell activation, high pro-fibrotic macrophage activation and neutrophil chemotaxis were similarly observed in patients with pre-existing fibrotic ILD following COVID-19. These findings suggest that immune response imbalance leading to prolonged activation of innate immunity and subdued adaptive immune responses may be associated with persistent post-COVID-19 ILD and the development of pulmonary fibrosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3f0faca69cfb328bb72907f38427c47bebf12818" target='_blank'>
              BALF gene expression profiling reveals a fibrosis associated innate immune activation bias in persistent post-COVID-19 ILD.
              </a>
            </td>
          <td>
            Katerina M Katerina Antoniou, E. Vasarmidi, A. Galaras, M. Lourou, Ioanna Argyriou, D. Zevla, N. Bizymi, C. Skiadas, I. Lambiri, P. Hatzis, V. Aidinis, Nikolaos Tzanakis, A. Wells, E. Tsitoura
          </td>
          <td>2025-11-14</td>
          <td>American journal of physiology. Lung cellular and molecular physiology</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="Despite substantial progress in medical care, acute myocarditis remains a life-threatening disorder with a sudden onset, often unexpectedly complicating a simple and common upper respiratory tract infection. In most cases, myocarditis is triggered by viral infections (over 80%), with an estimated incidence of 10–106 per 100,000 annually. The clinical course may worsen in cases of mixed etiology, where a primary viral infection is complicated by secondary bacterial pathogens, leading to prolonged inflammation and an increased risk of progression to chronic active myocarditis or dilated cardiomyopathy. We present a case report illustrating the clinical problem of acute myocarditis progression into a chronic active form. A central element of host defense is the inflammasome—an intracellular complex that activates pyroptosis and cytokine release (IL-1β, IL-18). While these processes help combat pathogens, their persistent activation may sustain inflammation and trigger heart failure and cardiac fibrosis, eventually leading to dilated cardiomyopathy. In this review, we summarize the current understanding of inflammasome pathways and their dual clinical role in myocarditis: they are essential for controlling acute infection but may become harmful when overactivated, contributing to chronic myocardial injury. Additionally, we discuss both novel and established therapeutic strategies targeting inflammatory and anti-fibrotic mechanisms, including IL-1 receptor blockers (anakinra, canakinumab), NOD-like receptor protein 3 (NLRP3) inhibitors (colchicine, MCC950, dapansutrile, INF200), NF-κB inhibitors, and angiotensin receptor-neprilysin inhibitors (ARNI), as well as microRNAs. Our aim is to emphasize the clinical importance of early identification of patients at risk of transitioning from acute to chronic inflammation, elucidate the role of inflammasomes, and present emerging therapies that may improve outcomes by balancing effective pathogen clearance with limitation of chronic cardiac damage.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/406aee2694b0d02672b6d60a430b3502be128f69" target='_blank'>
              Inflammasomes as Potential Therapeutic Targets to Prevent Chronic Active Viral Myocarditis—Translating Basic Science into Clinical Practice
              </a>
            </td>
          <td>
            N. Przytuła, Jakub Podolec, T. Przewłocki, Piotr Podolec, A. Kabłak-Ziembicka
          </td>
          <td>2025-11-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Type I interferons (IFNs), particularly IFN-α, occupy a central paradox in HIV-1 infection: they provide an essential early antiviral barrier that limits initial dissemination, yet their sustained activation contributes to chronic immune activation, CD4+ T-cell dysfunction, and incomplete viral control. This duality—protective in acute infection but pathogenic during chronic disease—remains a major unresolved challenge for interferon-based therapeutic strategies in HIV-1. Recent advances in ISG functional profiling, IFN-α subtype–specific antiviral potency, and the development of targeted innate-pathway modulators (e.g., STING-selective agonists, ncRNA regulators, TLR7 activators) have renewed interest in reevaluating interferon-centered approaches. These developments make it timely to reassess whether IFN-α can be safely and effectively integrated into modern HIV-1 therapeutic concepts, particularly in early-infection windows or in rationally designed combination regimens. In this review, we synthesize current knowledge of interferon-mediated restriction mechanisms, the hierarchy of key antiviral ISGs (e.g., APOBEC3G, MX2, BST2), and HIV-1 evasion of the JAK–STAT and cGAS–STING pathways. We further analyze how dose, timing, and IFN-α subtype contribute to divergent antiviral versus inflammatory outcomes across different stages of infection. Emerging precision strategies that modulate interferon signaling without triggering systemic inflammation offer promising translational directions. Balancing antiviral efficacy with immune homeostasis will be essential for developing next-generation interferon-based interventions aimed at durable control or functional cure of HIV-1 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8e35155a074d508903b12fc5aa14a89c552c7604" target='_blank'>
              Interferons in HIV-1 infection: mechanisms, antiviral potentials, and therapeutic challenges
              </a>
            </td>
          <td>
            Luying Zhu, Jiahao Ji, Jing Xiao, Fuchun Wang, Jiaqi Yu, Yanmin Liu, Yang Zhang, Hao Wu, Bin Su, Xiaofan Lu, Tong Zhang
          </td>
          <td>2025-12-18</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="COVID-19 has caused millions of deaths worldwide since 2019. Vaccination has reduced both transmission and disease severity. However, emerging viral variants have weakened vaccine effectiveness, highlighting the need for new antiviral therapies. This study examines how the SARS-CoV-2-Spike protein (SARS-2-S) induces the VSIR-ISX signaling pathway, leading to metabolic disturbances that may worsen disease progression. Using RNA sequencing, we found that SARS-2-S expression in pulmonary cells activates genes involved in tryptophan and arachidonic acid (AA) metabolism, altering bioactive mediators like kynurenine and prostanoids, which are crucial for inflammation and immune responses. Mechanistically, the ACE2-MYD88 pathway, activated by SARS-2-S, enhances the VSIR-ISX axis through NF-κB signaling, driving these metabolic disruptions. Chromatin immunoprecipitation and genome sequencing revealed that ISX, activated via VSIR-MAPK signaling, upregulates enzymes involved in AA metabolism by binding directly to their gene promoters. Notably, disrupting the VSIR-ISX axis using shRNA interference or NF-κB inhibitors effectively mitigated these metabolic disturbances. Our findings suggest that the VSIR-ISX pathway could be a promising therapeutic target for treating COVID-19 by addressing virus-induced metabolic disruptions. Graphical Abstract Supplementary Information The online version contains supplementary material available at 10.1007/s10565-025-10119-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1db37c340568fba373a179f1ff4697d0067aea93" target='_blank'>
              Spike protein–induced VSIR–ISX signaling disrupts metabolic homeostasis and promotes COVID-19–related immune dysfunction
              </a>
            </td>
          <td>
            Li-Ting Wang, Shen-Nien Wang, Shyh-Shin Chiou, Chee-Yin Chai, Shih-Hsien Hsu
          </td>
          <td>2025-12-19</td>
          <td>Cell Biology and Toxicology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Tuberculosis (TB) remains a leading infectious cause of morbidity and mortality, and the development of a new, highly effective vaccine would have a tremendous beneficial impact on global health. Although conventional memory CD4 and CD8 T cells will likely be key mediators of long‐lived, vaccine‐elicited protection, a potent T cell–inducing vaccine against TB has been elusive. Protection by Mycobacterium tuberculosis (Mtb)‐specific T cells is mediated primarily through their communication with Mtb‐infected macrophages. Here, we discuss emerging evidence of multiple structural and immunoregulatory factors that limit effective T cell–macrophage interactions in TB granulomas, posing a unique challenge to vaccine‐induced protection. Developing new TB vaccination strategies will require a better understanding of the crosstalk between T cells and infected pulmonary macrophages and strategies to enhance these interactions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e57a70513267b900083d97f9bbbec632105edc5a" target='_blank'>
              T cell–macrophage interactions in tuberculosis: What we've got here is failure to communicate
              </a>
            </td>
          <td>
            R. Mortensen, C. S. Arlehamn, R. Coler, Michael Y Gerner, Delia Goletti, D. Lewinsohn, Robert L Modlin, Munyaradzi Musvosvi, Jyothi Rengarajan, K. Urdahl, G. Walzl, S. Behar, Daniel L Barber
          </td>
          <td>2025-11-22</td>
          <td>Journal of Internal Medicine</td>
          <td>0</td>
          <td>73</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is a major cause of severe respiratory tract infections in infants, older adults, and immunocompromised individuals. Despite decades of research, effective therapies are limited, largely due to an incomplete understanding of how infected cells and immune responses interact to shape disease outcomes. Recent evidence indicates that RSV activates multiple regulated cell death (RCD) programs-including apoptosis, necroptosis, pyroptosis, ferroptosis, and autophagy-associated cell death which interact through shared molecular mediators to form a multimodal cell death (MMCD) network. This integrated system regulates the balance between viral clearance and immunopathological injury. Central mediators such as caspase-8, RIPK3, and NLRP3 act as molecular hubs coordinating these death programs and amplifying inflammatory responses. Understanding how MMCD shapes RSV immunopathogenesis provides a unified framework linking cell death to immune dysfunction. This review summarizes recent progress in elucidating the MMCD network, highlights its role in death-inflammation feedback loops, and discusses potential strategies for therapeutic modulation. Conceptualizing RSV disease through the lens of MMCD may guide the development of precision interventions that restore immune homeostasis while preserving antiviral defense.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e48caf42a43b176c4dbbd30d2ec467dfbc9dd6c6" target='_blank'>
              Multimodal cell death drives the immunopathogenesis of RSV infection
              </a>
            </td>
          <td>
            Tianxiang Yang, Zhizhong Mi, Zhao-Min Li
          </td>
          <td>2025-12-12</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Sepsis remains a Major global health burden, accounting for an estimated 11 million deaths annually, and is characterized by a profoundly dysregulated host immune response to infection. Despite its significant morbidity and mortality, the immunopathogenesis of sepsis—particularly within underrepresented populations—remains inadequately understood. Here we report distinct immunological signatures associated with clinical outcomes among Vietnamese septic patients. To our knowledge, this represents the first comprehensive investigation of both cellular and cytokine immune parameters in the sepsis population. Our findings demonstrate that survivors of sepsis exhibited a higher proportion of circulating B cells, whereas non-survivors showed increased activation of T and natural killer (NK) cells, marked by elevated expression of activation molecules such as CD69 and GITR. There was a notable reduction in B cell numbers, and further phenotypic analysis revealed signs of B cell exhaustion, indicated by increased CD21low expression, as well as depletion of both memory and naïve B cell subsets. Collectively, these results establish compromised humoral immunity in septic patients. T cells in septic patients displayed a skewing toward effector memory phenotypes, and NK cells demonstrated impaired cytotoxic potential, as evidenced by decreased expression of key the key activating receptors including NKG2D and DNAM-1. Concurrent cytokine profiling revealed significantly elevated concentrations of both pro- and anti-inflammatory mediators in septic patients. A significantly diminished percentage of CD8+CD45RA+CD197⁻ T cells, alongside markedly elevated interleukin-6 (IL-6) levels, was observed in non-survivors, strongly supporting their role as key prognostic biomarkers for predicting sepsis-related mortality. Interestingly, tumor necrosis factor-alpha (TNF-α) levels did not significantly differ between those who survived and those who did not, a result that diverges from some prior reports and highlights the possibility of population-specific immunological nuances.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3d9ba93ec66c35e90540391732ef84f8ac8a5d76" target='_blank'>
              Molecular analysis of immune cell subsets and cytokine profiles in septic Vietnamese patients
              </a>
            </td>
          <td>
            Chien Dinh Huynh, Phuong Minh Nguyen, Trung Dinh Ngo, Hung Xuan Nguyen, Tu Dac Nguyen, Hien Thi Mai, Huyen Thi Le, Duy Hoang, Linh Khac Le, Quan Khoi Nguyen, Hoang Viet Nguyen, Keith W. Kelley
          </td>
          <td>2025-12-05</td>
          <td>Clinical and Experimental Medicine</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/74bf1f5c7085b9b7246d1ffcfbc5e550ba379ecf" target='_blank'>
              Microglia and its P2RY12 Receptors Regulate Seizure Severity
              </a>
            </td>
          <td>
            Leigh Ellen Fremuth, Synphane Gibbs-Shelton, Madison Doceti, Aída Oryza Lopez-Ortiz, Abigayle S Duffy, Ronald P. Gaykema, Kiran Singh, Audrey Nguyen, Sophia Cheng, Edward Perez-Reyes, Ukpong B. Eyo
          </td>
          <td>2025-12-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8484ee2588089976dc012a7dda6f35ef3e0a9fe0" target='_blank'>
              Sepsis-associated immunosuppression: mechanistic Insights, Biomarkers, and therapeutic perspectives
              </a>
            </td>
          <td>
            M. Ovalı, Şevval Perçin
          </td>
          <td>2025-12-01</td>
          <td>Molecular Biology Reports</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="The cyclic GMP‐AMP synthase–stimulator of interferon genes (cGAS–STING) pathway has emerged as a critical cytosolic DNA‐sensing mechanism that orchestrates innate immune activation in response to cellular stress. In the central nervous system (CNS), this pathway demonstrates highly context‐specific and cell‐type‐dependent functions, ranging from promoting neuroinflammation in neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), to modulating immune surveillance and therapeutic responsiveness in glioma. This review systematically delineates the molecular mechanisms, activation patterns, and regulatory networks of cGAS–STING signaling in the CNS. We highlight its dualistic roles in both inflammatory exacerbation and antitumor immunity, and further discuss recent advances in therapeutic strategies, including pharmacological modulators, blood–brain barrier (BBB)‐penetrating delivery platforms, and nanotechnology‐based precision interventions. Finally, we propose future directions focused on decoding tissue‐specific immunodynamics and developing spatiotemporally controlled, multiorgan immunoregulatory frameworks. Together, this review underscores cGAS–STING as a promising therapeutic axis in the evolving landscape of neuroimmunology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/548cae93845817793d6f5c0eb23200ba41a6278f" target='_blank'>
              cGAS–STING Signaling in Central Nervous System Diseases: Neuroinflammatory Mechanisms and Immune Regulation
              </a>
            </td>
          <td>
            Wujun Wang, Lijuan Wang, Xintong Zhong, Dong Li, Lingyun Zhang, Jun Hu
          </td>
          <td>2025-12-01</td>
          <td>Cell Biochemistry and Function</td>
          <td>1</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4597d63a4a6f0a5384246a0686fb949396ba9f56" target='_blank'>
              Microbiota-Derived SCFAs in Multiple Sclerosis: From Immune Priming to Neurodegeneration
              </a>
            </td>
          <td>
            Vivek Kumar Sharma
          </td>
          <td>2025-11-12</td>
          <td>Molecular Neurobiology</td>
          <td>1</td>
          <td>1</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a80bbb3790bf37a49652e840f00b66c360bfe299" target='_blank'>
              Monomeric C-reactive Protein Exacerbates Neuronal Injury and Enhances Microglial Activation after Global Cerebral Ischemia in Mice.
              </a>
            </td>
          <td>
            Gaowei Pan, Xiaoling Liu, Xiaoyue Zhang, Hao Gao, Ting Xu, Kemin Li, Lei Wang, Shangrong Ji, Ting Li, Shengxiang Zhang
          </td>
          <td>2025-12-29</td>
          <td>Molecular neurobiology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Acute infection with hepatitis C virus (HCV) is a rare event that can be treated successfully with direct-acting antivirals (DAAs). As Natural killer (NK) cells play an important role during the natural course of acute HCV, we assessed the NK cell compartment via flow cytometry and single-cell sequencing in longitudinally sampled patients with acute HCV and compared this to healthy controls and patients with chronic HCV. At the transcriptomic level, we identified a subset of highly activated NK cells with a robust type-I interferon imprint. While the population of activated NK cells vanished after DAA-mediated cure, a long-term phenotypic imprint of infection was observed in comparison to healthy controls. Collectively, these data suggest an interferon-driven rise of an activated NK cell population during acute hepatitis C, that is largely restored upon viral clearance. This study provides insights into the immunological basis for successful antiviral response to hepatitis C.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a355da8de02329f6d80de7720826866c27b1da02" target='_blank'>
              Transient interferon-driven NK cell activation in acute hepatitis C.
              </a>
            </td>
          <td>
            B. Strunz, Qiuyao Zhan, T. Khera, J. Hengst, Marija Jankovic, K. Deterding, Annika Niehrs, Markus Cornberg, Cheng-Jian Xu, H. Wedemeyer, N. Björkström
          </td>
          <td>2025-12-27</td>
          <td>The Journal of infectious diseases</td>
          <td>0</td>
          <td>52</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/29f76a55277cfc7ac327aabf44366ec7aa5e2076" target='_blank'>
              Single-cell transcriptomic profiling reveals aberrant CD4⁺ naive T cell differentiation driving immune activation in Behçet's uveitis.
              </a>
            </td>
          <td>
            Lu Zhang, Yimeng Sun, Xinyu Yao, Chun Yan, Yunfei Liu, D. Qiao, Ziyu Du, Cong Hu, Fuying Guo, Ziwei Meng, Wei Chi
          </td>
          <td>2025-12-02</td>
          <td>Journal of translational medicine</td>
          <td>0</td>
          <td>5</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2025', '2026'],
    y: [6, 0],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>